class,text
PRESCRIPTION,"Global Multispeciality Hospital  Dr. Lokesh Zanje 49> MBBS MD a Reg. No - M-02312  MD Medicine     Patient Details : Ganesh Chavan, Male / 43 yr, B+ Chief Complaint - Vomiting, Loss of appetite  Diagnosis - Food poisoning Treatment/Advice - Rest and drink fluids  Re  - Tabrol 2mg Stat (Immediately) for 1 Days  - Tab Demisone 0.5mg BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral)  We  Date : 18-May-2021 Signature Page No. 7     Working : Mon,Tue,Wed,Thu,Fri Contact : +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail td : zanjetokesh22@gmail.com  Address : Savarkar bridge Nashik"
PRESCRIPTION,"Patient Details : Tanushri dutt, Female / 19 yr, Ab+ Chief Complaint - Shortness of breath Tiredness  Diagnosis - Iron deficiency anaemia  Re  - Tab Losar 50 OD (Once A Day) for 15 Days , (Route/Form - Oral)  - Tab Enzoflam BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral) Stop if you develop any allergy or loose motion  Be  Date : 18-May-2021 Signature Page No. T     Working : Mon,Tue,Wed,Thu,Fri Contact : +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail (d ; zanjelokesh22@gmail.com  Address : Savarkar bridge Nashik"
PRESCRIPTION,"Deccan Multispeciality Hospital  Dr. Tushar Ghorpade V4 M.B.B.S., MD Reg. No - M-02587  MD medicine  Patient Details : Yogita karape, Female / 36 yr, B+ Chief Complaint - Leg Cramps  Re  - Tab Stugeron Forte BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral)  oe  Date : 08-May-2021 Signature Page No. 1  Working : Mon, Tue,Wed, Thu, Fri Contact : +9173787831 68  Time : 10am - 02pm, 04pm - 07pm  Mail Id : omkaranilmane1998@gmail.com  Address : Deccan chawk Pune"
PRESCRIPTION,"eciality Hospital Dr. Suvarna Garje MBBS MD Reg. No - M-02632 MD Medicine        Patient Details : Komal gaikwad, Female / 36 yr Chief Complaint - Stomach aches  Re  - Tab Albenex 400mg OD (Once A Day) Empty Stomach for 10 Days , (Route/Form - Oral)  Date : 12-May-2021 Signature Page No. 1     Working : Mon,Tue,Wed,Thu,Fri Contact ; +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail td : suvarnagarje1 @gmail.com  Address : shivaji chawk sangli "
PRESCRIPTION,"peciality Hospital Dr. Omkar A Mane BPTH MD Reg. No - M-02587 MD physiotherapy     Patient Details : Nishant Kudale, Male / 36 yr Chief Complaint - Shoulder ache  History - Accident Diagnosis - Shoulder pad dislocation  Re  - Tab Mucobalamin  BD (Twice A Day) After Meal for 10 Days , (Route/Form - Oral) - Syrup AtoZ 200 ml  OD (Once A Day) After Meal for 15 Days , (Route/Form - Oral)     Advice  - X-ray Chest  Date : 08-May-2021 Signature Page No.1  Working : Mon,Tue,Wed, Thu,Fri Contact : +917378783168  Time : 10am - 02pm, 04pm - 07pm Mail [d : omkaranilmane1998@gmail.com Address : Deccan chawk Pune "
PRESCRIPTION,"Deccan Multispeciality Hospital  Dr. Tushar Ghorpade V4 M.B.B.S., MD Reg. No - M-02587  MD medicine  Patient Details : Yogita karape, Female / 36 yr, B+ Chief Complaint - Leg Cramps  Re  - Tab Stugeron Forte BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral)  oe  Date : 08-May-2021 Signature Page No. 1  Working : Mon, Tue,Wed, Thu, Fri Contact : +9173787831 68  Time : 10am - 02pm, 04pm - 07pm  Mail Id : omkaranilmane1998@gmail.com  Address : Deccan chawk Pune "
PRESCRIPTION,"peciality Hospital Dr. Omkar A Mane BPTH MD Reg. No - M-02587 MD physiotherapy     Patient Details : Nishant Kudale, Male / 36 yr Chief Complaint - Shoulder ache  History - Accident Diagnosis - Shoulder pad dislocation  Re  - Tab Mucobalamin  BD (Twice A Day) After Meal for 10 Days , (Route/Form - Oral) - Syrup AtoZ 200 ml  OD (Once A Day) After Meal for 15 Days , (Route/Form - Oral)     Advice  - X-ray Chest  Date : 08-May-2021 Signature Page No.1  Working : Mon,Tue,Wed, Thu,Fri Contact : +917378783168  Time : 10am - 02pm, 04pm - 07pm Mail [d : omkaranilmane1998@gmail.com Address : Deccan chawk Pune "
PRESCRIPTION,"eciality Hospital Dr. Suvarna Garje MBBS MD Reg. No - M-02632 MD Medicine        Patient Details : Vijay salunkhe, Male / 38 yr, At Chief Complaint - Headache Nausea  Diagnosis - Migrain Treatment/Advice - Avoid oily food  Re - Tab Losar 50 OD (Gnce A Day) for 15 Days , (Route/Form - Oral) - Tab Amoxclav 625 BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral)  Date : 12-May-2021 Signature Page No. 7     Working : Mon,Tue,Wed,Thu,Fri Contact : +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail td: suvarnagarje1 @gmail.com  Address : shivaji chawk sangli"
PRESCRIPTION,"eciality Hospital Dr. Suvarna Garje MBBS MD Reg. No - M-02632 MD Medicine        Patient Details : Rajesh Kadam, Male / 12 yr, B+ Chief Complaint - Difficulty in swallowing  Diagnosis - Tonsilittos  Re  ~ Tab Rantac 150 BD (Twice A Day) Before Meal for 5 Days , (Route/Form - Oral)  - Tab Advil OD (Once A Day) After Meal for 3 Days , (Route/Form - Oral)  wt  Date : 12-May-2021 Signature Page No. 1 Working : Mon, Tue,Wed,Thu,Fri Contact : +918855805920  Time : 10am - 02pm, 64pm - 07pm Mail Id ; suvarnagarje1 @gmail.com Address : shivaji chawk sangli "
PRESCRIPTION,"Deccan Multispeciality Hospital  Dr. Tushar Ghorpade  W M.B.B.S., MD Reg. No - M-02587 MD medicine     Patient Details : Karan s more, Male / 28 yr, A+ Chief Complaint - Stomach ache  Diagnosis - Kidney stones  Re  - Betnovate 0.1%  BD (Twice A Day) Anytime Of The Day for 7 Days , (Route/Form - Ointment)  - Hetraoxide DP BD (Twice A Day) for 7 Days  oe  Date : 08-May-2021 Signature Page No. 1 Working : Mon,Tue,Wed, Thu, Fri Contact : +917378783168  Time : 10am - 02pm, 04pm - 07pm Mail td : omkaranilmane1998@gmail.com Address : Deccan chawk Pune "
PRESCRIPTION,"eciality Hospital Dr. Suvarna Garje MBBS MD Reg. No - M-02632 MD Medicine        Patient Details : Hiren chaudhari, Male / 35 yr Chief Complaint - Feeling weak body ache Fever  Diagnosis - Dengue fever  Re  ~ Tab Onlimox-CV 625mg OD (Once A Day) After Meal for 5 Days , (Route/Form - Oral).  - Tab Enzoflam BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral) Stop if you develop any allergy or loose motion  Advice  - Dengue test  Date : 12-May-2021 Signature Page No. 1     Working : Mon,Tue,Wed,Thu,Fri Contact : +918855805920 Time : 10am - 02pm, 64pm - 07pm  Mail Id : suvarnagarjel @gmail.com  Address : shivaji chawk sangli "
PRESCRIPTION,"  eciality Hospital  Dr. Suvarna Garje 49> MBBS MD a Reg. No - M-02632  MD Medicine     Patient Details : Vaishnavi sathe, Male / 17 yr, O- Chief Complaint - Fever Weakness  Diagnosis - Common flu  Re  ~ Tab Moxclav 625 BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral)  - Tab Enzoflam BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral) Stop if you develop any allergy or loose motion  Date : 14-May-2021 Signature Page No. 1     Working : Mon,Tue,Wed,Thu,Fri Contact : +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail Id: suvarnagarjel @gmail.com  Address : shivaji chawk sangli "
PRESCRIPTION,"Deccan Multispeciality Hospital  Dr. Tushar Ghorpade  W M.B.B.S., MD Reg. No - M-02587 MD medicine     Patient Details : Hiren S Deshpande, Male / 34 yr, 0+ Chief Complaint - High irregular fever  Diagnosis - Hay fever  ~ Tab Advil OD (Once A Day) After Meal for 3 Days , (Route/Form - Oral).  - Tabrol 2mg Stat (Immediately) for 1 Days  Advice - Blood sugar level checkup  oe  Date : 08-May-2021 Signature Page No. 1  Working : Mon,Tue,Wed, Thu,Fri Contact : +917378783168  Time : 10am - 02pm, 64pm - 07pm  Mail [d ; omkaranilmane1998@gmail.com  Address : Deccan chawk Pune"
PRESCRIPTION,"eciality Hospital Dr. Suvarna Garje MBBS MD Reg. No - M-02632 MD Medicine        Patient Details : Siddharth lad, Male / 15 yr, B+ Chief Complaint - Cold  Diagnosis - Common cold Treatment/Advice - Drink warm water  - Tab A-COLD PLUS BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral) - Tab Azee DT 200  OD (Once A Day) After Meal for 5 Days , (Route/Form - Oral} Donot exceed the dose more than 5 days  Date : 14-May-2021 Signature Page No. 1  Working : Mon,Tue,Wed, Thu, Fri Contact : +918855805920  Time : 10am - 02pm, G4pm - 07pm  Mail Id : suvarnagarje1 @gmail.com  Address : shivaji chawk sangli "
PRESCRIPTION," Global Multispeciality Hospital  Dr. Lokesh Zanje 49> MBBS MD a Reg. No - M-02312  MD Medicine     Patient Details : Nilesh patil, Male / 24 yr, At Chief Complaint - Headache weakness  Diagnosis - Migraine  Re  ~ Tab Omez 20mg OD (Once A Day) Before Meal for 5 Days , (Route/Form - Oral) Morning empty stomach  ~ Tab Limcee + BD (Twice A Day) After Meal for 10 Days , (Route/Form - Oral)  Ye  Date : 18-May-2021 Signature Page No. 1     Working : Mon,Tue,Wed,Thu,Fri Contact : +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail Id : zanjelokesh22@gmail.com  Address : Savarkar bridge Nashik "
PRESCRIPTION,"eciality Hospital Dr. Suvarna Garje MBBS MD Reg. No - M-02632 MD Medicine        Patient Details : Tanuj kumar, Male / 38 yr, AB+ Chief Complaint - Body ache weakness fever  Diagnosis - Common flu  Re  ~ Tab Crocin pain relief BD (Twice A Day) After Meal for 3 Days , (Route/Form - Oral) Not to exceed more than 3 tablets in a day  - Tab Onlimox-CV 625mg OD (Once A Day) After Meal for 5 Days , (Route/Form - Oral)  Date : 14-May-2021 Signature Page No. 1     Working : Mon,Tue,Wed,Thu,Fri Contact : +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail Id: suvarnagarjel @gmail.com  Address : shivaji chawk sangli "
PRESCRIPTION,"peciality Hospital  Dr. Omkar A Mane BPTH MD  Reg. No - M-02587 MD physiotherapy     Patient Details : Shanta Lokhande, Female / 52 yr, B+ Chief Complaint - Chronic Knee pain  History - Knee joint dislocation Diagnosis - Knee upheal  Re  - Tab Enzoflam BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral) Stop if you develop any allergy or loose motion  - Tab Moxclav 625 BD (Twice A Day) After Meal for 5 Days , (Route/Formi - Oral)  Ca  Date : 08-May-2021 Signature Page No. 1 Working : Mon,Tue,Wed, Thu, Fri Contact : +917378783168  Time : 10am - 02pm, G4pm - 07pm Mail Id : omkaranilmane1998@gmail.com Address : Deccan chawk Pune "
PRESCRIPTION,"Deccan Multispeciality Hospital  Dr. Tushar Ghorpade  W M.B.B.S., MD Reg. No - M-02587 MD medicine     Patient Details : Farhan kadri, Male / 56 yr, AB+ Chief Complaint - Seizure  Diagnosis - Febrile Seizures  Re  ~ Febielt S 5 injection  - Kitmox LD 5, Total Quantity : 10 OD (Once A Day) for 10 Days , (Route/Form - Oral)     Advice  - ANA test  Date : 08-May-2021 Signature Page No. 1  Working : Mon,Tue,Wed, Thu, Fri Contact : +917378783168  Time : 10am - 02pm, 04pm - 07pm Mail Id : omkaranilmane1998@gmail.com Address : Deccan chawk Pune "
PRESCRIPTION,"Global Multispe     ity Hospital  Dr. Lokesh Zanje 49> MBBS MD a Reg. No - M-02312  MD Medicine     Patient Details : Surendra Gawade, Male / 48 yr Chief Complaint - Severe stomach ache, diarrhea  Diagnosis - Acute pancreatitis Treatment/Advice - Drink fluids  Re  - Tab Pen LB 250 mg  - Tab Vertin - OD 48mg  OD (Once A Day) After Meal for 5 Days , (Route/Form - Oral) - Tubloid syrup  OD (Once A Day) Before Meal for 7 Days.  We  Date : 18-May-2021 Signature Page No. 1     Working : Mon,Tue,Wed, Thu, Fri Contact : +918855805920 Time : 10am - 02pm, 04pm - 07pm  Mail Id : zanjelokesh22@gmail.com  Address : Savarkar bridge Nashik. "
PRESCRIPTION,"Deccan Multispeciality Hospital  Dr. Tushar Ghorpade  W M.B.B.S., MD Reg. No - M-02587  MD medicine     Patient Details : Sagar paranjape, Male / 29 yr, sadashiv peth pune Chief Complaint - Breathing problem  Diagnosis - Malnutrition  Re  ~ Tab Stugeron Forte BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral)     - Dec - Dectral 5 mg BD (Twice A Day) for 10 Days , (Route/Form - Oral)  Advice  - Fluid test Date : 08-May-2021 Signature  Page No.1  Working : Mon,Tue,Wed,Thu,Fri Contact : +917378783168  Time : 10am - 02pm, 04pm - 07pm Mail td : omkaranilmane1998@gmail.com Address : Deccan chawk Pune "
PRESCRIPTION,"Deccan Multispeciality Hospital  Dr. Tushar Ghorpade V4 M.B.B.S., MD Reg. No - M-02587  MD medicine  Patient Details : Yogita karape, Female / 36 yr, B+ Chief Complaint - Leg Cramps  Re  - Tab Stugeron Forte BD (Twice A Day) After Meal for 5 Days , (Route/Form - Oral)  oe  Date : 08-May-2021 Signature Page No. 1  Working : Mon, Tue,Wed, Thu, Fri Contact : +9173787831 68  Time : 10am - 02pm, 04pm - 07pm  Mail Id : omkaranilmane1998@gmail.com  Address : Deccan chawk Pune "
PRESCRIPTION,"Dr. Ravindra Bhardwaj Dr. Ravindra Bhardwaj's Clinic  MBBS Reg. No: 2563  General physician Date: Sun, 09 May 2021, 12:31 PM  Id: 2 - Ruturaj Patil (M) / 28 Years        Diagnosis:  * TYPHOID  R  Sr.no. Medicine Dosage Duration  1) TAB. DEFLAZEN 30 MG 1 Morning, 1 Afternoon, 1 Evening, 1 Night 6 DAYS (DEFLAZACORT 30 MG)  2) TAB. CARTIDIN GM 7 DAYS  (DIACEREIN 50 MG, - 50 MG+500 MG)     TAB. CIPLOX-TZ H  3) 3 DAYS (CIPROFLOXACIN 250 MG + TINIDAZOLE 300 MG)     Dr. Ravindra Bhardwaj (MBBS) 2563 Get Well Soon."
PRESCRIPTION,"Dr. Ravindra Bhardwaj  MBBS Reg. No: 2563  General physician  Id: 3 - Arun Gavali (M) / 48 Years Referred By : DR. TUSHAR HINGANE  Complaints: Nausea  Feeling Tired  Diagnosis: * MEASLES  Re Sr.no. Medicine  1) TAB. FEBUCIP 80 (FEBUXOSTAT 80 MG)        2) CAP. DEPLATT CV     Investigations Advised:  ADRENALINE (EPINEPHRINE], PLASMA BY E.I.A  Advice:  * STOP SMOKING AND LIMIT YOUR INTAKE OF ALCOHOL.  Get Well Soon.  (CLOPIDOGREL 75 MG + ATORVASTATIN 10/20 MG + ASPIRIN 75 MG)  Dr. Ravindra Bhardwaj's Clinic  Date: Sun, 09 May 2021, 12:34 PM  Dosage Duration  1.25 Morning, 1.25 Night 7 DAYS  1 Morning, 1 Night 7 DAYS  Dr. Ravindra Bhardwaj (MBBS) 2563"
PRESCRIPTION,"Dr. Ravindra Bhardwaj Dr. Ravindra Bhardwaj's Clinic  MBBS Reg. No: 2563  General physician Date: Sun, 09 May 2021, 12:37 PM  Id: 4 - Drushti Kumbhar (F) / 26 Years Referred By : DR. SRIDHAR PATIL  Complaints:  DIFFICULTY IN SWALLOWING (4 DAYS)     Diagnosis: * TYPHOID R Sr.no. Medicine Dosage Duration 1) TAB. TYROGEF 1 Morning, 1 Night 7 DAYS (GEFITINIB - 250MG) After Lunch     FORACORT 71 MG RESPULES  2 ) (FORMOTEROL FUMARATE 20 MCG + BUDESONIDE RESPIRATOR 1 MG)  1 Morning, 1 Night 7DAYS     Advice: * AVOID OILY AND SPICY FOOD.  Follow-up Date: 16-May-2021  Dr. Ravindra Bhardwaj (MBBS) 2563 Get Well Soon. "
PRESCRIPTION,"Dr. Kshitij Zade Hill Rest  SOLAPUR. MBBS Monday [ 10:00 AM - 02:10 PM ] Tuesday, Wednesday, Thursday [ 11:00 AM - 04:00 PM J Friday, Saturday, Sunday [ Closed ]  Reg. No: 2563  General physician Date: Sun, 09 May 2021, 12:44 PM  Id: 5 - Yogesh Tbhare (M) / 38 Years  Complaints: Short of breath Diagnosis: * BRUCELLOSIS R Sr.no. Medicine Dosage Duration 1) TAB. BRUTACEF-200 1 Morning, 1 Night 7 DAYS (CEFIXIME 200MG) After Food ASTHAFEN SYRUP 1 (Teaspoon) Morning, 1 (Teaspoon) Night 2) 7 DAYS (KETOTIFEN 1 MG/5 ML (60 ML)) After Lunch Advice:  » AVOID CROWDED PLACES.  Dr. Kshitij Zade (MBBS) 2563 Get Well Soon. "
PRESCRIPTION,"Dr. Kshitij Zade Hill Rest  SOLAPUR. MBBS Monday [ 10:00 AM - 02:10 PM ] Tuesday, Wednesday, Thursday [ 11:00 AM - 04:00 PM ] Friday, Saturday, Sunday [ Closed ]  Reg. No: 2563  General physician  Date: Sun, 09 May 2021, 01:03 PM  Id: 7 - Viraj Deshmukh (M) / 48 Years Referred By : DR. Y. PATIL  Complaints:  Pain in Chest Short of breath  Diagnosis: * TUBERCULOSIS  R  Sr.no. Medicine Dosage Duration 1) VOLITRA + GEL 30G TUBE Morning 1 DAYS (DICLOFENAC COMB. - 30 GM)  2) DROXYL INSTA USE (SUSPENSION) 1 (ml) Morning, 1 (ml) Night 7 DAYS (CEFADROXIL 250 MG/5ML (30 ML),)  3) CAP. MEBIZ-SR  1.25 Morning, 71.25 Night 7 DAYS (MEBEVERINE HYDROCHLORIDE IP - 200MG)  Investigations Advised:  BLOOD PRESSURE  Advice: * AVOID CROWDED PLACES. * CONSULT A DOCTOR IF THE FEVER DOES NOT SUBSIDE.  Follow-up Date: 16-May-2021  Dr. Kshitij Zade (MBBS)  2563 Get Well Soon. "
PRESCRIPTION,"Dr. Kshitij Zade  Hill Rest  SOLAPUR.  MBBS Monday [ 10:00 AM - 02:10 PM ] Tuesday, Wednesday, Thursday [ 11:00 AM -  Reg. No: 2563  General physician  04:00 PM ] Friday, Saturday, Sunday [ Closed ]  Date: Sun, 09 May 2021, 12:53 PM  Id: 6 - Gayatri Rajvade (F) / 36 Years Referred By : DR. DHIRAJ S.  Complaints:  Pain in Abdomen  Diagnosis: * DIARRHOEA  R  Sr.no. Medicine  1) ACIVIR 200 DT (DISPERSIBLE TABLET)  (ACICLOVIR 200 MG)  TAB. DICLOGESIC TH  2 ) (DICLOFENAC 50 MG + THIOCOLCHICOSIDE 4/8 MG)  Advice: * AVOID HEAVY AND FRIED FOODS.  Follow-up Date: 23-May-2021  Dosage Duration 1 Morning, 1 Evening, 1 Night 7 DAYS 1 Morning, 1 Evening, 1 Night 7 DAYS  Dr. Kshitij Zade (MBBS) 2563  Get Well Soon. "
PRESCRIPTION,"Ravindra Bhardwaj's Clinic Pe MBBS  Reg. No: 2563  General physician  Date: Thu, 06 May 2021, 09:21 PM UID: 1 - Shraddha Jagtap (M) / 28 Years     Re  Sr.no. Medicine Dosage Duration  1) ADCEF DT 125 MG (DISPERSIBLE TABLET) ADAYS (CEFDINIR 125 MG) After Breakfast  2) ACOSTIN FORTE (INJECTABLE POWDER) ADAYS (COLISTIMETHATE SODIUM - 2 MILLION IU)  Dr. Kshitij Zade (MBBS)  2563 Get Well Soon. "
PRESCRIPTION,"Dr. Kshitij Zade  MBBS Reg. No: 2563     General physician  Id: 8 - Tushar Dande (M) / 34 Years Referred By : DR.MALI  Complaints:  FEELING FEVERISH (3 DAYS)  Diagnosis: * FEVER WITH CHILLS  R  Sr. no.  1) CEFBACT T INJECTION 1G (CEFTRIAXONE 1G + TAZOBACTAM 125 MG)  TAB. | - VIT TAB  Medicine  2) {ASTAXANTHIN 2MG + VITAMIN A 5000 IU+ VITAMIN C 75 MG + VITAMIN E 25 IU+ ZINC 40 MG+ COPPER 2 MG+ SELENIUM 40 MCG+ CHROMIUM 80 MCG)  Advice:  Hill Rest  SOLAPUR. Monday [ 10:00 AM - 02:10 PM ] Tuesday, Wednesday, Thursday [ 11:00 AM - 04:00 PM ] Friday, Saturday, Sunday [ Closed ]  Date: Tue, 11 May 2021, 11:52 AM  Dosage Duration 1 DAYS  1 Morning,  TNight 3 DAYS  * DRINK LOTS OF FLUIDS TO PREVENT DEHYDRATION.  Dr. Kshitij Zade (MBBS) 2563 Get Well Soon. "
PRESCRIPTION,"General physician  Id: 9 - Rajesh Gadkari (M) / 29 Years Complaints:  HEADACHE (2 DAYS)  Diagnosis: * FILARIASIS  R  Sr. Medicine  1) CEFADUR 125 DT (DISPERSIBLE TABLET) (CEFADROXIL 125 MG)  URIKIND-KM SACHET (POWDER) 2) (EACH 5GM: CRANBERRY EXTRACT 200MG + D-MANNOSE 300MG + POTASSIUM MAGNESIUM CITRATE 978MG)  Follow-up Date: 18-May-2021  Get Well Soon.  Hill Rest  SOLAPUR.  MBBS Monday [ 10:00 AM - 02:10 PM ] Tuesday, Wednesday, Thursday [ 11:00 AM -  04:00 PM ] Friday, Saturday, Sunday [ Closed ]  Date: Tue, 11 May 2021, 11:58 AM  Dosage  1 Morning, 1 Afternoon, 1 Night  1 (Teaspoon) Morning, 1 (Teaspoon) Night  Duration  7 DAYS  7 DAYS  Dr. Kshitij Zade  (MBBS) 2563 "
PRESCRIPTION,"Siddhivanayak Multispeciality Clinic  Dr. Bhavesh Jain Gadave chawk, NANDED. Monday, Tuesday, Wednesday, Thursday, Friday [ 10:00 PM - 02:00 PM, 03:00 —_~ MBBS PM - 06:00 PM | Saturday, Sunday [ Closed ]  Reg. No: M-2559 General physician Date: Tue, 11 May 2021  Id: 11 - Harshita Kamble (F) / 35 Years Referred By : DR. DR SWATI  Complaints:  NAUSEA (3 DAYS)  Diagnosis: * AMOEBIASIS R Sr.no. Medicine Dosage Duration 1) TAB. AMAZEO 100 MG 1 Morning, 1 Night 7 DAYS (AMISULPRIDE 100 MG)  INJECTION DARBESURE 40MG  2 ) (DARBEPOETIN ALFA - 40 MCG)  1 ml Morning, 1 ml Night 3 DAYS Advice:  * EAT A VARIETY OF PROTEIN RICH FOODS LIKE FISH, BEANS, PEAS, NUTS AND SEEDS.  aie  Dr. Bhavesh Jain (MBBS) M-2559 Wish you a speedy recovery"
PRESCRIPTION,"Siddhivanayak Multispeciality Clinic  Gadave chawk, NANDED.  Dr. Bhavesh Jain ; Monday, Tuesday, Wednesday, Thursday, Friday [ 10:00 PM - 02:00 PM, 03:00 MBBS PM - 06:00 PM | Saturday, Sunday [ Closed ]  Reg. No: M-2559  General physician  Id: 12 - Vishwas Rawat (M) / 56 Years Complaints:  FEELING WEAK (2 DAYS) Diagnosis: * COMMON COLD  R  Sr. no.  Medicine     DARBATITOR 25 MCG (PRE-FILLED  Date: Tue, 11 May 2021  Dosage Duration  1 ml Morning, 1 ml     1) SYRINGE) Night 3 DAYS (DARBEPOETIN ALFA 25MCG) ASTHAKIND EXP (SYRUP) :  2) (GUAIPHENESIN 50 MG + TERBUTALINE 1.25MG + 1 (ml) Morning, 1 (ml) 3 DAYS  BROMHEXINE2MG / 5ML)     Investigations Advised:  BLOOD PRESSURE  Night  Ba  Dr. Bhavesh Jain (MBBS) M-2559  Wish you a speedy recovery "
PRESCRIPTION,"Clinic  Gadave chawk, NANDED.  Dr. Bhavesh Jain ; Monday, Tuesday, Wednesday, Thursday, Friday [ 10:00 PM - 02:00 PM, 03:00 MBBS PM - 06:00 PM | Saturday, Sunday [ Closed ]  Reg. No: M-2559  General physician  Id: 13 - Sunil S Patil (M) / 56 Years Referred By : DR. MAHAJAN  Complaints:  Nausea Short of breath  Diagnosis: * TUBERCULOSIS  R Sr.no. Medicine  1) CAP. CALCIGARD 5 MG (NIFEDIPINE 5MG)  Date: Wed, 12 May 2021  Dosage Duration  1 Morning, 1 Night 7 DAYS     TAB. TUFPRO  2 ) (BACILLUS CLAUSII SPORES - 5ML X10 BOTTLES)  Investigations Advised:  BLOOD PRESSURE  Follow-up Date: 19-May-2021  1 Morning, 1 Night 7 DAYS  ain  Dr. Bhavesh Jain (MBBS) M-2559  Wish you a speedy recovery "
PRESCRIPTION," Dr. Bhavesh Jain iii MBBS  Reg. No: M-2559  General physician  Id: 15 - Neerav Kumar (M) / 28 Years Referred By : DR. DR NILAM  Complaints:  Feeling Weak Nausea  Diagnosis: * CHOLERA  R Sr. no. Medicine  1) TAB. HISTAFREE-180 (FEXOFENADINE 180 MG)  Siddhivanayak Multispeciality Clinic  Gadave chawk, NANDED. Monday, Tuesday, Wednesday, Thursday, Friday [ 10:00 PM - 02:00 PM, 03:00 PM - 06:00 PM | Saturday, Sunday [ Closed ]  Date: Fri, 14 May 2021  Dosage Duration  1 Morning, 1 Night 7 DAYS     TAB. REBOSE-25  2) (ACARBOSE - 25MG)  Investigations Advised:  BLOOD PRESSURE  Follow-up Date: 21-May-2021  1 Morning, 1 Night 7 DAYS  aie  Dr. Bhavesh Jain (MBBS) M-2559  Wish you a speedy recovery "
PRESCRIPTION,"Siddhivanayak Multispeciality Clinic  Dr. Bhavesh Jain Gadave chawk, NANDED. Monday, Tuesday, Wednesday, Thursday, Friday [ 10:00 PM - 02:00 PM, 03:00 —_~ MBBS PM - 06:00 PM | Saturday, Sunday [ Closed ]  Reg. No: M-2559  General physician Date: Fri, 14 May 2021  Id: 16 - Firoj Khan (M) / 58 Years Referred By : DR. FAIZAL  Complaints:  Pain in Chest Feeling Weak  Re Sr.no. Medicine Dosage Duration  1) TAB. TERBINAFORCE TAB (TERBINAFINE 250 MG)  TAB. HEXIDOL 5 MG (HALOPERIDOL 5 MG)     1 Morning, 1 Afternoon, 1 Night 7 DAYS  2) 1 Night 7 DAYS  Investigations Advised:  BLOOD PRESSURE  Advice: * AVOID CROWDED PLACES.  ain  Dr. Bhavesh Jain (MBBS) M-2559 Wish you a speedy recovery"
PRESCRIPTION,"Siddhivanayak Multispeciality Clinic 4» Dr. Bhavesh Jain ¥ pecs  a Gadave chawk, NANDED. Monday, Tuesday, Wednesday, Thursday, Friday [ 10:00 PM - 02:00 PM, 03:00 MBBS  —_ PM - 06:00 PM | Saturday, Sunday [ Closed ] Reg. No: M-2559  General physician  Date: Sat, 15 May 2021 Id: 17 - Dharmesh Jadhav (M) / 37 Years Complaints:  Feeling Feverish  Cold Diagnosis: * COMMON COLD R Sr.no. Medicine Dosage Duration 1) TAB. ADFOVIR 1 Morning, 1 Afternoon, 1 Night 4 DAYS (ADEFOVIR DIPIVOXIL - 10MG) Advice:  * CONSULT A DOCTOR IF THE FEVER DOES NOT SUBSIDE. Follow-up Date: 20-May-2021  Ske  Dr. Bhavesh Jain (MBBS) M-2559 Wish you a speedy recovery "
PRESCRIPTION,"Dr. Ravindra Bhardwaj's Clinic  “yy Dr. Bhavesh Jain ist MBBS  Reg. No: M-2559  General physician  Date: Sat, 15 May 2021  Id: 18 - Neerav Wankhede (M) / 29 Years Complaints:  Feeling Weak  R  Sr. no. Medicine Dosage Duration  1) FEVAGO SUSPENSION (PARACETAMOL 120 MG / 5 ML)  TAB. TECHLOR 40 (TELMISARTAN 40 MG + CHLORTHALIDONE 12.5 MG)     1 (ml) Morning, 1 (ml) Night 7 DAYS  2) 1 Morning, 1 Night 7 DAYS  Advice: * TAKE COMPLETE BED REST.  Ske  Dr. Bhavesh Jain (MBBS) M-2559 Wish you a speedy recovery "
PRESCRIPTION,"Hill Rest  Dr. Bhavesh Jain SOLAPUR. Monday [ 10:00 AM - 02:10 PM ] Tuesday, Wednesday, Thursday [ 11:00 AM - = MBBS 04:00 PM ] Friday, Saturday, Sunday [ Closed ]  Reg. No: M-2559  General physician Date: Tue, 18 May 2021  Id: 19 - Vivek Rao (M) / 38 Years Referred By : DR. DR VARUN K  Complaints:  Feeling Feverish  Diagnosis: * INFLUENZA R  Sr.no. Medicine Dosage Duration  1) ADVENT I.V. 1.2 G INJECTION (VIAL) (AMOXYCILLIN SODIUM 1000 MG + CLAVULANIC ACID 200 MG)  TAB. FELIZ-S 10 MG (ESCITALOPRAM 10 MG)     1 ml Morning 1 DAYS     2) 1 Morning, 1 Night 3 DAYS  Advice: * CONSULT A DOCTOR IF THE FEVER DOES NOT SUBSIDE.  Ske  Dr. Bhavesh Jain (MBBS) M-2559 Wish you a speedy recovery "
PRESCRIPTION,"Seven Hills Hospital Dr. Vivek Sutar Pp  seven hills, west mumbai 400018, MUMBAI.  Phone : 9548652121 MBBS Monday, Tuesday, Wednesday, Thursday, Friday [ 09:00 AM - 01:00 PM, 03:00  Reg. No: M-2538 PM - 06:00 PM | Saturday, Sunday [ Closed ] General physician  Date: Tue, 18 May 2021 Id: 20 - Mohit Salunkhe (M) / 27 Years Complaints:  Feeling Tired Cold  Diagnosis: * COMMON COLD  R  Sr.no. Medicine Dosage Duration  1) TAB. STANLIP 145 MG 1 Morning,1 Night 7DAYS (FENOFIBRATE - 145MG)  TAB. BETACARD H  2 ) (ATENOLOL 50 MG + HYDROCHLORTHIAZIDE 2.5 MG)  1 Morning, 1 Night 7DAYS  Follow-up Date: 25-May-2021  Ae  Dr. Vivek Sutar (MBBS) M-2538 Wish you a speedy recovery _x000c_"
PRESCRIPTION," Seven Hills Hospital Dr. Vivek Sutar Pp seven hills, west mumbai 400018, MUMBAI. Phone : 9548652121 MBBS Monday, Tuesday, Wednesday, Thursday, Friday [ 09:00 AM - 01:00 PM, 03:00  Reg. No: M-2538  General physician  Id: 21 - Hiren Dhar (M) / 42 Years Complaints:  Pain in Chest Short of breath  Diagnosis: * HEART PROBLEM  R Sr.no. Medicine  1) TAB. TECHLOR 80 (TELMISARTAN 80 MG + CHLORTHALIDONE 12.5 MG)  2) TAB. RESPIDON 2 MG (RISPERIDONE 2 MG)  Advice:  * AVOID HEAVY AND FRIED FOODS.  Follow-up Date: 25-May-2021  PM - 06:00 PM | Saturday, Sunday [ Closed ]  Date: Tue, 18 May 2021  Dosage Duration  1 Morning, 1 Night 7 DAYS  1 Morning, 1 Night 7 DAYS  Ba  Dr. Vivek Sutar (MBBS) M-2538  Wish you a speedy recovery"
PRESCRIPTION,"Seven Hills Hospital Dr. Vivek Sutar Pp  seven hills, west mumbai 400018, MUMBAI. Phone : 9548652121 MBBS Monday, Tuesday, Wednesday, Thursday, Friday [ 09:00 AM - 01:00 PM, 03:00  Reg No: M-2538 PM - 06:00 PM | Saturday, Sunday [ Closed ] General physician Date: Tue, 18 May 2021 UID: 22 - Rohit Paranjape (M) / 29 Years Complaints:  Pain in Abdomen     Diagnosis: * DIARRHOEA R Sr. no. Medicine Dosage Duration 1) CAP. KELFER-S00 1 Morning, 1 Night 7 DAYS (DEFERIPRONE 500 MG) 2) TAB. SELZIC 600 MG 1 Morning, 1 Night 7 DAYS (OXCARBAZEPINE - 600 MG) Advice:  * AVOID HEAVY AND FRIED FOODS.  eae  Dr. Vivek Sutar (MBBS) M-2538 Wish you a speedy recovery "
REPORT,"PROCESSED AT:  Thyrocare Thyrocare’  103, Kanakia - 8. Zillion building,  Ibs marg, kurla (w), Think Thyroid. Think Thyrocare. Mumbai - 400 070  Corporate Office : Thyrocare Technologies Limited  D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703 © 022 - 3090 0000 / 4125 2525 © 8691866066 Ei wellness@thyrocare.com @www.thyrocare.com        REPORT NAME 3 MANJU SHAH KALSHETTI(40Y/F) SAMPLE COLLECTED AT : REF. BY 2 SELF Bar NO 103 C WING GANESHAM PHASE 1 PIMPRE TEST ASKED == HEMOGRAM - 6 PART (DIFF),HBA. TEST NAME TECHNOLOGY VALUE UNITS HbA1c - (HPLC - NGSP Certified) HbAic H.P.LC 5.9 % Reference Range :  Below 6.0% - Normal Value  6.0% - 7.0% - Good Control  7.0% - 8.0% - Falr Control  8.0% - 10% - Unsatisfactory Control  Above 10% - Poor Control  Method : Fully Automated H.P.L.C. using Blorad Variant IT Turbo, NGSP Certified.     AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl Reference Range: 90 - 120 mg/dl : Excellent Control  121 - 150 mg/dl jo0d Control      151 - 180 mg/dl erage Control 181 - 210 mg/dl : Action Suggested > 211 mg/dl : Panic Value  (Note: Average Blood Glucose value Is calculated from HBA1c value and it indicates Average Blood Sugar level over past three months.) Method : Derived from HBAic values  Please correlate with clinical conditions.        Sample Collected on (SCT) 113 Feb 2018 08:58  Sample Received on (SRT) £13 Feb 2018 22:44 Gull be  Report Released on (RRT) —: 14 Feb 2018 06:13 ra a Sample Type TEDTA Dr.Prachi Sinkar MD Dr.Caesar Sengupta MD Labcode 1 130239067/8T005 Page :10f8  Barcode 2G8525450 "
REPORT,"PROCESSED AT:  ‘iyrecere Thyrocare’  103, Kanakia - 8. Zillion building, Ibs marg, kurla (w), Think Thyroid. Think Thyrocare.  Mumbai. ann n7n  Corporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703  © 022 - 3090 0000 / 4125 2525 © 8691866066 i wellness@thyrocare.com @www.thyrocare.com REPORT  NAME : MANJU SHAH KALSHETTI(40Y/F) SAMPLE COLLECTED AT : REF. BY : SELF FLAT NO 103 C WING GANESHAM PHASE 1 PIMPRI SWADGARA  TEST ASKED : HEMOGRAM - 6 PART (DIFF),HBA        TEST NAME VALUE UNITS REFERENCE RANGE TOTAL LEUCOCYTES COUNT 7.86 X102/pL 4.0-10.0 NEUTROPHILS 52.3 % 40-80 LYMPHOCYTE PERCENTAGE 37 ‘% 20.0-40.0 MONOCYTES 34 % 0.0-10.0 EOSINOPHILS 7.3 % 0.0-6.0 BASOPHILS 0.2 % <2 IMMATURE GRANULOCYTE PERCENTAGE(IG%) 0.1 % 00-04 NEUTROPHILS - ABSOLUTE COUNT 4.13 X103/pL  2.0-7.0 LYMPHOCYTES - ABSOLUTE COUNT 2.91 X103/pL 1.03.0 MONOCYTES - ABSOLUTE COUNT 0.24 X102f/pL 021.0 BASOPHILS - ABSOLUTE COUNT 0.02 X103/ pL  0.02-0.1 EOSINOPHILS - ABSOLUTE COUNT 0.57 X 102 / pL 0.02-0.5 IMMATURE GRANULOCYTES(IG) 0.01 X10? /uL 0.0-0.3 TOTAL RBC 441 X10°6/uL_ 3.9-4.8 NUCLEATED RED BLOOD CELLS Nil X103/pL  <0.01 NUCLEATED RED BLOOD CELLS % Nil % 0.01 HEMOGLOBIN 13.2 afd 12.0-15.0 HEMATOCRIT(PCV) 42.9 % 36.0-46.0 MEAN CORPUSCULAR VOLUME(MCV} 97.3 fl 83.0-101.0 MEAN CORPUSCULAR HEMOGLOBIN(MCH) 29.9 pa 27.0-32.0 MEAN CORP.HEMO.CONC(MCHC) 30.8 a/di 315-345 RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) 48.8 5 39.0-46.0 RED CELL DISTRIBUTION WIDTH (ROW-CV) 13.6 % 11.6-14.0 PLATELET DISTRIBUTION WIDTH(PDW) 11.6 fi 9.6-15.2 MEAN PLATELET VOLUME(MPV) 10.4 fl 65-12 PLATELET COUNT 354 X103/ pL 150-400 PLATELET TO LARGE CELL RATIO(PLCR) 27.3 % 19.7-42.4 PLATELETCRIT(PCT) 0.37 % 0.19-0,39     Please Correlate with clinical conditions.  Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)  (This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Mathod (using a semiconductor laser), and SLS- hemoglobin method)  Sample Collected on (SCT) 213 Feb 2018 08:58  Sample Received on (SRT) 213 Feb 2018 22:44 ule  Report Released on (RRT) 214 Feb 2018 06:13 a“ =  Sample Type : EDTA  Labeode 130239067/BTOO5 Dr.Prachi Sinkar MD. Dr.Caesar Sengupta MD Page : 2 of 8      Barcode  G8525450 "
REPORT,"PROCESSED AT:  Thyrocare  103, Kanakia - 8. Zillion building, Ibs marg, kurla (w),  Mumbai - 400 070  Thyrocare’  Think Thyroid. Think Thyrocare,  ~ Corporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIOC, Turbhe, Navi Mumbai - 400703 © 022 - 3090 0000 / 4125 2525 @ 8691866066 MB wellness@thyrocare.com —®www:thyracare.com  PORT     NAME + MANJU SHAH KALSHETTI(40¥/F) SAMPLE COLLECTED AT :  REF. BY TEST ASKED  SELF SWADGARA AAROGYAM 1.2  FLAT NO 103 C WING GANESHAM PHASE 1 PIMPRI  UNITS  TEST NAME TECHNOLOGY VALUE  IRON PHOTOMETRY 69.29 Reference Rang Male : 65 - 175 Female : 50 - 170  Method : FERROZINE METHOD WITHOUT DEPROTEINIZATION      uo/dl     TOTAL IRON BINDING CAPACITY (TIBC}) = PHOTOMETRY 317.42 Reference Rang  Male: 225 - 535 g/dl Female: 215 - 535 po/dl Method :SPECTROPHOTOMETRIC ASSAY        tg/dl  % TRANSFERRIN SATURATION CALCULATED 21.83  Reference Range :  13 - 45  Method : DERIVED FROM IRON AND TIBC VALUES Please correlate with clinical conditions.        Sample Collected on (SCT) 113 Feb 2018 08:58  Sample Received on (SRT) 313 Feb 2018 22:44 Guill oe Report Released on (RRT) —_— 14 Feb 2018 02:34 rn Sample Type +SERUM Dr.Prachi Sinkar MD Labcode + 130239022/8T00S  Barcode 2G8472631  Dr.Caesar Sengupta MD Page : 30f 8    _x000c_"
REPORT,"   PROCESSED AT:  tno Thyrocare’  103, Kanakia - B. Zillion building,  lbs marg, kurla (w), Think Thyroid. Think Thyrocare. Mumbai - 400 070  ~ Corporate Office : Thyrocare Technologies Limited % D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703  © 022 - 3090. 0000 / 4125 2525 © 8691866066 Ei wellness@thyrocare.com www.thyrocare.com REPORT  NAME MANJU SHAH KALSHETTI(40Y/F) SAMPLE COLLECTED AT : REF. BY SELF FLAT NO 103 C WING GANESHAM PHASE 1 PIMPRI SWADGARA  TEST ASKED =: AAROGYAM 1.2         TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE ALKALINE PHOSPHATASE PHOTOMETRY 103.59 ust BILIRUBIN -DIRECT PHOTOMETRY 0.13 mo/dl BILIRUBIN - TOTAL PHOTOMETRY 0.42 mo/dl BILIRUBIN (INDIRECT) CALCULATED 0.29 mo/dl GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 36.23 uf ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 21.86 uf ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 18.82 uf PROTEIN - TOTAL PHOTOMETRY 7.65 arm/dl ALBUMIN - SERUM PHOTOMETRY 4.3 qroj/dl SERUM GLOBULIN PHOTOMETRY 3.35 qm/dl SERUM ALB/GLOBULIN RATIO CALCULATED 1.28 Ratlo     Please correlate with clinical conditions.  Method:  ALKP - Modified IFCC method  BILD - Vanadate Oxidation  BILT - Vanadate Oxidation  BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES GGT - Modified IFCC method  SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION PROT - BIURET METHOD  SALB - ALBUMIN BCG?METHOD (COLORIMETRIC ASSAY ENDPOINT) SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES.  Sample Collected on (SCT) 2:13 Feb 2018 08:58 Sample Received on (SRT) 2 13 Feb 2018 2:     dey     Report Released on (RRT) —: 14 Feb 2018 02: Sample Type + SERUM Dr.Prachi Sinkar MD Dr.Caesar Sengupta MD Labcode 2 130239022/BT005  Page : 4 of 8  Barcode = G8472631 "
REPORT,"Thyrecar” ttn bullding, Thyra care’  Ibs marg, kurla (w), Think Thyroid. Think Thyrocare, Mumbai - 400 070 void  ~ Corporate Office : Thyrocare Technologies Limited 9 0-37/3, TTC MIDC, Turbhe, Navi Mumbal - 400703 Y andl  © 022 - 30900000 / 4125 2525 8691866066 HA weliness@thyrocare.com @®www.thyrocare.com REPORT     NAME + MANJU SHAH KALSHETTI(40¥/F) SAMPLE COLLECTED AT :  REF. BY + SELF FLAT NO 103 C WING GANESHAM PHASE 1 PIMPRI SWADGARA TEST ASKED =: AAROGYAM 1.2  TEST NAME TECHNOLOGY VALUE UNITS = NORMAL RANGE TOTAL CHOLESTEROL PHOTOMETRY 255, mg/dl 125-200  HDL CHOLESTEROL - DIRECT PHOTOMETRY 47 ma/dl 35-80  LDL CHOLESTEROL - DIRECT PHOTOMETRY = 175 mg/dl 85-130 TRIGLYCERIDES PHOTOMETRY 151 ma/dl 25-200  TC/ HOL CHOLESTEROL RATIO CALCULATED 5.4 Ratio 3-5  LDL / HDL RATIO CALCULATED 3.7 Ratio 1,5-3.5  VLOL CHOLESTEROL CALCULATED 30.1 ma/dl 5 - 40  NON-HDL CHOLESTEROL CALCULATED mg/dl < 160       Please correlate with clinical conditions.  Method:  CHOL - CHOD POD METHOD  HCHO - ENZYME SELECTIVE PROTECTION METHOD.  LDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY  TRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING] TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES.  LDL - Derived from serum HDL and LDL Values  VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES  NHDL - Derived from serum Cholesterol and HDL values  “REFERENCE RAI     AS PER NCEP ATP III GUIDELINES:        TOTAL CHOLESTEROL (mg/dl) MDL __(mp/dl) “LDL ====~=C((mnp/dl)«—“WRIGLYCERIDES (mg/dl) _ DESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150 GORDERLINE HIGH 200-239 0 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199 HIGH >2a0 BORDERLINE HIGH 130-159 HIGH 200-499  HIGH 160-189 VERY HIGH >500 VERY HIGH >190  Alert Itl 10-12 hours fasting is mandatory for lipid parameters. if not, values might fluctuate.     Sample Collected on (SCT) 13 Feb 2018 08:58 Sample Received on (SRT)  213 Feb 2018 22:44 Report Released on (RRT) 14 Feb 2018 02:34 3  Sample Type SERUM Dr.Prachi Sinkar MD Dr.Caesar Sengupta MD Labcode + 130239022/8T005 sors Barcode 1 G8472631 age: "
REPORT," Thyrecare” ""ater bullding, Thyro care’  Ibs marg, kurla (w), Think Thyroid. Think Thyrocare, Mumbai - 400 070  ~ Corporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbal - 400703  © 022 - 30900000 / 4125 2525 © 8691866066 EA weliness@thyrocare.com @www.thyrocare.com eel        NAME s MANJU SHAH KALSHETTI(40Y/F) SAMPLE COLLECTED AT :  REF. BY 1: SELF FLAT NO 103 C WING GANESHAM PHASE 1 PIMPRI SWADGARA TEST ASKED =: AAROGYAM 1.2  TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE  BLOOD UREA NITROGEN (BUN) PHOTOMETRY 7.02 mo/dl 7-25  CREATININE - SERUM PHOTOMETRY 0.71 mo/dl 0.5-0.8  URIC ACID PHOTOMETRY 5.72 mo/dl 3.1-7.8  CALCIUM PHOTOMETRY 9.66 mo/dl 8.8-10.6  BUN / SR.CREATININE RATIO CALCULATED. 9.89 Ratio 9:1-23:1  Please correlate with clinical conditions.  Method:  BUN - KINETIC UV ASSAY.  SCRE - CREATININE ENZYMATIC METHOD  URIC - Uricase / Peroxidase Method  CALC - ARSENAZO III METHOD, END POINT.  B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES  Sample Collected on (SCT) Sample Received on (SRT) Report Released on (RRT)  13 Feb 2018 08:58  13 Feb 2018 22:44 14 Feb 2018 02:34 (ye Z  Sample Type SERUM Dr.Prachi Sinkar MO- Or.Caesar Sengupta MD Labcode + 130239022/BT00S ‘ects Barcode s G8472631 ge: "
REPORT,"PROCESSED AT:  rryrecae Thyrocare’  103, Kanakia - B. Zillion building, . . . Ibs marg, kurla (w), Think Thyroid. Think Thyrocare, Mumbai - 400 070  Corporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbal - 400703  © 022 - 30900000 / 4125 2525 2691866066 wellness@thyrocal im Bwew.thyrocare.com REPORT     NAME + MANU SHAH KALSHETTI(40Y/F) SAMPLE COLLECTED AT : 5  REF. BY 1 SELF FLAT NO 103 C WING GANESHAM PHASE 2 PIMPRI SWADGARA TEST ASKED + AAROGYAM 1.2  TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE  TOTAL TRIIODOTHYRONINE (T3) CLLA 126 ng/dl = 60-200  TOTAL THYROXINE (74) CLLA 8.8 vo/dl = 4.5-12  THYROID STIMULATING HORMONE (TSH) CLLA 1.77 plu/ml 0.3-5.5     Comments: SUGGESTING THYRONORMALCY Please correlate with clinical conditions.  Mathod :  T3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY  T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY  TSH - ULTRA SENSITIVE SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY Pregnancy reference ranges for TSH  Ast Trimester : 0.10 - 2.50  2nd Trimester : 0.20 - 3.00  3rd Trimester : 0.30 - 3.00  Reference: Guidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum, Thyroid, 2011, 21; 1-46  Sample Collected on (SCT) 2 13 Feb 2018 08:58 Sample Received on (SRT) 2 13 Feb 2018 22:44 Guill ne Report Released on (RRT) 2 14 Feb 2018 02:34 ra - Sample Type : SERUM 7  Dr.Prachi Sinkar MD Dr.Caesar Sengupta MD Labcode 2 130239022/BT005 Page : 7 of 8  Barcode : GB472631 "
REPORT,"PROCESSED AT:  Thyrocare Thyrocare’  103, Kanakia - B. Zillion building,  Ibs marg, kurla (w), Think Thyroid. Think Thyrocare, Mumbai - 400 070  ~ Corporate Office : Thyrocare Tachnologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703  © 022 - 3090-0000 / 4125 2525 8691866066 i wellness@thyrocare.com www-thyrocare.com REPORT  NAME + MANJU SHAH KALSHETTI(40Y/F) SAMPLE COLLECTED AT : REF. BY + SELF FLAT NO 103 C WING GANESHAM PHASE 1 PIMPRI SWADGARA  TEST ASKED 1 AAROGYAM 1.2  TEST NAME TECHNOLOGY VALUE UNITS EST. GLOMERULAR FILTRATION RATE (eGFR} CALCULATED 107 mL/min/1.73 m2 Referance Range :-  > = 90 : Normal  60 - 89 : Mild Decrease  45-59 ! Mild to Moderate Decrease 30-44 ! Moderate to Severe Decrease 15-29 : Severe Decrease  Clinical Significance  The normal serum creatinine reference interval does not necessarily reflect a nermal GFR for a patient. Because mild and moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for qinical laboratories to routinely estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum ie, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and management of patients with CKD.     Reference  Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12.  Please correlate with clinical conditions.  Method:- CKD-EPI Creatinine Equation        ~~ End of report ~~ Sample Collected on (SCT) 113 Feb 2018 08:58 Sample Received on (SRT) 113 Feb 2018 22:44 Guiblee Report Released on (RRT) 114 Feb 2018 02:34 ¢ Sample Type + SERUM Dr.Prachi Sinkar MD Dr.Caesar Sengupta MD ~ Labcode + 130239022/BT005 ;  Barcode + G8472631 8 / 8 x ( ~ N J\Y "
REPORT,"PROCESSED AT : Thyrocare        @cap, Thyrocare’  D-37/1,TTC MIDC,Turbhe, Seo Navi Mumbai-400 703 SMEAR RMT, Think Thyroid. Think Thyrocare.  ~ Corporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbat - 400703  © 022 - 3090 0000 / 4125 2525 & 8691866066 wellness@thyrocare.com www .thyrocare.com REPORT        NAME : Manjusha Kalshetti (42¥/F) SAMPLE COLLECTED AT =  REF. BY : SELF C 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR PUNE, ALT NO 9860792972 ,SAUDAGAR, Pune,  TEST ASKED =: AAROGYAM B 411027, Pimple Saudagar, Pune, Pune,  Maharashtra, 411027     TEST NAME TECHNOLOGY VALUE UNITS TRON PHOTOMETRY 75.3 pg/dl Reference Range t  Male : 65 - 175  Female : 50 - 170  Method ;__FERROZINE METHOD WITHOUT DEPROTEINIZATION  TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 287 g/dl Reference Range :  Male: 225 - 535 ug/dl Female: 215 - 535 pg/dl  Mathod ;_SPECTROPHOTOMETRIC ASSAY     % TRANSFERRIN SATURATION CALCULATED 26.24 % Reference Range:  13-45  Method ;_ DERIVED FROM IRON AND TIBC VALUES.  Please corralate with clinical conditions.  Sample Collected on (SCT) 231 Oct 2019 08:49  Sample Received on (SRT) 31 Oct 2019 23:58 Report Released on (RRT) £01 Nov 2019 01:19 wr“ Sample Type Lie @ : SERUM  Labeode iC) 3110039993/NCR22 _ Or.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro} Barcode Ox 230116405 Page :"
REPORT,"PROCESSED AT: Thyrocare  D-37/1,TTC MIDC,Turbhe, Poy Thyrocare  Navi Mumbai-400 703 Souctasmonnmaracest Think Thyroid, Think Thyrocare. ~ Corporate Office : Thyracare Technologies Limited @ D-37/3, TIC MIDC, Turbhe, Navi Mumbal - 400703  © 022 - 30900000 / 4125 2525 @ 8691866066 EB wellness@thyrocare.com www.thyrocare.com REPORT     NAME : Manjusha Kalshetti (42Y/F) SAMPLE COLLECTED AT : REF. BY : SELF C 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR PUNE, TEST ASKED = AAROGYAMB ALT NO 9860792972 ,SAUDAGAR, Pune, 411027, Pimple  Saudagar, Pune, Pune, Maharashtra, 411027     TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE ALKALINE PHOSPHATASE PHOTOMETRY 89 U/L 45 - 129 BILIRUBIN - TOTAL PHOTOMETRY 0.34 ma/dl 0.3-1.2 BILIRUBIN -DIRECT PHOTOMETRY 0.11 mag/dl < 0.3 BILIRUBIN (INDIRECT) CALCULATED 0.24 ma/dl 0-0.9 GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 33 ul <38 ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 23.8 uf <31 ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 22.2 ul <x PROTEIN - TOTAL PHOTOMETRY 75 gm/dl 5.7-8.2 ALBUMIN - SERUM PHOTOMETRY 46 am/dl 3.2-4.8 SERUM ALB/GLOBULIN RATIO. CALCULATED 1.59 Ratio 0.9-2 SERUM GLOBULIN PHOTOMETRY 2.9 am/dl. 2.5-3.4  Please correlate with     Method :  ALKP - MODIFIED IFCC METHOD  BILT - VANADATE OXIDATION  BILD - VANADATE OXIDATION  BILI - DERIVED FROM SERUM TOTAL AND DIRECT BILIRUBIN VALUES GGT - MODIFIED IFCC METHOD.  SGOT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION SGPT - IFCC* WITHOUT PYRIDOXAL PHOSPHATE ACTIVATION PROT - BIURET METHOD  SALB - ALBUMIN BCG?METHOD (COLORIMETRIC ASSAY ENDPOINT) A/GR - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES     Sample Collected on (SCT) : 31 Oct 2019 08:49  Sample Received on (SRT) 2 31 Oct 2019 23:58 Goal te? Report Released on (RRT) 219  Sample Type  Labcode : 3110039993/NCR22 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro) Barcode : 30116405 Page : 2 of 10  "
REPORT,"PROCESSED AT: Thyrocare     € Thyrocare’  A SCARY D-37/1,TTC MIDC,Turbhe, Navi Mumbai-400 703 courceenumcmecioam — Think Thyroid. Think Thyrocare,  ~ Corporate Office : Tryrocare Technologies United © 0-37/3, TC MIDC, Twbhe, Navi Mumba - 400703  © 022 - 300.0000 /4125 2525 © 8691866066 i wellness@thyrocare.com www:thyrocare.com REPORT        NAME : Manjusha Kalshett! (42¥/F) SAMPLE COLLECTED AT : REF. BY : SELF C 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR PUNE, TEST ASKED —: AAROGYAMB ALT NO 9860792972 ,SAUDAGAR, Pune, 411027, Pimple  Saudagar, Pune, Pune, Maharashtra, 411027     TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE TOTAL CHOLESTEROL PHOTOMETRY 232 mg/dl 125-200  HDL CHOLESTEROL - DIRECT PHOTOMETRY 46 ma/di 35-80  LDL CHOLESTEROL - DIRECT PHOTOMETRY 174 mg/dl 85-130 TRIGLYCERIDES PHOTOMETRY 159 ma/d) 25-200  TC/ HDL CHOLESTEROL RATIO CALCULATED 5.1 Ratio 3-5  LDL / HDL RATIO CALCULATED 3.8 Ratio 1.5-3.5  VLDL CHOLESTEROL ‘CALCULATED 31.8 ma/dl 5-40  NON-HDL CHOLESTEROL CALCULATED 186.4 mg/dl < 160     Please correlate with clinical conditions.  Method =  CHOL - CHOD POD METHOD  HCHO - ENZYME SELECTIVE PROTECTION METHOD  LDL - HOMOGENOUS ENZYMATIC COLORIMETRIC ASSAY  TRIG - ENZYMATIC COLORIMETRIC METHOD (GPO) [HIGHLY INFLUENCED BY LEVEL OF FASTING] TC/H - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES  LDL/ - DERIVED FROM SERUM HDL AND LDL VALUES  VLDL - DERIVED FROM SERUM TRIGLYCERIDE VALUES.  NHDL - DERIVED FROM SERUM CHOLESTEROL AND HDL VALUES.  *REFERENCE RANGES AS PER NCEP ATP IIT GUIDELINES:        TOTAL CHOLESTEROL (mg/dl) HDL (mg/dt) LDL (mg/dl) TRIGLYCERIDES Gng/dly  DESIRABLE <200 Low <40 OPTIMAL <100 NORMAL <150  BORDERLINE HIGH 200-239 «HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199  HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499 HIGH 160-189 VERY HIGH >S00 VERY HIGH >190     Alert 111 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.     Sample Collected on (SCT) _ 31 Oct 2019 08:49  Sample Received on (SRT) _—: 31 Oct 2019 23:58 Goal de  Report Released on(RRT) _—: 01 Nov 2019 01:19 =  Sample Type + SERUM .  Labeode + 3110039903/NCR22__D!-Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)  Barcode + J0116405 Page : 3 of 10"
REPORT,"PROCESSED AT: Thyrocare  D-37/1,TTC MIDC,Turbhe, escono Thyro care’  Souter amemcan nce . oa Th Navi Mumbai-400 703 Think Thyroid. Think Thyrocare. ~ Corporate Office : Thyrocare Technologies Limited  D-37/3, TTC MIDC, Turbhe, Navi Mumbat - 400703 T andl  © 022 - 3090 0000 / 4125 2525 © 8691866066 HB wellness@thyrocare.com @www.thyrocare.com >...           NAME + Manjusha Kalshetti (42¥/F) SAMPLE COLLECTED AT : REF. BY : € 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR PUNE, . SELF ALT NO 9860792972 ,SAUDAGAR, Pune, 411027, Pimple  TEST ASKED = *_ AAROGYAMB Saudagar, Pune, Pune, Maharashtra, 411027  TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE  TOTAL TRIIODOTHYRONINE (T3) C.LLA 132 ng/dl 60-200  TOTAL THYROXINE (T4) C.LLA 8.2 ua/dl  4.5-12  THYROID STIMULATING HORMONE (TSH) C.LLA 2.15 plu/ml 0.3-5.5     Comments: SUGGESTING THYRONORMALCY  Please correlate with clinical conditions.  Method:  T3 - COMPETITIVE CHEM] LUMINESCENT IMMUNO ASSAY T4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY TSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY Pregnancy reference ranges for TSH  Ast Trimester : 0.10 - 2.50  2nd Trimester : 0.20 - 3.00  3rd Trimester : 0.30 - 3.00  Reference: Guidelines of American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum, Thyroid, 2011, 21; 1-46     Sample Collected on (SCT) £31 Oct 2019 08:49 Sample Received on (SRT) £31 Oct 2019 23:58 Cuil oe  Report Released on (RRT) : Q1 Nov 2019 01:19 wn  Sample Type : SERUM .  Labcode + 3110039993/NCR22 —_-‘D-Prachi Sinkar MD (Path) Dr.Caesar Sengupta MD(Micro)  Barcode = 30116405 Page : 4 of 10 "
REPORT,"PROCESSED AT : Thyrocare  D-37/1,TTC MIDC,Turbhe, RegNoW Thyrocare’  Navi Mumbai-400 703 Saurcremenconnencio® Think Thyroid. Think Thyrocare. ~ Corporate Office : TTryrocare Technologies ited © D-32/3, TTC MIDC, Tube, Kavi Mumbal - 400703  @ 022 - 3090 0000/4125 2525 @ 8691866066 i wellness@thyrocare.com €@www.thyrocare.com REPORT                      NAME fanjusha Kalshetti (42¥/F) SAMPLE COLLECTED AT :  REF. BY ELF C 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR PUNE, ALT NO 9860792972 ,SAUDAGAR, Pune, 411027, Pimple  TEST ASKED 3 AAROGYAM B Saudagar, Pune, Pune, Maharashtra, 411027  TEST NAME TECHNOLOGY VALUE UNITS NORMAL RANGE  BLOOD UREA NITROGEN (BUN) PHOTOMETRY 6.87 mg/dl 7-25  CREATININE - SERUM PHOTOMETRY 0.66 mo/dl 0.5-0.8  BUN / SR.CREATININE RATIO CALCULATED 10.41 Ratio 9:4-23:1  CALCIUM PHOTOMETRY 9.27 mo/dl 8.8-10.6  URIC ACID PHOTOMETRY 5.5 mg/dl 3.2-6.1     Please correlate with clinical conditions.  BUN - KINETIC UV ASSAY.  SCRE - CREATININE ENZYMATIC METHOD  B/CR - DERIVED FROM SERUM BUN AND CREATININE VALUES. CALC - ARSENAZO III METHOD, END POINT.  URIC - URICASE / PEROXIDASE METHOD:         Sample Collected an (SCT) 2 31 Oct 2019 08:49  Sample Received on (SRT) 31 Oct 2019 23:58 Goch ee  Report Released on (RRT) 2 01 Nov 2019 01:19 -  Samele Type : SERUM .  Labcode : 3110039993/NCR22 Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro)  Barcode : J0116405 Page : 5 of 10"
REPORT,"PROCESSED AT:  rence Thyrocare’  D-37/1,TTC MIDC,Turbhe, Navi Mumbai-400 703 Think Thyroid. Think Thyrocare.  ~ Corporate Office : Thyrocare Technologies Limited 9 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703  © 022 - 3090 0000 / 4125 2525 @ 8691866066 wellness@thyrocare.com @www.thyrocare.com ) ee le ia  NAME = Manjusha Kalshetti (42¥/F) SAMPLE COLLECTED AT = REF. BY : SELF C103 GANESHAM PHASE 1 PIMPLE SAUDAGAR TEST ASKED + AAROGYAM B PUNE, ALT NO 9860792972 ,SAUDAGAR, Pune,  411027, Pimple Saudagar, Pune, Pune, Maharashtra, 411027  TEST NAME TECHNOLOGY VALUE UNITS EST. GLOMERULAR FILTRATION RATE {eGFR} (CALCULATED 109 mLfmin/1.73 m2 Reference Range :-        : Normal        > = 90 60-89 : Decrease  45-59 : Mild to Moderate Decrease 30-44 : Moderate to Severe Decrease 15-29  : Severe Decrease  Clinical Significance  The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because miki and moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for diinical laboratories to routinely estimate glomerular filtration rate (eGFR), a ""gold standard” measurement for assessment of renal function, and report the value when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal medicine will further improve the detection and management of patients with CKD.  Reference  Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-12.  Plesse correlate with clinical conditions.  Method:- CKD-EPI Creatinine Equation     Sample Collected on (SCT) 231 Oct 2019 08:49 Sample Recelved on (SRT) 231 Oct 2019 23:58 wr“ Report Released on (RRT) 201 Nov 2019 01:19 ”  Sample Type SERUM Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MDXMicro)  Labcode 2 3110039993/NCR22 Barcode 230116405 Page : 6 of 10"
REPORT,"PROCESSED AT: Thyrocare  D-37/1,TTC MIDC,Turbhe, A noe Thyrocare  Navi Mumbai-400 703 coureearmmenmmnese® Think Thyroid. Think Thyrocare, ~ Corporate Office : Thyrocare Technotogies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbat - 400703  © 022 - 3090 0000 / 4125 2525 @ 8691866066 weliness@thyrocare.com @www.thyrocare.com REPORT     NAME 2 Manjusha Kalshetti (42¥/F) SAMPLE COLLECTED AT =  REF. BY : SELF C 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR PUNE, ALT NO 9860792972 ,SAUDAGAR, Pune,  TEST ASKED =: HBA,HEMOGRAM - 6 PART (DIFF) 411027, Pimple Saudagar, Pune, Pune,  Maharashtra, 411027                                   TEST NAME TECHNOLOGY VALUE UNITS HbAic - (HPLC - NGSP Certified) HP.L.C 5.9 Ye Reference Range : Reference Range: As per ADA Guidelines Guidance For Known Diabetics Below 5.7% : Normal Below 6.5% : Good Control 5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control >=6.5% — : Diabetic 7.0% - 8% : Unsatisfactory Control >8% : Poor Control Method :__ Fully Automated H.P.L.C. using Biorad Variant Il Turbo, NGSP Certified. AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 123 mg/dl Reference Range : 90 - 120 mg/dl_ : Good Control 121 - 150 mg/d i 151 - 180 mg/d > 180 mg/dl: Poor Control Method : Derived from HBA1c_ values Please correlate with clinical conditions. Sample Collected on (SCT) 231 Oct 2019 08:49 Sample Received on (SRT) £31 Oct 2019 23:58 Report Released on (RRT) 201 Nov 2019 02:36 wr“ Sample Type : EDTA c Labcode 3110039996/NCR22 _Dr.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro}  Barcode :Q0909557 Page :7 of 10 "
REPORT,"PROCESSED AT: Thyrocare  D-37/1,TTC MIDC,Turbhe, Aon Thyrocare”  Navi Mumbai-400 703 UREN OEE Think Thyroid. Think Thyrocare. ~ Corporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703 T adh  © 022 - 3090 0000 / 41252525 @ 8691866066 weliness@thyrocare.com @www.thyrocare.com REPORT              NAME Manjusha Kalshettl (42¥/F) SAMPLE COLLECTED AT :  REF. BY SELF C 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR : . PUNE, ALT NO 9860792972 ,SAUDAGAR, Pune,  TEST ASKED =: _-HBA,HEMOGRAM - 6 PART (DIFF) 411037, Pimple Saudagar, Pune, Pune,  Maharashtra, 411027  TEST NAME VALUE UNITS REFERENCE RANGE  TOTAL LEUCOCYTES COUNT X103/yL 4.0-10.0  NEUTROPHILS % 40-80  LYMPHOCYTE PERCENTAGE % 20.0-40.0  MONOCYTES % 0.0-10.0  EOSINOPHILS % 0.0-6.0  BASOPHILS % <2  IMMATURE GRANULOCYTE PERCENTAGE(IG%) % 0.0.0.4  NEUTROPHILS - ABSOLUTE COUNT LYMPHOCYTES - ABSOLUTE COUNT MONOCYTES - ABSOLUTE COUNT BASOPHILS - ABSOLUTE COUNT EOSINOPHILS - ABSOLUTE COUNT  X103/ pL — 2.0-7.0 X10? ful 1.03.0 103 /pL — 0.2-1.0 X107 /pl 0.0201 X 103 fy 0.02.05     IMMATURE GRANULGCYTES(IG) X103/ pL 0.0-0.3 TOTAL RBC X10%6/uL 3.94.8 NUCLEATED RED BLOOD CELLS 103 /pL «0.01 NUCLEATED RED BLOOD CELLS % % <0.01 HEMOGLOBIN afd. 12.0-15.0 HEMATOCRIT(PCV) % 36.0-46.0 MEAN CORPUSCULAR VOLUME(MCY) fl 83.0-101.0 MEAN CORPUSCULAR HEMOGLOBIN(MCH) Pq 27.0-32.0 MEAN CORP.HEMO.CONC(MCHC) g/dL 31.5-34.5 RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) fl 39.0-46.0 RED CELL DISTRIBUTION WIDTH (RDW-CV) % 11.6-14.0 PLATELET DISTRIBUTION WIDTH(PDW) fl 9.6-15.2 MEAN PLATELET VOLUME(MPV) fl 65-12 PLATELET COUNT X103/pL 180-400 PLATELET TO LARGE CELL RATIO(PLCR) % 19.7424 PLATELETCRIT(PCT) % 0.19-0.39        Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000) (This device performs hematology analyses according to the Hydrodynamic Focussing (DC method), Flow Cytometry Method (using 2 semiconductor laser), and SL$- hemoglobin method)     ~~ End of report —~ Sample Collected on (SCT) 231 Oct 2019 08:49 Sample Received on (SRT) 231 Oct 2019 23:58 Goal ee Report Released on (RRT) 201 Nov 2019 02:36 SampleType (8) ree 1 EDTA . Labcode ©) + 3110039996/NCR22__D¥.Prachi Sinkar MD(Path) Dr.Caesar Sengupta MD(Micro) Barcode + 90909557 Page : 8 of 10  Se "
REPORT,"| Barcodes/Sample_Type  Labcode Ref By | Sample_Type/Tests  : Sample Collected At  Sample Collected on (SCT) Report Released on (RRT)  Amount Collected         : Q0909557 (EDTA),J0116405 (SERUM) : 3110039998,3110039993 : SELF  : EDTA:HBA , HEMOGRAM - 6 PART (DIFF) SERUM:AAROGYAM B  : © 103 GANESHAM PHASE 1 PIMPLE SAUDAGAR PUNE, ALT NO 9860792972 ,SAUDAGAR, Pune, 411027, Pimple Saudagar, Pune, Pune, Maharashtra, 411027  : 31 Oct 2019 08:49  : 01 Nov 2019 02:36  : Rs.600/-(six hundred only)     Page : 9 of 10 "
REPORT,"(FE conomions OF REPORTING  The reported results are for information and interpretation of the referring doctor only.  It is presumed that the tests performed on the specimen belong to the patient; named or identified.  Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same patient.  Should the results indicate an unexpected abnormality, the same should be reconfirmed.  Only such medical professionals who understand reporting units, reference ranges and limitations of technologies should interpret results.  This report is not valid for medico-legal purpose.  Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or  L damage that may be incurred by any person as a result of presuming the meaning or contents of the report.     ooo  oe  oo           la f EXPLANATIONS XN + ~ Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them  as ""Clients”.  Name - The name is as declared by the client and recored by the personnel who collected the specimen.  Ref.Dr - The name of the doctor who has recommended testing as declared by the client.  Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.  Barcode - This is the specimen identity number and it states that the results are for the specimen bearing  the barcode (irrespective of the name).  SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by  the client.  SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.  SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.  RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.  Refarence Range - Means the range of values in which 95% of the normal population would fall.  oOo%  °  oooed        SUGGESTIONS,  Values out of reference range requires reconfirmation before starting any medical treatment. Retesting is needed if you suspect any quality shortcomings.  Testing or retesting should be done in accredited laboratories.  For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on 022-3090 0000 / 4125 2525  SMS: <Labcode No.> to 9870666333  Healthear  Towards a TB free world        * + + +     °                                                       Download Thyroapp Now                 -     Focus TB, powered by Thyrocare. A brand that will focus on TS, which is one of the major public health     Tuberculosis (TB) is a transmissible, airbome infection caused by Mycobacterium tuberculosis (MT). \t transpires usually when a person inhales microscopic droplet nuclei containing viable bacteria, spread through coughing by persons who have infectious TB.       Thyroca  re             Page : 10 of 10 "
REPORT,"GENERAL DIAGNOSTICS Eas See PreventiNe Life Gere (P) Ltd. ® @ Iso &          ® Plot-6, Sector -24, Navi Mumbal wow Oe naan = aa Gb BIAGNOSTICS Maharashtra, india, Pin - 400705 NO GLP nears conten Tal: +91-22-40450000 0) EE PME. Ge @& =, Nome: ‘MANIJUSHA KALSHETTI Age/Gender: Deyeiiende ° ‘Referred By: SHREE CLINICAL LABORATORY Clicat Name: NA Collection Date: 08-02-2021 13:49:03 Report Release Date: 08-02-2021 21:19:18       Observed Value Reference Range     Lipid Profile 1 Total Cholesterol 245.3 Desirable: <200 mg/dl Serum, Method: Photometry Borderline high = 200- High: > 240 2 ‘Triglycerides 1445 Desirable: <150 mg/dl . i is assay Borderline High: 150- 199 ‘Serum, Method: Enzymatic, end point coupled assay Hight > 200 a. 3 BDL Cholesterol 334 30-60 mg/dL Serum, Method: Photometry 4 LDL. Cholesterol 163.00 Optimal: <100; mg/dl ‘ Near Optimal: 100. 129; Serum, Method: Photometry pI Borderline High: 130- High: 160-189; Very high: >190 5 Cholestero/HDL ratio 459 Optimal: <3.5 . Near 45-50 ‘Serum, Method: Calculated Big Spuimal: 6 ‘VLDL Cholesterol 28.90 6-40 mg/dL Serum, Method: Calculated 7 Non HDL Cholesterol 191.99 Desirable: <130 mg/dl Serum, Method: Calculated Borderline high: 130-159 High : 160-18! ‘Very High :>190 8 LDL /ADL ratio 3.05 Optimal: <2.5 . ‘Near Optimal: 2.5-3.5 Serum, Method: Calculated wore Interpretation  L.Triglycerides: When triglycerides are very high greater than 1000 mg/4L,, there is a risk of developing pancreatitis in children and adults. Triglycerides change dramatically in response to meals, increasing as much as 5 to 10 times higher than fasting levels just a few hours after eating. Even fasting levels vary considerably day to day. Therefore, modest changes in fasting triglycerides measured on different days are not considered to be abnormal.  2. HDL-Cholesterol: HDL- C is considered to he beneficial, the so-called “good” cholesterol, because it removes excess cholesterol from tissues and carries it to the liver for disposal. If HDL-C is less than 40 mg/dL for men and less than 50 mg/dL. for women, there is an increased risk of heart disease that is independent of other risk factors, including the LDL-C level. The NCEP guidelines suggest that an HDL cholesterol value greater than 60 mg/dL is protective and should be treated as a negative risk factor.  3. LDL-Cholesterol: Desired goals for LDL-C levels change based on individual risk factors. For young adults, less than 120 mg/dL is acceptable. Values between 120-159 mg/dL are considered Borderline high. Values greater than 160 mg/dL. are considered high. Low levels of LDL cholesterol may be seen in people with an inherited lipoprotein deficiency and in people with hyperthyroidism, infection, inflammation, or citthasis.     CRM No :2126989 Yue ont  Sample Received Time: 08-02-2021 13:53:04     Report Release Date: 08-02-2021 21:19:18 Authorized Signatory Authorized Signatory Patient Name: MANJUSHA KALSHETT! Dr. Dina Abhani Dr. Mahesh Hampe Patient ID: 2126989 DCP, DNB (Pathology) MD @iochemistry) Page lof 3  ‘To view your report, log in www.preventine. org/reports. Feed your Patient [D to download your report."
REPORT,"GENERAL DIAGNOSTICS PreventiNe Life Care (P) Ltd. Plot-6, Sector - 24, Navi Mumbai     @ O22 G GD sez  ae Oe ” DIAGNOSTICS         Maharashtra, india, Pin - 400705 reli Tel: +91-22-40450000 0) EE PME. Ge @& => . . 42 Year(s) 0 Months{s) 0 ‘Name: MANIJUSHA KALSHETTI AgeGender: Day(syPemale ‘Referred By: SHREE CLINICAL LABORATORY Clicat Name: NA Collection Date: 08-02-2021 13:49:03 Report Release Date: 08-02-2021 21:19:18       Observed Value Reference Range            Lipid Profile 1 Total Cholesterol 245.3 Desirable: <200 mg/dl Serum, Method: Photometry Borderline high = 200- High: > 240 2 ‘Triglycerides 1445 Desirable: <150 mg/dl i: i it | aSSH rline High: 150 - 199 Serum, Method: Enzymatic, end point coupled assay Bee line High 3 BDL Cholesterol 334 30-60 mg/dL Serum, Method: Photometry 4 LDL. Cholesterol 163.00 Optimal: <100; mg/dl ‘ imal: 100-129; Serum, Method: Photometry 2 Borderline High: 130- 159; High: 160-189; Very high: >190 5 Cholestero/HDL ratio 459 Optimal: <3.5 - ‘Near Optimal: 3.5 - $.0 Serum, Method: Calculated ware 6 ‘VLDL Cholesterol 28.90 6-40 mg/dL Serum, Method: Calculated 7 Non HDL Cholesterol 191.99 Desirable mg/dl Serum, Method: Calculated Borderline high: 130-159 High : 160-18! ‘Very High :>190 8 LDL /ADL ratio 3.05 Optimal: <2.5 . ‘Near Optimal: 2.5-3.5 Serum, Method: Calculated wore Interpretation  L.Triglycerides: When triglycerides are very high greater than 1000 mg/4L,, there is a risk of developing pancreatitis in children and adults. Triglycerides change dramatically in response to meals, increasing as much as 5 to 10 times higher than fasting levels just a few hours after eating. Even fasting levels vary considerably day to day. Therefore, modest changes in fasting triglycerides measured on different days are not considered to be abnormal.  2. HDL-Cholesterol: HDL- C is considered to he beneficial, the so-called “good” cholesterol, because it removes excess cholesterol from tissues and carries it to the liver for disposal. If HDL-C is less than 40 mg/dL for men and less than 50 mg/dL. for women, there is an increased risk of heart disease that is independent of other risk factors, including the LDL-C level. The NCEP guidelines suggest that an HDL cholesterol value greater than 60 mg/dL is protective and should be treated as a negative risk factor.  3. LDL-Cholesterol: Desired goals for LDL-C levels change based on individual risk factors. For young adults, less than 120 mg/dL is acceptable. Values between 120-159 mg/dL are considered Borderline high. Values greater than 160 mg/dL. are considered high. Low levels of LDL cholesterol may be seen in people with an inherited lipoprotein deficiency and in people with hyperthyroidism, infection, inflammation, or citthasis.        CRM No :2126989 Yue ont  Sample Received Time: 08-02-2021 13:53:04     Report Release Date: 08-02-2021 21:19:18 Authorized Signatory Authorized Signatory Patient Name: MANJUSHA KALSHETT! Dr. Dina Abhani Dr. Mahesh Hampe Patient ID: 2126989 DCP, DNB (Pathology) MD @iochemistry) Page Lof 4  ‘To view your report, log in www.preventine. org/reports. Feed your Patient [D to download your report.    _x000c_"
REPORT," GENERAL DIAGNOSTICS a gue PreventiNe Life Care (P) Ltd. ne & ro  G General SVE? DIAGNOSTICS        Plot-6, Sector - 24, Navi Mumbai kos Desa Sa Maharashtra, india, Pin - 400705 rertteacon Tel: +91-22-40450000 0) EE PME. Ge @&  Name: MANTUSHA KALSHETTI Age/Gender: Deyeiiende e  ‘Referred By: SHREE CLINICAL LABORATORY Clicat Name: NA  ‘Collection Date: 08-02-2021 13:49:03 Report Release Date: 08-02-2021 21:19:18     Observed Value Reference Range     1 Vitamin B12 1206.0 75 - 807 Pe/ml ‘Serum, Method: CLIA  Remarks  Kindly correlate clinically with treatment history,  Interpretation  Low B12 level in a person with signs and symptoms indicates that the person has a deficiency but does not necessarily reflect the severity of the anemia or associated neuropathy. Vitamin B12 levels are decreased in megaloblastic anaemia, partial/total gastrectomy, pemicious anaemia, peripheral neuropathy, chronic alcoholism, senile dementia, and treated - “ ~ated increased in homacysteine levels and Vitamin B12 has better predictivity for cardiovascular disease and 7 Holo-Transcobalamin II levels and methylmalonic acid levels are more accurate markers of active V  Additional tests are usually done to investigate the underlying cause of the deficiency. 2 / 3     j In method comparison study done at our centre, we found acceptable correlation and these results show no statistically significant between our methods and other Lab procedures (like, CLIA, CMIA, ELISA, IFA etc). Ine Tarmonization between total vitamin B12 assays is variable and individual results can differ significantly between assays. Though cut-off value of 200 pg/mL was used commonly, however, since there is not a reference method for measuring vitamin B12, this eut- off value may not be suitable to use in the evaluation of cobalamin deficiency diagnosis. Until the harmonization study between measurement methods is concluded, it is always suggested by NABL that laboratories should use their own reference values or reference values for Lab assay methods instead of cut-off value of 200 pg/ml.        CRM No :2126989 Yue ont  Sample Received Time: 08-02-2021 13:53:04  Report Release Date: 08-02-2021 21:19:18 Authorized Signatory Authorized Signatory Patient Name: MANJUSHA KALSHETT! Dr. Dina Abhani Dr. Mahesh Hampe Patient ID: 2126989 DCP, DNB (Pathology) MD Biochemistry) Page 2of 4  ‘To view your report, lag in www.preventine.orgireports. Feed your Patient [D to download your report.     a> "
REPORT,"GENERAL DIAGNOSTICS PreventiNe Lite Care (P) Lid. Plot-6, Sector - 24, Navi Mumbal Maharashira, India. Pin - 400705 Tol: +91-22-40450000        2 oO &  soe. @ PME ste ®@     General” Gi SiéNosnes     42 Year(s) 0 Months(s) @ MANIUSHA KALSHETTI AgeGender: DayisyFx  SHREE CLINICAL LABORATORY —Client Name NA  08-02-2021 13:49:03 Report Release Date: 08-02-2021 21:19:19        Interpretation  Glucose is the primary energy source for the body’s cells and the only energy source for the beain and nervous system.High  levels of glucose most frequently indicae diabetes, but many other diseases and conditions can also cause elevated blood glucose. Hypoglycemia is cl  terized by a drop in blood glucose to a level where first it causes nervous system symptoms  (sweating, palpitations, hunger, trembling, and anxiety), then begins to affect the brain (causing confusion, hallucinations, blurred vision, and sometimes even coma and death).  CRM No :2126989  Patient ID: 2126989  End Of Report Ww 3/3 ‘Sample Received Time: 08-02-2021 13:53:04 _ Report Release Date: 08-02-2021 21:19:19 Authorized Signatory Authorized Si Patient Name: MANJUSHA KALSHETTI Dr Anju Dhar Dr. Mahesh Hampe  MD (Microbiologist) MD @iochemistry) Page 3 of 3  ‘To view your report, log in waw_preventine.org/reports. Feed your Patient ID to download your report."
REPORT,"REPORT ABHAY APATIL Reference:Dr.PHADNIS MADAN, MD SID: 130003608  ADITI, BHUSARI COLONY 130003608 KOTHRUD Collection Date:  07/04/2013 09:57 AM Tel No: 9823147602, Sample Date:  07/04/2013 09:57 am PID NO: 68144 Report Date: Age:41.09 Years Sex: MALE 07/04/2013 01:44 pm     Test Description Observed Value Biological Reference Interval Haematology : Erythrocyte Sedimentation Rate, EDTA Whole Blood 13 Male under 50 Yrs : Upto 15mm/hr  Male 50 - 85 Yrs : Upto 20mm/hr. Results corrected to 18 deg. celsius  Technique : Automated Westergren Method.  Kidney Function  Creatinine,serum by Jaffe w/o deproteinization 1.01 0.6 to 1.2 mg/dL  Clinical Chemistry  Urea, serum by GLDH-urease 25 10 to 50 mg/dL BUN-Blood Urea Nitrogen,serum by calculation 11.68 4-22 mg/dL  Uric Acid, serum by Uricase method 4.94 2.0 to 7.0 mg/dL Hormones  T3 (Total), serum by CMIA 1.18 0.58 - 1.59 ng/mL T4 (Total), serum by CMIA 7.50 4.87 - 11.72 pg/dL TSH(Ultrasensitive), serum by CMIA 2.45 0.40 - 4.00 IU/mL  Ref: NACB guideline 2002  Dr. Ajit S Golwilkar, MD, DCP Regn.No.: 32660  Page 6 of 7              METROPOLIS  EXCELLENCE IN DIAGNOSTICS Isr your heslth, nothing [ess willl da            Tel: 020-4100 8200 / 2566 6612 Email: drgl@metropolisindia.com        _x000c_"
REPORT,"REPORT ABHAY APATIL Reference:Dr.PHADNIS MADAN, MD SID: 130003608  ADITI, BHUSARI COLONY 130003608 KOTHRUD Collection Date: 07/04/2013 09:57 AM Tel No: 9823147602, Sample Date: 07/04/2013 09:57 am PID NO: 68144 Report Date:     Age:41.09 Years Sex: MALE Urine Routine Examination  07/04/2013 01:44 pm  (Sample : Urine) Result Reference Range Physical  Quantity Examined 5 ml  Appearance Clear -  Colour Pale yellow >  Chemical (Dipstick)  pH 5 4.6 - 8.0 Albumin Absent Absent Glucose Absent Absent Acetone Absent Absent Bile Pigments Absent Absent Urobilinogen Not Significant Not Significant Microscopy R.B.Cs Absent 0 - 2 per hpf Pus cells Occasional 0 - 5 per hpf Epithelial cells 1-2 0 - 5 per hpf Casts Not Detected - Crystals Not Detected - End of Report Dr. Ajit S Golwilkar, MD, DCP Regn.No.: 32660 Page 7 of 7              METROPOLIS  EXCELLENCE IN DIAGNOSTICS Isr your heslth, nothing [ess willl da            Tel: 020-4100 8200 / 2566 6612 Email: drgl@metropolisindia.com        _x000c_"
REPORT,"ABHAY ASHOK PATIL ADITI, BHUSARI COLONY KOTHRUD  REPORT  PID NO: 68144 Age:45.07 Years Sex: MALE  Complete Blood Count  (EDTA Whole Blood, Automated Cell Counter) Hemoglobin, EDTA whole blood  Total Leucocytes (WBC) count Platelet count  Red blocd cell count  PCV (Packed Cell Volume)  MCV (Mean Corpuscular Volume)  MCH (Mean Corpuscular Haemoglobin)  MCHG (Mean Corpuscular Haemoglobin Concentration) RDW (Red blood cell distribution width)  Differential Count  Neutrophils  Absolute Neutrophils  Eosinophils Absolute Eosinophils  Basophils Absolute Basophils  Lymphocytes Absolute Lymphocytes  Monocytes Absolute Monocytes     Result 12.20  8,900 307,000  4.95  38.00 76.80 24.60 32.00 13.60  61 5,429  Page 1 of 9  GOLWILKAR  METROP@LIS  e. Pathology Sp:                  Reference:Dr.PHADNIS MADAN, MD     1,000 - 3,000 /pL                      SID: 160614473 Collection Date: 01/02/2017 08:43 AM Sample Date: 01/02/2017 08:43 am Report Date: 01/02/2017 06:47 PM       Biological Reference Interval Male : 14.0 - 17.50 g/dL  Female : 12.3 - 15.3 g/dL  Male & Female : 4,000 - 10,000 /uL 150,000 - 450,000 /uL  Male : 4.5 - 5.9 X 10°6 /uL Female : 4.1 - 5.1 x 1046 / pL  Male : 41.50 - 50.40 % 80.0 - 96.0 fL  27.5 - 33.2 pgms  33.4 - 35.5 g/dL 12-14%  40 - 80 % - - 2,000 - 7,000 /uL co’  1-6%  20 - 500 /UL ar ~~  <1-2%  0-100 /uL  20-40% an 2-10% 200 - 1000 /uL  i  Dr.(Mrs.) Manisha S. Patwardhan MD, DPB Reg.No.: 69229            _x000c_"
REPORT,"ABHAY ASHOK PATIL Reference:Dr.PHADNIS MADAN, MD  ADITI, BHUSARI COLONY SID: 160614473  KOTHRUD Collection Date:  01/02/2017 08:43 AM  REPORT Sample Date: 01/02/2017 08:43 am  PID NO: 68144 Report Date:  01/02/2017 06:47 PM  Age:45.07 Years Sex: MALE     Peripheral Blood Smear Examination  R.B.C. Morphology : Normocytic, Normochromic W.B.C. Abnormalities : Mild eosinophilia Platelets : Adequate Parasites : Not detected Comment Do s 7 / - Ls a) I me é * Ne é a te a wk as « . Tr a wo : 4 oy \ ~ on.) te - 4 s, h .(Mrs.) Manisha S. Patwardh: Page 2 of 9 Or (ttaD, DPB Reg.Nos 69229              GOLWILKAR  METROP@LIS  Pathology Sp             _x000c_"
REPORT,"ABHAY ASHOK PATIL Reference:Dr.PHADNIS MADAN, MD  ADITI, BHUSARI COLONY SID: 160614473  KOTHRUD Collection Date:  01/02/2017 08:43 AM  REPORT Sample Date: 01/02/2017 08:43 am  PID NO: 68144 Report Date:  Age:45.07 Years Sex: MALE 01/02/2017 06:47 PM     Test Description Observed Value Biological Reference Interval Lipid Profile Mini:  Cholesterol (Total), serum by Enzymatic method 173 a NCEP Guidelines  Triglycerides, serum by Enzymatic method 124 NCEP Guidelines  HDL Cholesterol, serum by Enzymatic method 50 a NCEP Guidelines  VLDL Cholestrol, serum by calculation 25 5 to 51 mg/dL LDL Cholesterol, serum by calculation 98 NCEP Guidelines Cholesterol(Total)/HDL Cholesterol Ratio 3.46 Males : Acceptable ratio </= 5.00  Females : Acceptable ratio </= 4.50  LDL Cholesterol/HDL Cholesterol Ratio 1.96 Males : Acceptable ratio </= 3.60 Females : Acceptable ratio </= 3.20  NCEP Guidelines  Desirable Borderline Undesirable _ Total Cholesterol (mg/dl) Below 200 200-240 Above 240 % y HDL Cholesterol (mg/dl) Above 60 40-59 Below 40 . Triglycerides (mg/dl) Below 150 150-499 Above 500 , LDL Cholesterol (mg/dl) Below 130 130-160 £ Above 160 e  te a wt as < - r —_ a : 4 on ‘ ~ on.) » i 4 1 s, ry Dr.(Nirs.) Manisha S. Patwardh Page 3 of 9 rl MD, DPB Reg.No.: cone  GOLWILKAR        _x000c_"
REPORT,"ABHAY ASHOK PATIL ADITI, BHUSARI COLONY KOTHRUD  REPORT  PID NO: 68144 Age:45.07 Years Sex: MALE  Test Description Liver Function Test :  Bilirubin-Total, serum by Diazo method  Bilirubin-Conjugated, serum by Diazo method Bilirubin-Unconjugated, serum by calculation SGOT (AST), serum by Enzymatic method SGPT (ALT), serum by Enzymatic Method Alkaline Phosphatase,serum by pNPP-kinetic Protein (total), serum by Biuret method Albumin, serum by Bromocresol purple method  Globulin, serum by calculation  GOLWILKAR        Page 4 of 9        Reference:Dr.PHADNIS MADAN, MD                    SID: 160614473 Collection Date: 01/02/2017 08:43 AM Sample Date: 01/02/2017 08:43 am Report Date: 01/02/2017 06:47 PM       Observed Biological Reference Interval  0.33 0.10 - 1.20 mg/dL Neonates : Upto 15.0 mg/dL  0.10 Upto 0.3 mg/dL 0.23 0.1 to 1.0 mg/dL 35 15 - 37 U/Lt 48 Upto 65 U/Lt 75 Adult Male : 46 - 116 U/Lt 771 6.4 to 8.2 g/dL 4.24 3.4 to 5.0 g/dL 3.47 2.3 - 3.5 g/dL 7 ° - —-XX— ; Le Ne ; ra °  Dr.(Mrs.) Manisha S. Patwardhan MD, DPB Reg.No.: 69229  "
REPORT,"NIRAJ A PATIL                  Reference:Dr.BHOME ARVIND MD,FAARC]SID: 120307012  120307012 Collection Date: 14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am Report Date: 14-01-2021 07:42 PM  REPORT a No 919823147602  PID: 11202219  Age:14.80 Years SexMALE  Test Description Haematology : Erythrocyte Sedimentation Rate, EDTA Whok Blood 20  Observed Value Biological Reference Interval  Male under 50 Yrs : Upto 15mm/hr Male 50 - 85.Yrs : Upto 20mm/hr. Male > 85 yrs : Upto 30mm/hr.  “a Results corrected to 18 deg. celsius Technique : Automated Westergren Method .  = = 4. ESR is markedly elevated in monoclonal gammopathy such as multiple m yeloma, in severe. polyctonal hyperglobulinemia due | to inflammatory disease, and in hyperfibrinogenemia. 2. Moderate ekvations are common in active inflammatory disease such as rheumatoid arthritis, chronic infections, collagen disease and neoplastic disease  re has little diagnostic value in these disorders but can be useful in monitoring disease activity. - * ,2Useful in the diagnosis and in monitoring polymyalgia rheumatica and tem,          poral arteritis. : 5. Moderate increase is seen in pregnancy (beginning at the 10th to 12th week) and returns to normal about 1 month ‘  1 postpartum . , : a : '- x1 6. Red cells with an abnormal or irregular shape, such as sickle cells or spherocytes, hinder rouleaux formation and ‘ we - lower the ESR. ES “F  Re  oh  ny       ais ae ito ee *  we     re epee ee ny wv at Nas  2 |  ce rk are     Dr. Venkatesh Keralapurkai  M.8.B.S.,D.C.P., D.N.B.(Patt Page 5 of 12 M3143 Reg.No.: 076020 “accreditation as per ISO 15819:2012, Cert.No. MC-3143. Refer scope@ www.nabi-india.org” AG Diagnostics Pvt. Ltd.             RRR EE BR PIER PT PPOTS               {Dr. AwantiGolwitkar |  MD (Pathology)        ca i            { Dr. Vinanti Golwitkar_ | "
PRESCRIPTION,"CLINIC : A1_x0005_, New Friends Soc,  DR. ASHOK N SOHONI ope vanaz’. Paud Road, Kothrud, mane NBS. D.C.H ween Pune 411 038.  Ragd. No. 48430 Ph. 8975345221 ‘or Emerue ty 7H  y & Sunday Closed      79:00 a.m. 10 12:30 p.m. & §.00 p.m. to 9:00 p.m. Saturda         Piaase apply for number on “SMINQ™ app  Name: Sakshi Pell Date: 06-12-2019 11:08 am Age’Sex: 19y /F Mobile: 8975345221 Office ID: AS2923 sie: +. Tablet Zenrid Pius: 1-1-4X5 few +  rea Beare, ZANT weve, TAT 2, Tablet Montek LC (10 & 5): 0-0-1X 10 ae  y De. hok Sohon! ard erap! tenderers SaPTT dovon.28 Ie "
REPORT,"    ancnetr Diagnostic Services  vanchetl Campus, 12/2/1,  Thube Park, Shivajinagar, Pune - 411005. Tel. : 020 - 28999800, 27999999, Fax : 020 - 25539675                                               SONAWANE PRANITA RAMCHANDRA | 5@x/ Age Ff 4glyPate of Repart 1702/2014 1702103097 Referring Doctor PURAM CHETAN 000000381367 Address cAI2 > a . HAEMATOLOGY Parameter Value Normal Range HAEMOGRAM ESR HB 11.8 gidb Female: 12 - 16 g/dL Male : 14 - 18 g/dL RBC COUNT 2:76 Milv/cumm Female: 3.8 - 5B ts Male :4.5 - 6.5 Mille PACKED CELL VOLUME 33.4 % Female: 37 - 47 % : Male :40 - 54 % MCV 121.01 cumics 80.0 - 100.0 cu.mics MCH 42.75 pgms 27.0 - 32.0 pgms MCHC 35.33 % 32.0 - 36.0% TOTAL WBC COUNT 42600 fcumm 4000 - 11000 fcumm DIFFERENTIAL WHITE CELL COUNT . NEUTROPHILS 86% 40 - 75 % EOSINOPHILS 1% 1-6 % LYMPHOCYTES 8% 20 - 45 % MONOCYTES 4% 2 - 10 % ‘BASOPHILS 1% SR WESTERNGREN 17 mmr PERIPHERAL BLOOD SMEAR Platelets- Adequate 257000/Cumm COMMENTS: This report is generated by theYumizen H 500 cell counter 1 instrument. < End of Report > a DR.WIRS.JOBH SAMPADA Pathologist MD, DCP Reg. No. 37050 q Collection Date: 17/02/2018 / 19:45 ! Accoptance Date: 17/02/2018 / 19:51 + Renort Date: 7022018 120:24 \ Renart Print Date; 17/02/2018 / 20:25"
REPORT,"Reference:Dr.BHOME ARVIND MD,FAARC|SID: 120307012 120307012 Collection Date: 14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am Report Date: 14-01-2021 07:42 PM                   NIRAJ A PATIL  REPORT Ta No 919823147602  PID: 11202219             Age:14.80 Years Sex:MALE               Test Description _ Observed Value Biological Reference Interval TEST NAME ; | Glycated Hemoglobin (HbA1C), by HPLC 5.30 . ; 4.01056 %  gene tye oT  ea eng, ARAL TER Ch TER Rg Me  fy  iemcrniieas  interpretation : '  HbA‘1C level reflects the mean glucose concentration over previous 8-12 weeks and provides better indication of long term glycemic control.  For diagnosis of Diabetes Mellitus (>= 18 yrs of age): 5.7 %-6.4 % : Increased risk for developing diabetes.  sf 6.5% : Diabetes  Therapeutic goals for glycemic control :  Adults :< 7% MS Toddlers and Preschoolers : < 8.5% (but > 7.5 %) =. School age (6-12 yrs) : < 8% “s Adolescents and young adults (13 - 19 yrs) : <75 % be. Levels of HbA1C may be low as result of shortened RBC life span in case of hemolytic anemia. ra Increased HbA1C values may be found in patients with polycythemia or post splenectomy patients. aS  Patients with Homozygous forms of rare variant Hb(CC,SS,EE,SC) HbA1c can not be quantitated as there  is no HbA. In such circumstances glycemic control can be monitored using | Plasma glucose levels or serum Fructosamine. oo  . eer: -  The A1c target should be individualized based on numerous factors, such as age, life expectancy, a comorbid conditions, duration of diabetes, risk of hypog lycemia oradverseconsequences from § - ; Pypoaiyeemis, patient motivation and adherence.  Ref : ADA (Standards of Medical Care in Diabetes - 2017)  . ~ _ , poe 2 oo ae rr Ct Tee EEP RR FGI EE ge regen fT EA a ory il a eh     Dr. Venkatesh Keralapurkai  M.B.B.S.,D.C.P., D.N.B.(Patt Page 4 of 12 BSS Reg.No.: 076020 ""Accreditation as per ISO 15819:2012, Cert.No. MC-3143. Refer scope@ www. nabl-india.¢ org"" AG Diagnostics Pvt. Ltd.  { Dr. Awanti Golwilkar |} MO (Pathology) oF  4 Dr. Vinanti Golwilkar § | gmmanpnenrermemmenmcconeenomame!                                     ce carrying forwardly ieee, Dr. Ajit Gols $ "
PRESCRIPTION," Michael Haster, DMD £509)363-5432 1462 Commercial St SE 10/04/2006 Salem, OR 97302 DEAH: HG4564  Jason Spander DOB: 85/18/1958 (603)745-1248  2240 Applewood Dr N Salem, OR $7306  Rx Penvx sotmg Disp: 40 Sig Take 2 tabs ASAP, then 1 tab 4 times a day.  Refils: 9  1 Dispense as Whitten [HI Generic Substitution Pemritted Signature of Prescrber"
PRESCRIPTION,"ZL. AGIA q.aa ds 8 wee “eS  dunt. waste, teu.sies wa.(F) Hs. (ata) ed eve tera. : 1.A.C003  A  watt ae., AAA. (Fs ) Pr.af. :2009/02/0089  CaUT Wet Asal  CAAT WaT Asst 9330, WaiSra Ao, Ig Pras, ARATCATAIER KT, ot 30. TAIT : &4233605 ' ' ,  Reg. No : 25255/15  Name : Ms Sakshi Patil Female  o * 191) CANTHEX CAPS (CURATIO) > 1 Wet Ot TN Feaoaz Ay 1 2) ABZORB POWDER  STANAMAAL Tay 3) GRAZIA UP CREAM  Utd Saaqvarel AMA 8 16-11-2017  16-10-2017 16 years  30 Raw 30 feaa  30 feag  cae  sprerreart See: BeDTOAY 888 aH, ce enerare AereoTaAt amr feral ot aa "
PRESCRIPTION,~ Reg. No : 06152 : 14-04-2015 Name : Mrs Vidya Patil Female 37 years  QO  1) ALASPAN TAB Rar UST WaT AISI 1 GH er.  2) NUTEX TAB 10 MG ws Raw 1 Test ot cat Aaa aay  3) KETO B LOTION as Raw | ea ia ch se  Utd araquaret arte 8 28-04-2015     &  The Scheduled vpdicine:s is/are  Sunspied For \y__ Days/Months  wie at ise = BA SST : HTS 29? AREAL erferardt araoralt afar zfarst yet  Saat: STAT Wd Acie ad Seg AR sHOTaT 
REPORT,"J. SMOLIN te                     | /  § NIRAJ A PATIL Reference:Dr.KHADILKAR VAMAN MD,DNB|SID: 119304904 — 4-20- . 119304904 ‘ Collection Date: +-201 RE ° 44-07-2019 09:18 AM — EPORT sano: 919828147602 Sample Date: . PID: 11202350 14-07-2019 09:18 am I Report Date: Age:13.04 Years Sex:MALE 14-07-2019 02:39 PM tole cose Observed Value Biological Reference Interval Nos  Test Description Hormones:  —————  End of Report  ‘ | Vewilct     7)  ‘ Dr. Venkatesh Keralapurkar M.B.B.S.,D.C.P., D.N.B. (Path;  | Page 2 of 2 Reg.No.: 076020 |  ig vv Mie Segre rt ‘ne ASO “AWW     _EnaljnoOagtiagnosts oo a : 4 ; REx ertise Based On A Legacy Of Over Four Decades     & { g ae) i) Pahoa Dope  "
PRESCRIPTION,"Dr. Abhijit V. Bhandari M.S. (Ortho), D.N.B. (Ortho) Orthopaedic & Arthroscopy Surgeon Regd.No. 079213 e SANJEEVAN HOSPITAL - ERANDAWANE, TUE. 9 to 11. A.M, = 020- 67250000 e@ SAHYADRI HOSPITAL - KOTHRUD, MON / WED / FRI. 12.30 to 2. P.M. w020-25393333 / 25393334 @ RAHUL COMPLEX - D-WING, 21/22, 3, FLOOR PAUD ROAD, PUNE. 6 to 9 P.M. = 8237001610 / 9552017476  ee . ~ 07.03. 2020 Mrs. PATIL VIDYA ABHAY — Age: 42 Years/F Investigations : — X RAY Lumbosacral Spine LAT & X RAY PBH- “AP X RAY Rt. Knee AP/LAT — , Gts 2 are a cor a a, ween,  aaa Tea ras TY ae ATA mis wa. TATA | He = a, HH MWA TITS Aa Treatment Advised Physiotherapy - IFT x 7d ce  Rest x 7d  — Tab. Flexura-D  — Tab. Razberg 20mg  — Voveran Gel Vy  Sawa SAM ATA, aT AT  e@ PANEL CONSULTANT - KRISHNA HOSPITAL / DEENANATH MANGESHKAR HOSPITAL "
REPORT,"Registration Id = fatent Namie? MS. PRANITA SONAWANE  ferred By + Sancheti / Puram Chetan De Age /Sex     CO Pune 0 Bangalore O Ahmedabad  www.rmmeadical.com     498323054 Registration Date/Time: 17/02/2018 7:22:14PM  Coltection Date/Time + 17/02/2018 12:00:00AM_ Reporting Date/Time +; 17/02/2018 / 09:47PM. + 8 Years 7 Femate            diologist, Radiologist.     R Scan of knee joint reveals :-  Depressed comminuted intrarticular fracture of the medial, lateral tibial plateau and intercondylar region of tibia with diffuse marrow edema.  An asteachondral defect in the medial tibial plateau, measures approx. 6.5 (transvers: 4,0 {depth).  Bone —_ bruise with marrow edema in head of fibula.  . Lager intercondylar displaced fracture tibia, measures approx. 32 (AP) x 28 (RL) 7  involved the attachment site of the ACL, suggestive of an ACL avulsion fracture. Contusion of proximal two-third of the posterior cruciate ligament,  Complex _ tear of the anterior horn of lateral meniscus.  Grade = sprain of the conjoined tendon at its attachment to the head of fibula,  . Grade I sprain of the mid and distal third of the MCL with wavy appearance, suggest  of high grade tear from its tibial attachment.  . High — grade tear of the medial patello-femoral retinaculum. 10,Moderate —_lipo-haemarthrosis.  DR. AMIT KHARAT  AL. SHAH, } RD Radiologist.   "
PRESCRIPTION,"UNMESH ORTHOPAEDIC CLINIC Dr. Atul A. Patil Consultant : Trauma Fellow,Katherinen Hospital,Germany, * Sancheti Hospital,Pune. Pelviacetabular Fellow Park]  and Hospital,U.S.A. ' Ph. : 25533333, 28999108 Hip Arthrosocopy Fellow,Herentals,Belgium.  @ Sanjeevani Hospital, Varvand. Mobile : 9422015760, Ph.:(02119) 283438  Date:- / f 03.05.2018 | Mrs. Patil Vidya Abhay Age: 41 Y/F/  Chief Complaints : C/O Rt > Lt knee pain  neck pain 2 LBP  heel pain 7 Bone profile: WNL  O/E Knee  Medicines : Cap. Altraday (Sun) 1....x.....x After food aathi  Tab. B-29( Corona) x....x.....1 car  Icegel  1....x.....1 2 weeks  Next Followup : 17/5/2018  Dr. Atul A. Patil  ts           d.Near Sane Guruji Smarak,Pune-411030 ,6.00 p.m. to 9.00 p.m no E- mail : atulapati!@hotmail.com Saturday, Sunday Closed.         J . ’ d Clinic Address-133 D/2,Parvati,Sinhaga "
REPORT," Bx  INCTS. | | rence:Dr.KHADILKAR VAMAN MD.DNBI - '. SUP. 44annannn .  ' NIRAJ A PATIL Reference:Dr. KHADILKAR VAMAN MD,ONB|SID: 119304904                              bo f oo f & 8 419304904 Re . Collection Date: bes REPORT > 14-07-2019 09:18 AM [ - Tal No: 919823 147602 Sample Date: po PID: 11202350 14-07-2019 09:18 am a_ Report Date: PO Age:13.04 Years Sex:MALE 14-07-2019 02:39 PM : - C * oe i s Test Description Observed Value Biological Reference Interval oe Plasma Glucose : re Plasma Glucose post glucose, by Hexokinase method 105 A < 140 mg/dL : Normal glucose tolerance i ‘ 140 - 199 mg/dL : Impaired glucose a tolerance / Prediabetes = >= 200 mg/dL : Provisional diagnosis E of diabetes Be American Diabetes Assodation bd Guidelines 2019 a | | < Glucose load given 75 gms E - aa rn post glucose load 2 hrs a - Hormones —_ Insulin, post glucose, serum by CMIA 95.40 / Peak upto 150 pU/mL = 1. Levels are increased in insulinomas, factitious hypoglycemia, insulin autoimmune syndrome, acromegaly bo : (after ingestion of glucose), Cushings syndrome, corticosteroid administration and levodopa usage. 2. Levels is are depressed to absent in diabetes mellitus, pituitary tumors and chronic pancreatic diseases te. cystic fibrosis. a 3, Insulin/C-peptide ratio Is used for differentiating between factitious hypoglycemia and insulinomas where Pe aratio < 1.0 indicates insulinoma; but results may vary in renal failure. 4, Antibodies to insulin form ts longstanding ee diabetes mellitus treated with insulin hence in these patients monitoring insulin levels gives better prognosis. . . : € ,  nee nee ape ace e RGE TLITE AE          - ° Dr. Venkatesh Keralapurkar  M.B.B.S.,D.C.P., D.N.B.(Path),  Page 1 of 2 Reg.No.: 076020       ment: pier wicttrenig’ Pare CragnOslice PVULICe hears, Bhandarkar Roa, Per CONTIN. (5 ww"" »* foe ' Ajit Golwilkary): tei%+91 20 6763 676372568 1400 / 2565 1407 as | a  tid ai ; a i woe eR y Ly a . 44 a ws 4 s on a . : ; 7 saat \10 (Pathology), DCP.g| ,EmaljJnfo@aadlagnostcs.com | yw anc ayn Sa = os Pe on’ oe ae ae - me ; rl i bi :  mn RE 7% AJ        a "
PRESCRIPTION,"Mansa Clinic...  Address: Flat No.6, Raviraj Apartment. Opp, Tennis Court, DP Road, Aundh, Pune - 07 Contact: 098 81 875915 / 020-41220466 Email :- dmvb@yahoo.in  Website :-www.mansacilinic.in  ~t Reg No: 2001/03/1356; MD [Psychological Medicine] (Clinic for Psychological and Sexual Health)  Niraj Patil Kothrud Depot, pune Patient id: P4740 By: Dr. Ninad Baste Prescription(Rx) Date: 12 Feb, 2021 Drug Name Strength _ Frequency instructions ; wh ke en a a ee ae man od Tablet Provanol (20 . 1. Mg) ""20 mg ED rae 10 tablets Moming Afternoon Night Tablet Pexep Cr (25 2M por 0 - 0 - 1 10 day(s) - Mo) - 25mg After Food 10 tablets Morning Afternoon Night 3, Tablet Arpizol (5 Mg) 0 - 0 - t 10 day(s) -"""" 5 tablets 9 ; 2 After Food Morning Afternoon Night  WISH YOU A SPEEDY RECOVERY  <= Dr-Ninad—  Baste  Generated On: 12 Feb 2021 Page 1 of 1 Powered by Practa "
REPORT,"| |        ae  ee i  7 4  a 7  (2. Vitamin B12 is decreased in  Reference:Dr.BHOME ARVIND MD, FAARC]SID: 120307012 —  420307012  | Collection Date: 14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am Report Date:  14-01-2021 07:42 PM                    NIRAJ A PATIL  REPORT Te No: 919823147602 PID: 11202219             Age:14.80 Years SexMALE Test Description a . Observed Value Biological Reference Inte rval TEST NAME Vitamin B12, serum by CMIA_ ° 269.0 - 187 - 883 pg/mL  eM 7  Interpretation : . . 14. Vitamin B12 (cobalamin) is necessary for hematopoiesis and normal neuronal function.      ES K, i 1 . : ; bv                                  Pregnancy Contraceptive hormones Malabsorption  Ethanol ingestion Smoking . Strict vegan diet Pemicious anemia  3. Serum methylmalonic acid and homocysteine levels are also elevated in vitamin B12 deficiency states. Active B12 ( Holotranscobalamin) is low in Vitamin B12 deficiency. a  4. Please correlate in case of patients taking vitamin B12 supplementation.  “> 7. pr. Venkatesh Keralapurkal  M.B.B.S.,D.C.P., D.N.B.(Patt  Page 40 of 1 MC-3t4 ~ Reg.No.: 076020. "" Accreditation as per ISO 15819:2012, Cert.No. MC-3143. Refer — www. nablindia. org"" A.G Diagnostics Pvt. Ltd.               { Dr. Awanti Golwilkar MO {Pathology’  4 Dr. Vinanti Golwilkat MD (Pathology   "
PRESCRIPTION,"@  Apert ata Stet Were aa Sasi wg da vat, rata ee., Stu wa.ses Ba.(G) wath. e.,  Aaa. (ST) tata. (Fae ) UBL. :3268C UPA.a. + 1A.C008 Prat. :2009/02/0880 CaM Wet Ase  cau Ue Ase  93 308d 4s, 32 Fare, SRGAIGERRL TEM, YET Bo HH | WHO WES  ata: Reg. No: 22416/15 01/10/16 | Name : Mast Neeraj Patil Male 10 years Rx 1) ZEMPRED 4MG TAB | 20 days ©) half tablet after breakfast 2) PRACTIN TAB  , 20 days half tablet after dinner .  3) FUSIWAL B CREAM 20 days apply after bath & at bedtime 7) MOIZ LMF 48 CREAM 20 days  apply after bath & at bedtime  Called on: 22-10-2016  BES  ————E Breve eT : IDIOT 8 9419 UAL. AC orferarht arreralt aftr eeant yof ea SA + PUA Ra daian wd SrTg NR STAT» "
PRESCRIPTION," T at W.da 2L.Wel 4.aa at.at.arerdt Watt ZL.at.at  ¥ wat ah. duet wade, aeursics (ge) a aah ad) Sata. (airs) a 008 ara. :2009/02/0088 Ura. 33 9ENC TATA. 2 LA cqar det asst Har Ase ) +390, Bo, 43 Pers werenHeR ey, SY VIN Reg. No : 25255/15 Date : 07-07-2018 Name: Ms Sakshi Patil 19 years / Female Rx » 1) NUTRET 5 MGM TAB , 1 WAT Oot Tat Sada Aer 20 Raa 2) PAPULEX CREAM (WOCKHARDT) Tal soar aray 20 feaaq 3) FASH FOAMING GEL (CURA TIO) UT ASTM ATTA. 20 Raa Wed aretawarat atte : 28-07-2018 = | yt 9 y —_—ooeo  ayerrean Soar : VETS 84s Ae. eate eafrarh arreoraht anh wears got ae ™ wa: BIA wee Sat we wIHTG AAA STMT "
PRESCRIPTION,Reg. No : 25255/15 Date : 07-07-2018 Name: Ms Sakshi Patil 19 years / Female  Rx .) 1) NUTRET 5 MGM TAB a 1 HAT Oot TEN Aaa Aer 20 Raa 2) PAPULEX CREAM (WOCKHARDT) Tat AAT aay. 20 feaa  3) FASH FOAMING GEL (CURA TIO)  Uo GeTEaATS aT. 20 Raa  Wd aratewaredt ake : 28-07-2018 +8        BIRT Tepret 9149 UE wferarh arrorat afer eidrarkt got aq sm qa : eM eta a eer ae TOME 
REPORT,"Reference-Dr.BHOME ARVIND MD, FAARC SID: 420307042                           NIRAJ A PATIL 1230712 Collection Date: 14-01-2021 10:37 AM REPORT Tal No; 919823147602 Registration Date: | D; 11202219 44-01-2021 10:31 am 7 Report Date. ‘ Age:14.80 Years SexMALE 14-01-2021 07:42 Pts 3 Test Description Observed Value Biological Reference interval : Serology : ; t Hormones , Insulin Fasting, Serum by CMIA 21.70 - Fasting : 2.5 to 25 pU/mL | . | SO - Peak upto 150 pU/mL |  Q        i #: i - % Page 9 of 12 © D ~e q “Accreditation 25 pot ISO 15819:2012, CertNo. MC-3143, Refer scope@ www nabl-india org Mi Venkatesh Keralapurkat Vy . - am ge cu _ ee de ‘|        _ pa pA se baeeiaty leg iw gives "
PRESCRIPTION,"Sense ata Becht weoter ta Ferrel mgs tat Rut, wahaien, Meerats gga) washed.  Cee, (ae) vee Fe ee Ur, .A.c008 Pra, 2009/02 /0080  "" "" + w t . eggouaitra A, 32 fara, maeaiit wan, FA Ro HM Vey WC}     Reg. No : 22416/15 28-11-2015 Name : Mast Neeraj Patil Male 9 years @ Rx 1) XYZAL SYRUP 10 eae 5 fi ot cat sacar ar. 2) FUTOP B CREAM (CHC) 20 eae AHO STAAL F TAY AoA watery . Utd seared ART s 19-12-2015 _ 2, __  Berea Foot ; VTS 1IaA3 UL.EA erferand areroralt aftr eaard qof ag aA | PIN Re Aaa Ud GIG Niaz Hosa "
REPORT,"Reference:Dr.BHOME ARVIND MD, FAARC|SID: 420307012 420307012  Collectio Date: 44-01-2021 10:31 AM Registration Date: 44-01-2021 10:31 am Report Date: 44-01-2021 07:42 PM  NIRAJ A PATIL  »  REPORT Tel No: 919823147602  PID: 11202219         Age:14.80 Years Sex.MALE Observed Value Biological Reference interval 3.40 See clinical information below .  Test Description Method : Nephelometry/ Immunoturbidimetry  CRP(hs) - C- Reactive Protein high sensitivity     _-  biomarker of inflamm atio n response to tissue injury or inflam mation.  Clinical Information : 1. C-reactive protein (CRP) is a and dramatically (1 00-fold or more) i  n. Plasma CRP concentrations increase rapidly  2. High-sensitivity CRP (hs-CRP) is more precise than standard CRP when measuring baseline (i.e.  a concentrations and enables a measure of chronic inflammation. It is recommended for ” Jrdiovascular risk assessm ent. Atherosclerosis is an inflammatory disease and hs-CRP has been  endorsed by multiple guidelines as a biomarker of atherosclerotic cardiovascular disease risk.     Low cardiovascular risk :< 2.0 mg/L High cardiovascular risk 2 >/= 2.0 mg/L Acute inflammation 21> 10.0 mg  -sensitivity CRP (hs-CRP) may not reflect an individual patient's basal hs-CRP level. required to firmly establish an individual's basal hs-CRP concentration. | hould be used as the predictive value. —  3. A single test for high Repeat measurement may be The lowest of the measurements S  Reference : Mayo Medical Laboratories  End of Report  ae     case  a ""oe Dr, Venkatesh Keralapurka M.B.B.S.,D.C.P., D.N.B.(Pat  Reg.No.: 076020  _. AG Diagnostics Pvt. Ltd.               Dr. Awanti Golwil : MO (Pat  { Dr. Vinanti Gotwi "
PRESCRIPTION,Reg. No : 06152 03-10-2017 Name: Mrs Vidya Patil Female 41 years  1) ALASPAN TAB 5 feqa aera 1 TU 1 eT ay |  2) CALOSOFT LOTION 5 eae. feaega am aor aratt     Wed areqearet ake s 09-10-2017 | an  Photestalste Letion     DTA eT : USTAT VIA UL. Mferara ArSrat afer zaarh yof tq Gat : SIN Ka Aaron ud Here Raz Honda     | . a ; eee ee : eee aS —E— ES eee ee. a ge A eer en ee 
REPORT," EE          NIRAJ A PATIL |Reference:Dr.BHOME ARVIND MD,FAARC)SID: 120307012                      120307012 ‘ . Collection Date: 14-01-2021 10:31 AM REPORT ta No 919823147602 Registration Date: PID: 11202219 14-01-2021 10:31 am Report Date: Age:14.80 Years SexMALE 14-01-2021 07:42 PM Test Description - Observed Value Biological Reference Interval Clinical Chemistry : Uric Acid, serum by Uricase method 6.90 - + Male child : (mg/dL)  ’ 1- 10 yrs : 2.4 to 5.4 a 11 yrs : 2.7 to 5.9 re 12 yrs : 3.1 to 6.4 13 yrs : 3.4 to 6.9 14 yrs : 3.7 to 7.4 15 yrs : 4.0 to 7.8  Female child : (mg/dL) lyr: 2.1 to 49 2 yrs : 2.1 to 5.0 3 yrs: 2.2 to5.1 4 yrs : 2.3 to 5.2 5 yrs : 2.3 to 5.3 6 yrs : 2.3 to 5.4 7- 8 yrs : 2.3 to 5.5 -. 9- 10 yrs : 2.3 to 5.7  ' U1yrs : 2.3 to 5.8 12 yrs : 2.3 to 5.9 13- 15 yrs : 2.6 to 6.0 Reference values have not been established for patients who are < 12 mths ofage.  DQ.  * aie - acid I is useful for 1. Diagnosis and follow up of renal failure. 2, Monitoring patients r receiving oytotoxic gs and a variety of other disorders, induding gout, leukem{a, psoriasis, starvation and other wasting conditions ae Increased uric acid is seen in following conditions ¢ 1. Increased purine synthesis 2. Inherited metabolic disorders 3. Excess dietary purine intake . 4, Increased nudeic acid tumover 5. Malignancy, cytotoxic drugs 6. Decreased urinary excretion . (due to CRF) 7. Increased renal reabsorption . : * Uric acid is decreased in: 1. Hepatocellular disease with reduced purine synthesis  2. Defective renal reabsorption 3. Overtreatment of uricemia 2 (allopurinol or cancer therpies like 6-mercaptopurine, etc).                     =  Dr. ""Venkatesh Keralapurkai  M.B.B.S.,D.C.P., D.N.B.(Patt Reg.No.: 076020  A.G Diagnostics Pvt. Ltd,  Page7of1i2. ""Accreditation as per ISO 15819:2012, Cert. No. MC-3143. Refer scope@ www. nablit        Dr. Awanti Golwilkar  MD (Pathology)  Dr. Vinanti Golwilkar  reorTey  IE an) ATs Oe dk Se ae  7 Aj Lo a = 7  5 =  q i . .     HO Ley a ? pee ers BBs a a RG Bo ma ee fen. ; 1 of NS ek Cana Ly \ 2 on 7 ft ye? SF ee Roto on ; ‘ eo an Me oe Re Pity | a B € >    "
PRESCRIPTION,"a 7” ,  UNMESH ORTHOPAEDIC CLINIC ~~  Dr. Atul A. Patil M.S.Orthopaedics Consultant : Trauma Fellow,Katherinen Hospital, Germany, # Sancheti Hospital,Pune. Pelviacetabular Fellow Parkland Hospital,U.S.A. Ph. : 25533333, 28999108 Hip Afthrosocopy Fellow,Herentals,Belgium. ‘ # Sanjeevani Hospital, Varvand. Mobile’: 9422015760. Ph.:(02119) 283438 “RK oe , Date:- l [ . 19.09.2017 | Chief Complaints : . C/O Rt > Lt knee pain { : neck pain &) 7 | LBP. 7 | heel pain O/E ' Knee Palpation : Tenderness joint line Movements : - * ‘i Painful & restricted terminally Special Tests : PF stress+ . Investigations 2 - | XR: Spondylosis _ ""be rr 4 ' Spur+ — DE | PF arthrosis mild =~ i “Medicines : Tab. Etoshine MR (SUN) 1....x...4 After Food race Tab. Razberg 20mg 1....x.....1 Before food ~c17 - | Cap. E-Cod plus — X..-X.... 1 After food , os Teegel 1.Xt | é lweek = Physiotherapy : LS Spine Extension Exercises, Core exercises Neck Scapular Exercises Knee Exercises - Q+H , Knee ROM, VMO strengtening IFT |  Ultrasound Stimulation  ; aaita ara 7a. aa SAG a - AG Wal ATE Ta « gal 8 west et AG AN A AT ST A JPA US Hare HAT Hr .                  Next Followup : 26/9/2017  ni 133 D/2,P —— —_ iran = E- mail : atulapatil@hotmail.com a p on797630 Saturday, Sunday Closed"
PRESCRIPTION,Reg.No:06152 22-07-2017 Name : Mrs Vidya Patil Female 41 years  Rx 1) Z CAPS CAPSULES 20 feaay 1 eat sat Saoae 2) CETAPHIL DAM CREAM 20 faq  Utd aaaqvardl ARG 8 12-08-2017  gel  WD).  — Bree Soo : WepraAt sects Ure. cac enferardt ararorat anf ears yet aq Get : Sua Ra Baten ud were Naz soda  . ee ee enn a 
PRESCRIPTION," Reg. No : 22416/15 | 7 Date: 29-02- 2020 . Name : Mast Neeraj Patil 4 3 years / Male  Rx oO 4) XYZAL 10 MG TAB Se WT 1 est Sweet As are 15 feaa . 2) FUCIBET CREAM  fo he ct gs ea. : ‘20 Raa  Wet arava arte : 21-03-2020 _  — amrfey zferarét gut ae ayapraft 19249 UR. c otras wrereralt sar: qa : 2 Pear Gea Salen ad ere SE SS  a= og, eee es ee 0 i ta tle mc wt A ahecd : i) ne "
REPORT," i General. tS, Setr 24, Nae Maal Gb Maharastra, i, Pn - 400705, VE? DIAGNOSTICS Tovar 22404500  21 Yer benae9 ANKYTA KALSHETT settee: aye Na estes Na sias20a 12500 eprtteene De 01-06992 00.00 Investigation ‘Observed Veine Reference Range ‘GD Wellness Kidney Profile 1 BUN God ea Nioogn) 298 33-17 = Sec, Mae: aed 2 Chin as or) not Se, Meo Aka pe 1 Ue mat 0 Se, Meo CeO, 4 BUNCreninin mia mm ses Seca, Mabe: aed S$ Ulead Fey 20-43 we See. Med ae OY © Cuan * 15-103 od Ser, Mee Oem cope 7 GPR (timed Glomerular tao Ra) wns Namo gg nL Sera Me: asin ieomacm! See doce nc ey fare <5  Interpretation  ‘A.tanal function panel could be ordered when a patient has rink factors for kidney dysfunction such as high blood pressuee (hypertension), diabetes, cardiovatcular disease, obesity, elevaied cholestesol, or u family history of kidney disease. A eenal function pane nay asa Be ordered when somone hs signs and yao of Kony case, dough ely Kidney ease fea dots nol cause any noticeable symptoms. I enay be initially detected reatine blood or urine testing, Renal function panel rele ae not diagno bu rather tia hat hee tay be a pote wih ie knoe un het fre esting is rye make a diagnosix and determine the cause, Rewults of the panel are usually considered togeiber, rather than separalely. Individual tant renult can be abnormal due to cuuses other than kidney disease, but taken together with risks and signs und symptoms, they may give an indicetion of whether kideey disease ia presen.           8 Viminai2 ns wont fe, be A  cave zzs2 ye ott,  Sep ese Tin 35-201 25041  ‘Report Relewse Date: 02-04-2021 00:00:00 ‘Avthorlzed Signasary Amaboriaed Signatory  Padent Name: ANKITA KALSHETTT Dr Anh Dhar De. Mabeds Hampe  Patient 1D: 2299942 MD (Microbiologia) (MD (Biochemistry == Page Yat 10,  “To lew your eapont. lg in war preventine orireponts, Feel your Patent 0 to download your report    "
PRESCRIPTION,"ald: : Reg. No : 06152 _ 25-04-2017 Name : Mrs Vidya Patil Female 3,738 years  !  > R& | 1) ZEMPRED 4MG TAB | 15 feat Ut Aare AVA 1 TAT ET. | 2) XYZAL 10 MG TAB 15 feae 1 Treat OT UN Fa aT | 3) DILUCORT OINTMENT (PRAISE PHARMA) 45 Raw Aa BAA | TA STATA TET  Utd argquaral aria 3 09-05-2017  > Be  a BeeAM AoaT : USTHt 293 WA.gac erferardt araorabt amnftr afcrandt ot a Saat : BINT Wa Aaion ud SHG Aa sa "
PRESCRIPTION,Reg. No : 06152 Name: Mrs Vidya Patil  Rx ; —) KERAGLO EVA TAB > 1 Wet et tet Aamac ay 30 faa ) MOMATE LOTION ware sintehar a ah Sadar 20 Raa aay  Date : 19-11-2018 42 years / Female  x  We aafevardh aie: 10-12-2018  \2     1.cdc enfant areraraht anftr zitrar&t gf aq 
PRESCRIPTION,"ae eS  Dr. Rahul Chaudhari  a Consultant Spine/Scoliosis Surgeon 3%  : 8 ‘ee y | HEALTH M.S.(Orthopedics), ECFMG(USA) 1% CLINIC Clinical Fellow - Adult Spine Surgery(USA) 2% : Complete Spine Care Clinical Fellow - Pediatric Spine/Scoliosis Surgery(USA) . *  Consultant Spine Surgeon | Jehangir | Hardikar | 7 Orange | KEM | Columbia Asia ———_ ee Ot DIA ASIA     UHID : PT00120 DATE : 04/01/2021 06:56 PM PATIENTNAME : MS SAKSHI PATIL AGE/SEX > 21 Yrs Female ADDRESS : Pune REFF. BY. 2 Q PRESENT COMPLAINTS NECK PAIN. LOSS OF CERVICAL LORDOSIS Rx MEDICINE NAME DOSAGE DAYS “ TABLET NUCOXIA MR 1---x---1 15 TAB. PAN 40 MG - 1-—-x---1 15     TREATMENT PLAN physio Neck ROM and shoulder scapular exercise with local ultrasound therapy with medicine  )  DR. RAWUW CHAUDHARI M.B.B.S., MS (Ortho), ECFMG(USA) Orthopedic Spine/Scoliosis Surgeon  Oo Winners Window, 202, Fergusson College Road, Behind Hotel Vaishali, Pune - 411 004 (91) 80101 30008) spinchealthpune@gmail.com @) spinehealthpune.com    "
REPORT,"NERAL DIAGNOSTICS 2e6 1 PrevantiNe Lile Care) Ltd. C=] General” Pot, Seclr-24, Naw Mumbai — Gi bKéNosnes                    ‘er orate ode! Mi PME, x2 @ — ‘MAHADEVI XALSHETA Aetoende Stony oMenaaeyo NA Cheetham: MA 4-3-2921 63600 (Reger Rekame Tike: 31-05-2001 P3085 SeNe Investigation Observed Valse ference Range Complete Haemogram Test Erythrocytes 1 Total RBC 455 4050 10%. 2 Hemoglobin 138 123.453 va. 3 Hematocrit (PCV) 43 3387 * 4 Mean Corpuscular Volume (MCV) 947 80-96 . 3) Mean Corpuscular Hemoglobin (MCH) 303 25-332 Pe 6 Mem Corpusculer Hemoglobin Concentration 320 94-345 ve 7 Red Cell Distribution Width (RDW-CV) 144 1245 * 8 Red Cell Distribution Wideh-SIXRDW-SD) 473 32.604 4 9 Nucleated Red Blood Cells 00 0-136 cells, 10 Nucleated Red Blood Cells Percentage 00 o4 * Platelets 14 Platelet Count 2700 150.450 10°9/uL 12 Mean Plateles Volume (MPV) 92 6-12 . 13, Platelet Distribution Width (PDW) 169 155-183 * 14° Plateletcrit (PCT) 028 0.12037 * Leucocytes 15 Total Leucocytes Count 90 4a 16 Neutrophils 528 on 17 Lymphocyte Percentage 330 1644 18 Monocytes Percentage 96 2.0100 19 Eosinophils Percemage at o7 20 Batophils Perceninge os O-1 21, Neuophils-Absolute Count ans 1.878 22 Lymphocytes-Absohite Count 297 148 22 Monacytes-Absolute Count 086 O10 24 Botinophilr-Absolute Count 037 0-045 25 Barophils-Absoluie Count 005 O02 ‘CRM No 2298400 er oth ‘Sample Recelved Time: 1-09-2001 16404 Report Release Duta 31-03-2021 2:01 Ahoried Signy Aucbodoud Suaony Frient Name: KAHADEVI KALSHETTE Dr. Dina Abba Dr. Mahesh Hampe Puen 1D: 2256400 DCP, DNB (Patios) MD (Biochemieny) Page hel 10  ‘To view your report, log in were.paeveniine.crgtepare. Feed you Puilant sD i dowedoad your mapas,"
PRESCRIPTION,ete. No : 22416/15 - 08-07-2017  Name : Mast Neeraj Pati| Male 11 years  Rx ‘o YW XYZAL5MGTABO OC; 15 Rag  17st et tet Aaoniae Shy |  2) EVION CAPS 400 CAps —_ 20 Raz 1 Het gat Saquriaz | |  3) ULAC CREAM . : 20Raq (6 oR carer 6 Fake mem aR Rah sae sere ery  4) FUCIBET CREAM 20 Rae 28 andthe @ wt ata are.  = Re ere mts 29-07-2017 IT  BUTEA eesr : ETA 8949 Ur. eae cafererdt wreroralt onftr want qof aq  at : SIG Wea Aare ud swag starz anonda 
PRESCRIPTION,Ads Reg. No : 06152 : 19-09-2015  Name : Mrs Vidya Patil Female 37 years : Rx ‘6 | 1) LAVETA M TAB 20 Raw 1 eat Ut TA Aaundacy ay 2) XERINA CREAM (RANBUXY) 20 fear  Ua Tal dows 15 Ae wea waa Moral Fat AeA TTT.  Utd argaqvaral ara 3 10-10-2015  5 oe.  eer ae ee ee SUA AST : WHT 88as U.EAC orfrarit arrerat anrfer efaardt gof «4 Ga : Hat wa daien ad Greg HR STOMA 
PRESCRIPTION,"Dr. Rahul Chaudhari aa  Consultant Spine/ Scoliosis Surgeon H . % S PINE HEALTH M.S.(Orthopedics), ECFMG(USA) °""e °, CLINIC Clinical Fellow - Adult Spine Surgery(USA) °: ; Complete Spine Care  Clinical Fellow - Pediatric Spine/Scoliosis Surgery(USA) :""  Consultant Spine Surgeon | Jehangir | Hardikar | 7 Orange | KEM | Columbia Asia Scan a etn ee     UHID : PT00120 DATE : 06/01/2021 04:03 PM PATIENT NAME : MS SAKSHI PATIL AGE/SEX : 21 Yrs Female ADDRESS : Pune REFF, BY. : Oo  PRESENT COMPLAINTS  CERVICAL PAIN WITH STRAIGHT SPINE. LOW VIT D3 AND VIT B12  \ { ‘ 1  \     Rx fo¥ j ‘ ‘  MEDICINE NAME a DOSAGE . DAYS INJ VITD3 6 LAK UNIT IM WEEKLY ONCE ~~ z 4 INJ VIT B12 500 MCG IM WEEKLY ONCE x 3 or le 1     DR. RAHUL CHAUDHARI M.B.B.S., MS (Ortho), ECFMG(USA) Orthopedic Spine/Scoliosis Surgeon  202, Fergusson College Road, Behind Hotel Vaishali, Pune - 411 004  ers Window Winn gmail.com spinehealthpune.com  @) (91) 80101 80003 © spinchealthpune@ "
REPORT,"1 Sancheti C: 42 ncheti ampus, +2/2/1, sa Thube Park, Shivajinagar, Pune - 411005.  ) Diagnostic Services Tel. : 020 - 28999800, 27999999, Fax : 020 - 25539675                                   yrs SONAWANE PRANITA RAMCHANDRA | S@X/ Age F_ 4 1g/Yiste of Report tno22014 Ho 1702103097 Referring Doctor | = pURAM CHETAN - pointe 000000381367 | Adress cara ] | HAEMATOLOGY 1 | | BLOOD GROUP A AH FACTOR POSITIVE < End of Report > & DR. MRS.JOSHI SAMPADA Pathologist Mp, DCP Reg. No. 37050  Collection Date: 1702/2018 / 19:45 9102/2018 / 19:51  Acceptance Date:  "
PRESCRIPTION,Reg. No : 06152 Date : 05-07-2019 Name: Mrs Vidya Patil 42 years / Female  > Rx | 1) KERAGLO EVA TAB 1 Hot Ut TA Hau AUT 30 feaa 2) MORR F 3 % LOTION  UAT SIAAT Tray . 30 faa  3) LIYANA HAIR REJUVINATOR  aieaerat arar 30 Raa  Utd arafevaredt attra : 02-08-2019 = Tey     Brrr Ser : Uepvasl 3 9cts UTei. ete enforarst aretorast anf ears yo eq Get : Eva Wa aren ud were eer soda 
PRESCRIPTION,Reg. No : 06152 16-09-2017 Name : Mrs Vidya Patil Female 41 years  Rx  1) XICTRA 250 MGM CAPS 30 fear 1 Test Ost Ue Hautarzt  2) MELALUMIN CREAM 30 Rae  3) BLISE FACE WASH (AJANTHA) 30 feae  ter Servant area.  Ut Saar aes s 14-10-2017  \2  Ady- SYR  DMCA SOT : eprest 8239 URL£ac orferardt areroralt anftr efter yor aq  Ta | PIM Wea Tarn ud Sarg ear anon 
REPORT,"NIRAJ A PATIL Reference:Dr.BHOME ARVIND MD,FAARC|SID: 120307012 120307012 Collection Date: 14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am                      iw. .  REPORT Tel No: 919823147602  PID: 11202219                                                   c Age:14.80 Years SexMALE 14-01 on a> ou (EDTAWhr et Result Biological Reference Interval Hemoglobin (Hb), EDTA whole blood — 13.60 VY 12.8 - 16.0 g/dL Method: Photometry So  Total Leucocytes (WBC) count. 10.700 4000 - 9100 /uL  ’ Method : Coulter Principle! Microscopy  *,  Plateletcount 308,000 450000 - 450000 /uL  \ Method : Coulter Principle / Microscopy *, Red blood cell (RBC) count 525 4.40 - 5.50 x 10%6 /uL 5 Method: Coulter Principle  PCV (Packed Cell Volume) = 41.50 37.3-473% -     \ Method: Calculated . . * CV (Mean Corpuscular Volume) . 79.00 81.4-91.9fL Ned Method: Derived from RBC histogram 7 a MCH (Mean Corpuscular Hb) 26.00 27.5 - 33.2 pgms Method: Calculated _ | MCHC (Mean Corpuscular Hb Conc. 32.90 33.4 - 35.5 g/dL Method: Calculated 7 . 0 RDW (RBC distribution width) 13.90 116-13.8% Method: Derived from RBC Histogram _ WBC Differential Count Method: VCSn / Microscopy / Calculated coe oa, ae Neutrophils se ; . os, 58 rn Absolute Neutrophils ee . 6,206 _ 1800 - 8000 ful. 7 Eosinophils 6 rh ae | Absolute Eosinophils — 642. | a 0 - 500 ful | | a: | of i Basophils - 0 %o “solute Basophils 0 0- 200 ub a t : ; : : ° mo, . ‘.ymphocy tes 30 . a 00 300 /ul ; Absolute Lymphocytes | 3,210 Naot “° re) | Monocy'* : 2 ne D 800 /uL Absolute Monocytes . 64 oe H ' @@# _ nn . ‘ . noe a | Rote . . ate . . ” . . : ) , , 7 . , ” F : : | ; < \ : | whe +» | pr. Venkatesh Keralapurka! , ; M.B.B.S.,D.C.P., D.N.B.(Pat! i : 020 Page 1 of 12 Reg.No.: 076 MC-3143. Refer scope@ www.nabl-india.o org"" A.G Diagnostics Pvt. Ltd. a as per ISO 15819: 2012, Cert.No. ae eee | | a . :          4 Dr. Awanti Golwilkar MD (Pathology)  4 Dr. Vinanti Golwilkar 4 340 (Pathology) "
REPORT," NIRAJ A PATIL  '  REPORT Ta No. 919823147602 PID: 11202219     Age:14.80 Years SexMALE  Test Description Observed Value — Biological Reference Interval  Clinical Chemistry :  Serology RA-Rheumatoid Arthritis, serum by Nephelometry Negative (<9.19)  Clinical Information : 1. The diagnosis of rheumatoid arthritis (RA) is established primarily on clinical criteria and seroloic findings. 2. Positive results indicate probability of RA . \ The tire of RA factor correlates poorly with disease activity. *y JHowe ver, patients with high titres tend to have more severe disease. 5 Patients with various non rheumatoid diseases characterised by chronic infammation (like SLE polymyositis tuberaulosis, viral hepatitis, infections mononucleosis and influenza) may have positive tests for RF.  *  Reference:Dr.BHOME ARVIND MD,FAARC}SID: 120307012  Collection Date: 14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am Report Date: 14-01-2021 07:42 PM  - Negative : Below 15.90 IU/mL  120307012        Page 8 of 12 MC-3143 . ""Accreditation as per ISO 45819:2012, Cert.No. MC-3143. Refer scope@ \ www.nabl-india.org”  Dr. Venkatesh Keralapurkal M.8.B.S.,D.C.P., D.N.B.(Patt  Reg.No.: 076020 A.G Diagnostics Pvt. Ltd,     { pr. Awanti Golwilkar  ! Dr. Vinanti Golwilkar  ann satiate    "
PRESCRIPTION,". ‘ Dr. Rahul Chaudhari 3 ; ne/Scoliosis Sur :  Onsultant Spine/Scoliosis Surgeon 3 eve, SPINE | HEALTH M.S.(Orthopedics), ECFMG(USA) : AA CLINIC Clinical Fellow - Adult Spine Surgery(USA) L °° : Complete Spine Care Clinical Fellow - Pediatric Spine/Scoliosis Surgery(USA) ° :  Consultant Spine Surgeon | Jehangir | Hardikar | 7 Orange | KEM | Columbia Asia           UHID : PT00119 DATE : 04/01/2021 06:08 PM PATIENT NAME =: MRS VIDYA PATIL AGE/SEX > 43 Yrs Female  ADDRESS : Pune REFF, BY. : oo  PRESENT COMPLAINTS  LOW BACK PAIN  BILATERAL HEEL PAIN  Rx  YAEDICINE NAME DOSAGE - DAYS TABLET GEMCAL PLUS noom o—[—°- 90 TABLET NUCOXIA MR ( ier food) 1a--x=-1 15 TABLETPAN-D | (0 fe Coos) oe 1-—-x---1 15 INVESTIGATION |  X RAY LS SPINE AP AND LATERAL  X RAY THORASIC SPINE AP AND LATERAL X RAY BOTH CALCANEUM LATERAL  MRI WHOLE SPINE SCREENING  TREATMENT PLAN : physio with medicine  4 A | . DR. RAH AUDHARI M.B.B.S., MS (Ortho), ECFMG(USA)  ED Ex A S com) . Orthopedic Spine/Scoliosis Surgeon we J [—  Spine     8 FEF8264 90° a Dipteec        Yet 342.356 #30        © Winners Window, 202, Fergusson College Road, Behind Hotel Vaishali, Pune - 411 004 (91) 80101 30003 © spinehealthpune@gmail.com © spinehealthpune.com "
REPORT,"NIRAJ A PATIL -  REPORT Tea No: 919823147602 PID: 11202219  Age:14.80 Years SexMALE  Test Description Plasma Glucose :  Plasma glucose fasting, by Hexokinase method     >  clinical Chemistry  Creatinine, serum by Jaffe w/o deproteinization  “Acc ee as per ISO 15819:2012, Cert.No. MC-3143. Refer scope@ www.nabl-india.c org""  4 yo                                Reference:Dr.BHOME ARVIND MD, FAARCISID: 120307012  120307012  . Collection Date: 14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am Report Date:  14-01-2021 07:42 PM  Observed Value  Biological Reference interval  80 < 100 tng/dL a 100 to 125 mg/dL : ‘Impaired fasting © glucose tolerance / Prediabetes  >/= 126 mg/dL : Suggestive of diabetes mellitus (On more than one occasion)  _ American Diabetes Association Guidelines 2020  0.63 0-11 mths : 0.17 - 0.42 mg/dL 1-5 yrs : 0.19 - 0.49 mg/dL  _ 6-10 yrs : 0.26 - 0.61 mg/dL 11-15 yrs : 0.35 - 0.86 mg/dL.  Veatch Dr. Venkatesh Keralapurka! M.B.B.S.,D.C.P., D.N.B.(Patt  Reg.No.: 076020  4.G Diagnostics Pvt. Ltd.     Page 6 of 12  { dr. Vinanti Golwilkar [| : MO (Pathology) |  ibdacaanbinliinetitenttn! J  . ne ames ape eg ltt HE A i catena ce te an ie ry . Pe ee rn,  j Dr. ‘Awanti Golwilkar MO (Pathology)        aa ef Fe cH  a  ate "
PRESCRIPTION,Reg. No : 22416/15 | Date : 26-09-2018 Name: Mast Neeraj Patil 13 years / Male  Rx 1) XYZAL 5 MG TAB oe TAT TOG 4 THY Boy 15 Raa 2) FUCIBET CREAM 3) JUENE OIL  Utd aaah arte: 10-10-2018  vTe     Bree oor : Herat svt UL.eae erferarh arrarat afer eearh gor aq Gat : Sv Wea garter ud were ataz senda 
PRESCRIPTION,"4 r Reg No: 2001/03/1356; Address: Flat No.6, Raviraj Apartment. Opp, MD [Psychological Medicine] Tennis Court, DP Road, Aundh, Pune - 07 (Clinic for Psychological and Sexual Health) Contact: 098 81 875915 / 020-41220466 Email :- dmvb@yahoo.in Website :-www.mansaciinic.in Niraj Patil Kothrud Depot, pune Patient Id: P4740 By: Dr. Ninad Baste Prescription(Rx) Date: 22 Feb, 2021 Drug Name ‘Strength Frequency | ; ~ Instructions Bed ete te ty eb ce cern ey la cnet punt gee Re a cana oe Be tare cet cct ent kat caer cer ce dd eeabilie ce led Bet tecae at ata decie eel fo SD tke Te cine a Be teat ee eee ated Og eet ote od Tablet Provanol (20 1 zomg ee 10 tablets Morning Afternoon Night . Tablet Pexep Cr (25 Pere 0 - oOo '- 4 10 day(s) 2. Mg) 25 mg After Food 10 tablets Moming Afternoon Night g, Tablet Arpizol(5Mg) o - ) - th 10 day(s) "" 15 tablets 9 2 | After Food Morning Afternoon Night WISH YOU A SPEEDY RECOVERY tC men Dr. Ninad 4 Baste SUPPLIED SCHEDULED H mae i . oot Oe Bul No [b3-1.....Date ba RES PRAKASH MED. & GET ‘andl : §, No. 157 Shop No. b- Pune? pA te q oO \ '~ ¢C O) \e rA Aste S¢ poh s ters R ut S: é Li] Q eeNnne OS age Generated On: 22 Feb 2021 Page 1 of 1 Powered by Practo "
PRESCRIPTION,"S.wert aaa State were ta seas nget aa  drt, wratatea., shew.sies wi. (got) wa at at.za.,  i Hata. (Ase ) (at anne Ur. : 1A.c008 Wr.aF. :2009/02/0030  Taal Wer Test Ta Wat Ave i 9 330d Ya, Fe Fare, wareaste Ta, Ft Fo GH: W¥¥O WL ara: Reg. No : 22416/15     05-12-2015 Name : Mast Neeraj Patil Male 9 years 9g Rx 1). PRACTIN SYRUP 20 Rag 5 fF ot cet sodrn ar. 2) FUTOP B CREAM (CHC) 20 fear UHIo STANAMAT I UAT AGATA MEY . Utd araqaquaret are s 02-01-2016 Se AT eA ~ _——  BUA AGT : AHS 13a B.edc crferardt areroralt anf ear qof aq Ga : PI Td Aare ad Seg Naz soda "
REPORT,"Po er a he = & GB Se2ebenc ""eh. a PE. Gk DIAGN ANKUTA KALSHETPY spite Bi Yost 0 Menticis) a cutee Ma svat ose ost ener anan           Investigation ‘Observed Valne Reference Range     ‘Tron Studies {Iron,TIBC, Transferrin saturation} 1 tm  wast 0-1 wa Sern, Mod: Fee  2 TC 008 20-40 we Sere, Meo Ferme  1 Transferin sturaion us 20-99 * Sera, Mend: Caled  Interpretation  1. Serum ison measures th Level at eon inthe guid portion of the blood. Low iow levels may een in anemia (uctocytc and $spachromie) «High levels ef seu ifn in hereiary hemochromeodts,malipe blood tanfusons, and «few other condiuans,  2, TIBC (Total iron-binding capacity) mesaures all the ‘in blood available to bied with iron, including transfertin.TIBC dent i a good inditoct measurement af transfertin. The Body produces transferrin in relationship to the need foe iron. When ftom,  frre ae lo, rnsfoin ves sncreae and vic vera, Sie ancerin ithe Piney soning poten the THBC tnt 2 food leciret meosierent of anfernavaabliy     CRM Ne 229942 ye owt. SanpleResived Tie 31-49-2001 200031  Rapert Relense Date: 01-04-2021 00-0000 ‘Auorlad Sipatory ‘Aaaboriaed Stgainry Prudent Name: ANKITA KALSHETTI Dr Anju Dar 1e. Mabesk Hampe Pada! 1D: 2299542 MD (Microbiologia) MD @lochemlary) — Page Sal 10  ‘To-vew your rapar, og is ww prevanine.orghepar, Feed your Patent iD to everina! your repost, "
PRESCRIPTION,"iuerwada shahwedty.ad siztecesituad ducted, tewsesengt) water,  : Asta. (Hag) rd ese Werat.:1acoot =a. :2008/02/o¥88 ea ate Rear diac a in SW Qo, ’ ‘ 320, WeIR 96, ak PTR, MReATEAATRE TAT, WH Ro, WH : WRK ORCO4 Reg. No : 22416/15 Date : 10-09-2019 Name : Mast Neeraj Patil 13 years / Male Rx Oo 1) ZEMPRED 4MG TAB 1 Test wears aeeartae aa | 15 fea 2) XYZAL 10 MG TaB  Cot TE 1 tit sitqwnamh fs ara 15 feqa aay  3) FLUTIVATE CREAM + NIVEA CREAM Coa OU Wale AeA aur 15 aq 4) VENUSIA MAX LOTION  Rare reheat welt ima . 15 Rag  S } 5) ABZORB POWDER  areata aaa : 15 Rag  WT araleward atte; 24-09-2019  pe  rere s: zr 481 are cc eed tera ont aah go we BITTE SOT : Borst 2949 wWesede orferargst arereredt . Nt : Sua we ain ad eae aera "
PRESCRIPTION,"DR. ASHOK N SOHONI CLINIC : A115, New Friends Soc  no _ Opp ‘Vanaz’, Paud Road, Kothrud, ~é@ M.B.B.S., D.C.H. grereee Pune 411 038. Regd. No. 48430 oe  Ph. : 8975345221 *For Emergency only Sn NN  Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to 9:00 p.m. Saturday & Sunday Closed - . Please apply for number on ""SMINQ"" app.        Name: Vidya Abhay Patil LO Date: 05-12-2019 11:04 am Age/Sex: 42y / F _--,- Mobile: 8830403320 Office ID: AS19235  sited: _ 1. Tablet Vocepo 200: 1-0-1X5 feag  MLA PRIA, wal Sava 2. Tablet Viscold:  1-1-1x5 féaa TRAT Hea, gut hme ha  Dr. Ashok Sohoni -- ~~"" 3Get sirens sitsatrar flesar docon.co.in "
REPORT,"fon @& O22 & ste Hora eecore ca navi varoes |S, ) Gi bixeNosnc  Maharanhisa, ins. Plo - 400708                   ‘aboard on PE. SP @ 7 aa 2 vent oMeomy0 soca KALSHETT setae na chet wa seo 193500 Anpethdneebue: 0104210000000 Tnvestigation ‘Observed Vale Reference Range HbAtc (Whole Blood) 1 eA te Gee amet 58 Hondas * (EDTA Whole Blood, Mathod: HPLC Excelleat Coutrol: 67 emt Poor Courot' 510 2 ina Aree nse AD) mez Selma ood. (EDTA Whole Blood, Mathod: Cucalaind ‘eoatral  12-150 mop: Feit contol $3190 mya  tad iSO mgd. Poor aairad  Interpretation  {the term HbA te refers to Clycea Haemoglobin, Measuring HbA le gives an overall picture of what the average Mood mgat  levels buve been aver a period of weeks/month, Higher the HbAl& the gresier he riak of developing disbeterrelnicd complications,  Alc has been eadocsed by clénical groups and ADA (American Diabetes Assocation) guidelines 2012, for the diagnosis of diabetes using a coLoff point of 6.5%. ADA defined biological reference range for HDAlc is between 46M. Patients with HBAle value between 6.0-6.5% are considered at risk for developing diabetes inthe future. Treads in HBAI< area a bet indicator of glucose contol than standalone tes.  3.To eatimate the €AG from the HbALe value he folowing equation a mcd: eAGImp/dl)=28.7°ATe-46.7.  ‘4.Diabetic must aspze to keep vanes under 7% to avoid the various complications resulting from dishetes.       4 Ghose (Farting) mm ‘Necuad :>70- 100 a. ‘vera Phare, Mutha: Habis Pre Diabars: 101 Bees Interpretation  ‘Glucose is the primary energy source fos the ed's cells and the only energy sowrce for the beain and nervous system High levels oF glucose most frequently indicate diabetes, but many oiber diseases and conditions can also case elevated blood glucose. Hypoglycemia is characterized by a drop in blood glacose to a level where first it causes nervous <ysiemn symptoms (eweating, palpilations, hunger, trembling, and anxiety), then begins to affect the braie (causing confasion,  ‘blurred vision, abd sometimes even coma and death.  Bad Of Report  oan sisser “ ot  Sample Received Time: 31-08-2001 20041  Report Release Dat: 07-04-2021 00:00:00 ‘Aseria Sigatmry acherznd Sgrsory  ‘Patiemt Name: ANKITA KALSHETTI ‘Dr. Dina Abbasi (De. Mahexh Home: eens CRD Pabeiogyd MD Qinchomingy) Page Wo 10 "
PRESCRIPTION,"| T ata SLUGW Aad SLaLaAradt waa st.aLeastt w teeth watdie., shuw.sies w.(gt) walaie.,     i. ehetet. (Gag ) oath oe) UST. : LA.C008 Uer.F. :2009/02/0088 waar  9330,u@Ira do, Ja forara, TRTATETHRAR VET, GT 30. THAT : &4293C04 ee OE ee  Reg. No : 06152 Date : 07-07-2018 Name : Mrs Vidya Patil 42 years / Female Rx  pa) 1) DOXYFINE LB APS  1 thet Reernens wet Saute bor. | 20 feaa  2) Z CAPS CAPSULES 1 Wat gat Sauer 20 ftaa 3) B GLOW CREAM (RELY ON) | SMA array 20 feaa 4) D ACNE PLUS GEL tet te Geoae aay | 20 feaq  5) GLYN GLOW FACE WASH  > tet Servarnsy argc 20 Raa  Re rela are : 28-07-2018  SF Ae  Se ST: Sa are ard ata a "
PRESCRIPTION,"DR. ASHO CLINIC : A1\5, New Friends Soc, ST MB. K N SOHONI Opp ‘Vanaz’, Paud Road, Kothrud, B.S., D.C.H. screen Pune 411 038. , Regd. No. 48430 Phone : 8975345221  Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to 9:00 p.m. Sunday Closed       _ Please apply for number on ""SMINQ"" app. Name: Abhay Patil Date: 19-04-2019 06:17 om Age/Sex: 48y /M Mobile: 8975345221 ID: AS4145  Medicines: 1. Tablet Symclav LB 625 1-1-1X5 feaa TA SIR, FIR aoa, Tat aaVAAT 2. Tablet Deriphyilin a y 1-1-1X5 faa , TRA BOTA, GIR OTA, WAT TOA 3. Tablet Predmet8mg | *-~. 7 ok ee ee 2-5: ee a ae TRA BIA, gant daorin, TA IITA 4. Syrup Mucolite 5 ml -5 ml - 5 miX 5 ae FO BIA, SIR ATOR, WA TOA 5. Tablet Montek LC (10 & 5) 0-0-1X 10 faqs - WA ATO     :  Dr. A$Shok Sohioni | Book appointments and view your prescription online at docon.co.in    "
REPORT,"GENERAL HAGNOSTICS raventiNe Lie Care (P) LS. Plot-6, Secor = 24, Navi Mumba     General’ Hahoreta: ide, Pr-O Gi bixeNosnes Tol #81-2240450000 a 2 Yam(o) 0 Mascttey = Be. were Bone           Within Normal Range 28 Pistelets Adequate Ou ‘Smear cane no 229860 uP ot Sample Received Tome: 31-09-2021 16a [Report Release Duta; 31-13-2025 20:30:18 Aathorized Sigmeory ‘Authesiand Signatory Pie Name: MAHADEVI KALSHETTE Dr. Dina Att y. Mabesh Hep Pen 1D: 298480  BCP. DAA (Pathology) MD (Biochemistry) §— Page 2 10  “To view vour menor. jog In wen. preventing crorencrie. Fed yous Patient ID so dawertned yous report,"
PRESCRIPTION,"etuset aaa statarerdt waa Za. aaa Wa funt.watidien., dewrses ea(gt) wate.  asta. (55 ) Beha (aa) Weta. LACOOS 2fr.F. :2009/02/0888 era  30 Ugiaa 8S, AH ferara, wRPATSAHHHeR LEM, GI 30. HPT: &42V3CO4 2330, ; , enn LC  Reg. No : 22416/15 Date : 07-07-2018 Name: Mast Neeraj Patil 11 years / Male Rx 1) ZEMPRED 4MG TAB 1 Meat wept ATCA Bey 15 faa 2) XYZAL 5 MG TAB - | UA Sao 1 aaAt aay 15 Raw  3) DILUCORT OINTMENT (PRAISE PHARMA Fe  HIG STG FT Tat sce | 15 faa eagy .  Wea ara hrwardt ake : 21-07-2018  rrr  —  sprerrear Sar « Beorast 4h aL che arent aera anh eheart yok aq lala Gaal : PUT wa dain ad erg ater asa "
PRESCRIPTION," CLINIC : A1\5, New Friends Soc, DR. ASHOK N SOHONI Opp ‘Vanaz’, Paud Road, Kothrud, Ett 238 M.B.B.S., D.C.H. ese Pune 411 038. Regd. No. 48430 . Phone : 8975345221  Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to 9:00 p.m. Sunday Closed     Please apply for number on ""SMINQ"" app.  Name: Abhay Patil Date: 23-07-20"" 9 06:55  pm  Age/Sex: 49y /M Mobile: 8975345221  ID: AS4145  airy: 1. Tablet Zincold: 1-1-1X5 feaa ALA BETA, FART HAO, WA SATA 2. Tablet Deriphyllin: 1-1-1%X5 feaa “Aeat SeareR, SANT AAO, Tat BAVA 3. Tablet Dexona:.. a __ 1-1-1X5G we En ALAT BRITA, FART HATA, TAT STOTT _4. Syrup Macbery: 5 mi - 5 ml - 5 miX 5 ae Teal eI, SANT HAAR, Wat AACA     Dr. Ashak Saqhoni sia sitremea aitewtoan firerat docon.no in   "
REPORT," LOWENT LRAT OF DETECTION OF Thal ABRAY: 4 COPERAA.,  (NOTE: Thia mena dows nat detgel HIV:2 infection.  (COMMENTS: Kindly corretate clinically. Paradaxicel requits can be due 10 1) sample collected In non replicating phase of Infection, 2) asl irtecion wit HIV-1 &2 wherein FV~ reptcaon le suppressed. Advieed to pent fe teal shar + month ¥ required.  ‘TEST INTERPRETATION:  Real Time HIV-1 assay uses primers mnt probes against he highly conserved region in the Ltr gene for the detection of HIV! Including genetypes A, 8, C,.01(0), D2(A}, 03(0). EYAE), Hand 01(0) anc O2(0). An unrelated RNA sequence Is simultaneously amplified by PCR, and serves 8s an Internal control to demonatnsts that the process has proceaded orrectty for each sample. Values below the detection limit of the asamy do not axcude possibity of pn infection. Wray fetect the viral ined betow the detection limit of the essay. Viral load can vary because of verous reseone Ike vertedon"
PRESCRIPTION,"Sr. Arereadt WHT Seer Sp erst Wert sal  | Shyer aaa = ios WIG) watatee., dzea waa. atewn.aias wa.(gt Bach Get) as 31EWe Ueor.a7. : LA.C008 ti. :2009/02/0080  wae a 933 08a 02, 8 Aare, WET wT, FI 0 GH 1 WV WC3  { afigg-NOTUSTSZ———— SSO 72017  Name: Mrs Vidya Patil Female 41 years |  Rx O 1) DERMALENE CAPS (SIRA NA TURALS) 20 fae 1 eat OH taht Aaorax ay 2) VENUSIA MAX LOTION 20 feae Rat oie & we stacen maT. Teg ye) 3) B GLOW CREAM (RELY ON) 20 fear aera srarsrat a wht SGA Tey  ~ pate We earavaret As 8 29-07-2017  40h     9  See Sor : VETS 333 URL.eac eferars arreret anh want oof aq Gat : PIM Wa Fare ud Grog RZ sO "
PRESCRIPTION,"DR. ASHOK N SOHONI CLINIC: ANS New Friends Soc,  ‘Vanaz’, Paud Road, Kothrud, Soh M. B. B. S. ,D. C. H. SERRE ag is Opp  Pune 411 038. Regd, No. 48430 Ph. : 8975345221 ‘For Emergency only  Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to 9:00 p.m. Saturday & Sunday Closed Please apply for number on ""SMINQ"" app.       Name: Vidya Abhay Patil Date: 10-01-2020 07:00 pm Age/Sex: 42y / F Mobile: 8830403320  Office ID: AS19235 Vitals: BP: 120/80 mmHg  site: oo 1. Tablet Eticort (6 mg) :1-1-1x3 faa TRA SIR, FIN Aare, wit daordaz | 2. Tablet Folvite 5mg : 4 - 0 - 1XSteay TRA Sea, Wat saondae  aan SE LER = aetna ape ey 0 — . o- toes pe ane | Deen gg  Dr. Ashok Sohoni 7 3ntet Srrenga strate fiwar docon.co.in "
REPORT,".qgnchetl Sancheti ¢  a i i Thube Pan oPus: 12/211, Fiagnostic Services k ube Park, Shiva                                   el. 020 - linagar, Pune - 441005. ‘0 - 28999800, 27999999, Fax : 020 - 25539675 SONAWANE PRANITA RAMCHANDRA, Sex /age e [pean 21g hpate of Repent 1a} 1702103097 Pavantoaw | po ‘722018 M CHETAN 000000381367 Adtress 6 Ai 2 ~ — - —-.__IMMUNOLoey  alue _...._ Normal Range        HBsAg (Screening Test) Non reactive (0.392} COI Non-reactive : < 0.9 COl Borderline Reactive : 0.9 - 1.0 COl Reactive : > 1.0 COI  Suggested confirmation on fresh sample followed , by HBV DNA PCR if necessary.  < End of Report > Ree iS DR. MRi JOSHISAI IPADA  Pathologist Mp, DCP Reg. No. 37050  srngqanrs 11945     Acceptance a 7 351  : pate. 1 19212018 #19:  mene 470212018 2036  oport Pi yo18 12027 cot Print Date! 17102 ; 7 Pp ° "
PRESCRIPTION,"Stuat aaa stated waa states waa dent watatiea, dtaewrsies wa.(yt) waft atea.,  Ata. (aia) otstedt. ae jesse Lae i: Wear.a. :2009/02/0  re, aneue UST. : 1A.C008 eee  caer  2330,4aila Yo, te fear, wRAAICAAaR TEM, FI 30. HET: &42V3CO4  Reg. No : 06152 Name: Mrs Vidya Patil     Date : 27-08-2018 42 years / Female        Rx 1) XICTRA 250 MGM CAPS . > ee wat hot tet Storer A 20 Raw 2) ME12 OD TAB 1 het gant Aaonar 20 fea 3) B GLOW CREAM (RELY ON) SANG aaty 20 feaa ™ 4) BILUMA CREAM Ue Ta STtiat Stat araty 20 Raa ) Ra setae ate : 17-09-2018 =P | > YT     Drea ToT : Herat 88a8 UA. afore arraraht anh esas yor xq "
PRESCRIPTION,"SLMS Tat Stared were Aa Seas wer fa ahentt, wradtatva., dhuwr.ates wa, (gt) wy ata,        Betas, (aia) acta. (Ase ) UST. 13 7ENC UL. : 1LA.C008 Tt.T. :2009/02/0030 TAU! War asst CaM Wet asst eee 8 83 ona 4d, Fo Para, warm KM, TA 30 TH : Wve WL3 ala: Reg. No : 06152 28-11-2015 Name : Mrs Vidya Patil Female 37 years Oo Rx 1) RX1 10MGM TAB 20 fear 1 Wet Vet Tet Aauax ay 2) ZEMPRED 4MG TAB 20 eae Cot AaTAY ATVATAAT 1 TAY Ar. 3) MOMTAS 10GM CREAM 20 Rag anlar sitalaslat a UA ATTA array. Od araaqvaread args 19-12-2015 ~c Wey red  iGfats .%  2h 77 ore The £00 ene  a oe oe - 9 ~ Daye"" Supplied For Lat Pay  BOTA AST : Barat 3949 Bs.Eae rferardt arereratt amfth earardt oot ag et : Sua wd Aaa ad were star soa"
PRESCRIPTION,"aiuegiada siabmedtuda sftahaor uda avert. wistat.es.,  shewr.sies wa.(Gtt) val acta,  Boast (as) stata. (7ag ) Pera. 132EUC Ura. 14.6009 Wer.a7. :2009/02/0030 SAU Wey ASST TAU WT ASST  aan antenatal nmmmnmmmmnnecmmmemmmanniel 9330, ualfsia 46, I2 fora, sRdoncadies WAI, YU 30. wWior : V2VEDN3COY ae mar nna enenrnenemnane eae naman  Reg. No : 22416/15 Date : 05-07-2019 Name: Mast Neeraj Patil 13 years / Male  1) CANDITRAL CAPSULES 200MG 1 Hot Tt TAN Aaa AUT 15 feaa 2) ABZORB POWDER | — AGMA ATA - 15 Raa 3) EBERNET 30GMCREAM |  TA AMT Aa . a 15 faa  aRat araiarit ari : 19-07-2019 | | —_ i ans     me BMA ser : Betast 1393 BL.ete erfrarht arerarat anf eaard gof aq = "
REPORT," IAGNOSTICS           fe Care (P) Lid. ‘ ny GD See Inca, Pin - 400708 pelotinc hi 0450000 at MAHADEVI KALSHETTI ‘AgeGoodar: woe o rred By! NA (Cllawt Neenet NA ctlon Dutet 31.08.2021 16: ‘Raport Bcease Deter 31.03.2021 20:30:15 Investigation Observed Vane Reference Range er Function Test 1 Billrubin Total 083 02-12 mg dL Serum, Method: endrauak rot 2 Billrubia Direct 004 001-04 mg dL Serum, Method: Diaroiztion a ‘Billeubia bndirect 079 001-10 mg/dL Serum, Method: Calculated 4 Aspartate Trunsaminase (AST/SGOT) AT <3s WL Serum, Method: UV Kisetic with PSP 3 Alanine Transaminase (ALT/SGPT) 18.2 <3s WL Serum, Method: UV Kinetic wits PSP 6 Alkaline Phosphatase 75.0 30-130 Ww Serum, Method: AMP ~ pNPP Kinetic 7 ‘Total Protein 674 64-82 wa Serum, Method: Biuret ead pot 8 ‘Albomin 416 34-5 va Serum, Method: Beomacrescl Purple (BCP) cy ‘Globulin: 288 1939 a Serum, Method: Calnlated 10 AG ratio 161 10-20 Serum, Method: Called 11 Gamma GT 82 $-85 ua.  ‘Serums, Method: C glotamyl exrbony sitroanilie        No 229840 ue ot  ale Received Time: 31-03-2021 16:40:45, °  Bans Dt 3-05-2001 20305 Atherie Sitry Aateracd Ste  ot Name: MAHADEVI KALSHETTI ‘Dr. Dina Abani Dr. Mabesh Hampe  nt ID. 2298440 DCP, DNB (Pathology) MD (Biochemisty) Page 4of 10 "
PRESCRIPTION," DR. ASHOK N SOHON] _ CLINIC: Atl5, New Friends Soc,  Opp ‘Vanaz’, Paud Road, Kothrud, Regd. No. 48430 , Ph. : 8975345221 ‘For Emergency only  ‘Sena etree nee anc A AE SAAS SS AAPA aE aS Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to 9:00 p.m. Saturday & Sunday Closed Aenean ag A A a PES SA A a TA SS       Please apply for number on ""SMINQ"" app.  Name: Niraj Abhay Patil = Date: 05-02-2020 08:51 pm Age/Sex: 13y 10m 16d/M Mobile: 8830403320 _ Office ID: AS1326  - site): | 1. Tablet Montecope : 0-0-1 X 10 faaq TAT HaOTAT 2. Tablet Deriphyllin:1-1-1xX5ff7q Tea Heariar, ZAR Sara, Wal Aaoay 3. Syrup Machery :5 mi -5 mi -5 mi X 5 feaa | ARG Sear, GIR Sao, Wat Savirdax  Dr. Ashok Sohoni ‘ .  a1aet sitters sitaetrar feat docon.co.in "
PRESCRIPTION,"Si. waned. da Si. Uh. aed w. da <i. dt. aati a da  aired. wataiue., Aag.aew.(g) Hat aR (E58)  Bz. (ate)  uf. i‘ vaeve TN. a. : 39gue CEM. FH. s JOoY/02/OURU a= aU WaT AST  Name: Mrs Vidya Patil 43 years / Female Rx >) 1) ZEMPRED 4MG TAB 1 Hol Geprat ATA ey 15 feaqe 2) RX1 10MGM TAB | | 1 host Ut Tet STANT ey 15 faa 3) FUCIBET CREAM |  tor aitdtaia @ walt diet ara. - is haa  Ua aaah ake : 29-01-2024     Tore amt: Terres 94.8 9 GE, & AC APTA MTereTAH onity eae Gut ae Gan : Poa wa Aah ad Bre Rar sondag   "
PRESCRIPTION,"Swope 4.4 Smedt weet ta seat wg ae divert, catate., ftuwa.ates BaF) wy tate.  dda. (air) asta. (Fae ) zara. “stew UST. : .A.c008 tfer.a. :2009/02/ 0939 Tae Ta Toe CAT Wey Ae  eae TT 933 oueitra te, 33 Prare, HETATeTARR Te, YT Fo HH: Wwe WER  ee Ae: Reg. No : 22416/15 25-04-2017 Name : Mast Neeraj Patil Male 11 years eS) Rx 1) MACPRED 4 MG TAB 15 fea UT MATS ALATA 1 Test GT. 2) PERITOL TAB . is heart 1 Tost Cet TAN STAT ITT 3) FUCIBET CREAM 15 feat Tat AGM 4 wl - Trea  Utd aaquaren artrat : 09-05-2017  ee aprerreent aan : Barat 8th Wea. cac orferardt mrrereorabt af efaardt of aq SN : BINT Wa Aaten ue Greve BTA aT "
REPORT,"es (A | nce:br BOM | fe NIRAJ A PATIL Reference:Dr.BHOME ARVIND MD,FAARCISID: 120307012 —~-4 420307012 a Collection Date:     * HDL Cholesterol, serum by Enzymaticmethod 41 _ i . Men :> 40 mg/dL - . . . Women : > 50 mg/dL  x VLDL Cholestrol, serum by calculation = .—s_ 20 me — $30 mg/dL ise th LDL Cholesterol, serum bycalculation . _ 440 t. '.. Optimal: <100 mg/dL  Near optimal/above optimal : 100-129 mg/dL  Borderline high : 130-159 mg/dL  High : 160-189 mg/dL  ; a Very high : >/= 190 mg/dL «|     Asse REPORT ta No 919823147602                          14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am Report Date: 14-01-2021 07:42 PM  PID: 11202219  Age:14.80 Years Sex MALE  Test Description Observed Value Biological Reference Interval Lipid Profile Mini: . —  Cholesterol (Total), serum by Enzymatic 4740 Desirable : < 200 mg/dL method Borderline high : 200 - 239 mg/dL — oo, =. High : >/= 240 mg/dL  Triglycerides, serum by Enzymatic method 100 = ’ Normal : < 150 mg/dL Borderline high : 150-199 mg/dL High : 200-499 mg/dL et ; Very high : >/= 500 mg/dL  Cholesterol(Total)/HDL CholesterolRatio «| 4.17 . Males: Acceptable ratio </= 5.00 He. 7. Females : Acceptable ratio </= 4.50  LDL CholesteroVHDL CholesterolRatio © 268 2 Males : Acceptable ratio </= 3.60 | a, oe - Females : Acceptable ratio </= 3.20  Reference : ATP Ill, NCEP Guidelines and National Lipid Association (NLA) 2014 Recommendations  As per most international and national guidelines including Lipid Association of India 2016 :  1. Lipoprotein and lipid levels should be considered in conjunction with other atherosclerofic cardiovascular disease (ASN) risk determinants to assess treatment goals and strategies. - .  2. Non-fasting lipid levels can be used in screening and in generd risk estimation.  Vebetk  Dr. Venkatesh Keralapurkal M.B.B.S.,D.C.P., D.N.B.(Patt Page 3 of 12 Reg.No.: 076020 ©  Hassan as per ISO 15819:2012, Cert. No. MC-3143. Refer scope@ ¥ www.nabl- india. org” , A.G Diagnostics Pvt. Led.           MD (Pathology)  me 4 j Dr. Vinanti Golwilkar  atte apeiniay f -  f ""a Legacy Of           a fora nant Colwilker’ )     : 7. am? OE . : | ' "
PRESCRIPTION,"Mansa Clinic  Phone: 088 81 875915     ‘Nie Patil Male, 15 Years Patient Id: P4740, Blood Group :At +918830403320 Kothrud Depot, pune vidyapatios05@gmalt.com     By: Dr. Ninad Baste        Prescription(Rx) Date: 14 Apr, 2021 Drug Name Frequency. fnstructions Tablet PEXEP PLUS oo 0 - 1 40 day(s)  1. Ao tablets 12.5 mg ea  ‘Tablet Provanol Sr (40  2 Ma) 40mg 1 = 0 - 0 40 eave) 40 tablets Moming Afternoon Night Tablot LOSURE o o - t 40 day(s) 3 4mg a Food T 20 tablets Moming Afternoon Night Aor  Gonaratad One 14 Aps 2024 (Computer Ganeritad, No Signature RequiredPage 1 of 1 Pawared by Pract "
REPORT,"O Pune 0 Bangalore O Ahmedabad     werwnmmedicat.com  registration Id : 498323054  i : Registration Date/Time patient Name: MS, PRANITA SONAWANE. Collection Date/Time: 17/02/2018 12:00:00AM  Reporting Date / Time 7102/2018 7 09:48PM. Age /Sex 2 18 Years / Femaie  7402/2018 7:22:14PM     Referred By + Sancheti/ Puram Chetan Dr     3D- CT SCAN OF LEFT KNEE JOINT     ‘he tibiofemoral and patellofemoral alignment is maintained  here is depressed comminuted intrarticular fracture of the medial and lateral tibial plateau and he intercondylar region of tibia. The attachment sites of ACL & PCL are involved. There is  pproximately 13 mm lateral tibial plateau depression posteriorly and approximately 3 mm medial ibial plateau depression.  2 larger intercondylar displaced fracture tibia, measures approx. 32 (AP) x 28 (RL) mm, involved @ attachment site of the ACL, suggestive of ACL avulsion fracture.  e lower end femur and head of fibula are intact.  ere is moderate lipo-haemarthrosis.  PRESSION:-  * Oo d intrarticular fracture of the medial and lateral tibial plateau and the intenondylar region of tibia. The attachment sites of ACL & PCI are invoived. There is approximately 13 mm lateral tibial plateau depression posteriorly and approximately 3  mm ial ti au depression. . . CTS a nar cieplaced fracture tibia, measures approx. 32 (AP) x 28 (RL} MM,  involved the attachment site of the ACL, suggestive of ACL avulsion fracture. * Moderate lipe-haemarthrosis.  7 DR, DIPAL SIAN DR AMT KLARA lotogist, Radiologist. "
PRESCRIPTION," T aa zi. were ade ait. merdt 0.2a a .al.aarsit 7  - wat ale. dentate, Heese) ae ad ) fateh. (ais) asi. + 10.c008 ara. 2009/02 /0088 efarat. 13 86¥C ae —  Reg. No : 06152 Date : 29-02-2020 .. Name: Mrs Vidya Patil 42 years / Female Rx S11) ME120D TAB 1 Mest Tet TAY Sao AT 20 faa - 2) CELIN 500 MG TAB US Aa AVA 1 Test Aer. 20 Raa 3) CETAPHIL DAM CREAM | Apia STAAL I UAT BTaTAT 20 faa 4) CITASIA CLEANSING LOTION | cee yoarerst a 20 faa ger aratwant arta: 21-03-2020 oot     eprerreey Sar : Tesrost 2949 WU. cae erferarh arereorast aftr waar got zg aA : SUN Wa Faia ud Seg ear aot "
REPORT,".< 5 _ NIRAJ A PATIL Reference:Dr.BHOME ARVIND MD,FAARC|SID: 120307012 4 . 120307042 Collection Date- 14-01-2021 10:31 AM     REPORT ta No. 919823147602     oe Registration Date:  r PID: 11202219 14-01-2021 10:31 am 4 Report Date: 4 | Age:14.80 Years SexMALE 14-01-2021 07:42 PM Sie  4 | Complete Blood Count Findings  R.B.C. : Normocytic, Normochromic ram | W.B.C. : Noabnormality detected Platelets  : Adequate  Remark |: ONFOLLOWUP.     ; . ure | ; »> e413  th 3     ~ « ten. 3  pam ee ao *  LR nS  ei  * Dr. Venkatesh Keralapurka! M.B.B.5.,0.C,P., D.N.B.(Pati  Reg.No.: 076020 AG agmenatice Pot. Lid,  a “_  mee     Page 2 of 12 itation as per [SO 15819:2012, Cart.No. MC-3143. Refer scope wee ratte of      , fo [ be. “want i Golwikar  | Dr. Vinarti Gotwilkar q MG Pamciogy!  op atl sabee eicitienians Al ited"
PRESCRIPTION,"Amer ata Stared waret ta Sheratt wget ta dtert. wsttie,, temas) wate,     Bata. (air) etetee. (Jae ) UBL. s38EVC UF. : LA.C008 Wr. :2009/02/ 080 TIT WET ATS CaaT WT Ass emer SS 9 3300s ta, Se Rava, we TAM, FT Fo HH: Wve We} ala: , Reg. No : 25255/15 24-12-2015 Name : Ms Sakshi Patil Female 16 years  ] Rx 1) CELIN 500 MG TAB 20 fear 1 Wet SUR Sao 2) ZOCON 200MG TAB 6 Raa 1 Wot arraret a Rare welt 3), ABZORB POWDER | 20 Raq “atch | 4) LITEARM CREAM 20 Rae  ey Utd arava aria 14-01-2016  2  BUTT Sear s WTO $19 GTA. EAe afore arrerat anf ears yor +e Ga : SIM wa Aaron Ud Bg Ra sO T "
PRESCRIPTION,"Zier dae tzid uaa | si zitereraff wad ft.vadh. waste, fu w.stes Ta.(G) wat atea.,     \ Ada. As ) ie ey waa. > LA.C008 erst, :2009/02/0888  wade 2330, warty %, ag PATS ARTISTA Taq, a 30, THA + WRAWYWRO 03204 |  Reg. No : 22416/15 Date : 11-10-2019 Name: Mast Neeraj Patil 13 years / Male ry 1) ZEMPRED 4MG TAB 1 eat aca Ue feaasHs 20 fea 2) FOLVITE TABLET 1 MoT SO SAU | 20 fede _ 3) HHLEVO TAB 1 Mot Tat TN Aa aT 20 fee - 4) FLUTIBACT OINTMENT ne AAT SHTATATAL SF TAT ATTA 20 faa  att . 9 ga araftwandt atte : 01-11-2019  ops  The Scheduled Medicine/s befare Supplied For -J.—Daysizonths  — eee tice aprrreet Set : TTT 9 tc Ua.gaC otftrarft arerareét aftr zfaandt got aa Gaal : PTA ora data ad wre AA SOTaA "
REPORT,"tre | GQ ze & é . Miseeort kine |e, oman Gb bikNosnc  Maharanhisa, ina, Pio - 400703        Tol: #91-22-40450000, BNO, as PME. ae @ 7 mere te rem me veenomame  a” ANKITA KALSHETTI Aetenter,  Esa SA conve na  BF comand nea isssen myn tie 0.06201 0000        Investigation ‘Observed Value Refereoce Range     ‘Thyroid Profile - Total T3,Total T4,TSH (TFT)  2 Touts sas4 0-200 a ‘ine, Mtoe CLA 2 Touts 3012 5-5 wa aru, Mat CIA TSH Thyroid Stimulating Hormone) am 035-55 suet ‘Sun, Mod CLA Interpretation 1. Triadothyronine (13) is produced by the thyroid gland and slong with thyroxine (T4) help contol the mat at which the Than cy levied Pace perdido wil aw tel acne pyran,” “  2.1the mast comman causes of thyroid dysfunction are related to autcimmune disorders, Graves disease canses hyperthyroidism, batt can uo be cand by thos, thyroid cancer, and excesive production of TSH. Total 13 is med w tess tyres tion.  3: Fly lvl may indy hey may sat oer ed pts mh ymin $v Tl ay nc peri Thy ma tes er pre ns me year spate go, Aeterna eae, et  4. Thyroid-tizulaling bormone (TSH) stimlates the production and eeate of T4 (primarily) and TS. They help contol the ‘ite al which tbe bod} tses energy abd ae regis fy a feedback system. Mout ofthe Ta cules tm the Bod omad 12 rein, while wall percentage Sree (ac bod).  45..ab has estimated Total TA reference intervals that are specific for toda, using the inlet sampling techaique  Eat eetd a desumeat: Ooning Houbithing aod Vniying Reference lnevas nt Clameal Caboray: Apel ‘Gcideline-Thind Ebon.  ‘5. Thyroid harmone atos during pregnancy:     cao 22982 1 ot  Soop Peed Time 318.2021 200-41  Report Release Date 017-042021 00:00:00 Anaborized Signatory Aabcxied Sigrery  ‘Patient Name: ANKITA KALSHETTI ‘Dr. Dina Abbani (De. Mahesh Hamp  Pee Nene: 4 Dor bi Pag Moa) repeat  “Tow your report, login wine praventine.orgapots. Feed your Patient ID to download your report.    "
PRESCRIPTION,"SLUM Ta SsLatarid! Wada stat.aasht nda derthwdtadte., dthuwrsies wi.(qt) wat at.ea.,  oLsledt. (Fae ) fea ene fina. : > 1A.C008 URr.T. :2009/02/ 0089  1330,daia Oo, 83 ferara, sRaATCaHeR VM, TH 30. HA: £ 4233604  Reg. No : 06152 Date : 26-09-2018 Name : Mrs Vidya Patil 42 years / Female Rx 3 1) ME12 OD TAB : 1d gard Sauiaz 20 fea 2) DOXYFINE LB APS 1 Wet Raesns wet aqua ey. 20 faa 3) D ACNE PLUS GEL te tel yroiax watt 20 Raa  Wea aretewardt ate : 19-10-2018  Emelene, Crear Acbeel oi Go)  eee Seem Sor : Harel 1249 Ul. erferardt arrerait anf efrart qof aq “sr ern: a See aon a eta TA"
PRESCRIPTION,"DR. ASHOK N SOHONI CLINIC : A1\5, New Friends Soc,  _ a Opp ‘Vanaz’, Paud Road, Kothrud, 2 M.B.B:S., D.C.H. ete Pune 411 038. Regd. No. 48430 Ph. : 8975345221 ‘For Emergency only  Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to9:00p.m. Saturday & Sunday Closed Please apply for number on ""SMINQ"" app.       Name: Niraj Abhay Patil . Date: 10-01-2020 07:02 pm Age/Sex: 13y 9m 21d/M | Mobile: 8830403320 _ Office ID: AS1326 7 .  aia: | 1. Tablet Viscold: 1-1-1 X5 faa 2. Tablet Vohist M : 0-0-1 10 faz Wat Aaa  Dr. Ashok Sohoni ~~ mmr atrten~ me Wet siteret siteutaar fisat docon.co.in   "
REPORT,"(GENERAL DIAGNOSTICS: PreventiNe Lil Cara (P) Lic. lok, Sector 24, Navi Mumba Mahareahia, lei. Pia 400705, Tel: ¥81-22-40450000,  Gi General” “WE? DIAGNOSTIC e@     21 Yeas) 0 Monacs) DeyayFomale                                  NA a1g-2021 1935:00 Rept Reese: 01-04-2771 0000-0 Investigation ‘Observed Volne Rference Range Lipid Profte 1 Tow Cheleserat m2 ~a ‘Sem, Meo: Pooomty 2 ‘Trighycerides Bo Ciel er, Med: yuan pol comida 1 HDL Ctoteneal 26 ed ‘ers, Meo: Peony 4 LL Cheteueeot wa.e0 mt ‘Ser Mae: Pvt $C ADL rato sas ‘erm Mahe Calehad 6 VDL Chateeert 1500 a ‘Ser Mei: Caled 7 NeaHDL Cholesterol 10 Dine 90 ay =a ‘Sie Matic: Cae Berrie ae Very High a ‘LDL /MDL mio 1st ‘Opeimal: <2.3- ‘Seeure, Mathad: Calevdatad News fig Interpretation LTeighyoerdes: When triglycerides are very high greater than 1000 mg/L there ie a ik of ocr citron n iycendct change deaatcaly tn feponue vo fasiatoeteasing ts chao $ to tes Niger as fang (eves ua af ours ater etn. Even fasting Yn vary coossiersly dag so ay. Taseotes odes changer asuog Iglycordes measured on differen days are nol ezmdered 1o be bvexmua,  2, HDL-Cholesterol: HDL- C is considered to be beneficial, the 20-called “good” cholesterol, because it removes excess  ‘cholesterel from tisaues and cares it to the Ker for diapoaa. If HDL-C ia less than 40 mig/AL. for men and leas har 50.  for women, there ia an increased rik of heart diseave that is independent of other risk factors including the LDL-C level. The  [NCEP guidelines muggeat hat an HDL. cholerl vale greater an 60 epi protective ad sow be eae ws egaive ok factor,  3. LDL-Cholesieral: Desired goals for LIDL-C levels change based on individual risk factors. Foe young adults less than 120 mg/dL in acceptable. Values between 120-159 mg/dL aze considered Borderline high. Values greater than 160 mg/dL. ae ‘conuidered high, Low levels af LDL choleateral may be seen in people with an inherited ltpoprottin deficiency abd in people with hypenhyraidiam, infection, inflammation, o¢ ciethosis.          CRM No 2199842 iad ot  Sanple Received Tima: 31-08-2021 2:0:41  Roper Release Dai: 03-04-2021 00:00:00 Anchorisd Signatory ‘teriacd Sigaiony  Front Name: ANKITA KALSHETTL Dr Dia Aan De Mabeah Hampe  Pao 1D: 2299542 DCP, DN (Patan?) MD (Blochemiary) Page SalI  “To view your report, log in wan pervenine.cegaparia. Feed yore Pasent iD to dowmtoad yon report. "
REPORT,"SENERAL OUAGNOSTICS 20 fo &  Preven le Care (P) Uk,  Plot-6, Sector - 24, Navi Mumbad ot Sa - ~~ Gb i ) BixeNosnc ®  Maharasic, nds, Po - 400708 “Fol: #81-22-40480000 GB PHE SLe                          21 Year) 0 Montes) ANUTA KALSHETT Awroanter 2iseom SE tae NA (Ca amt NA a Catton Date 31-o2annt i950 Rayert Reese Bet: 01-06-2021 0:00:00 No Investigation ‘Observed Value Reference Range Liver Function Test 2 labia Tout ost on12 wa Saran, Mao: ada at 2 pllrebia Dies, ont-o4 wa Saran, Mato: san 3 Bllabisfaitet ass rey orm Saran, Mato: Cleind 4 Asparate Tramarinee (AST/SGOT) mr as uw. ara, Mato: OV Mine i Pa 5 Ale Trazansinase (ALTISOPT) np a we Saran, Matt: OV Mint i PEP 6 Altaline Phosphate ao 0-10 wa Saran, Mand: AMP — pNP Kae 7 Total Proton 1 4-82 “7” ‘aca, Mad: Rae and pat 5 Attain ax was 7 eran, Mate Roc Pap (C7) 9 Globulin an sgas “7 ‘enum, Mato Calon 1 AKG 182 19-20 ‘Soran, Mood Caled 11 Gamat ma 5-88 wm ‘ican Mod G stacy ebay sania CRM No 2299942 ad oth ‘Semple Reorived Time: 31-08-2021 2004} Oe . Report Release Date: 01-04-2021 00:00:00 Authorize Signatory 7 Aathoxized Sigrmsnry ‘Patiemt Name: ANKITA KALSHETTI ‘Dr Dina Abani (De. Mabe Hepa: Paine iby 2069842 DCP. DNB (Pabalogy) MD Ginchomiay) age ted 1D  “To.siow your report, loin rm. gepvnine ong. Face your Potent XD 20 omndote your rps. "
PRESCRIPTION,"siyergia.aa — sieitarerdt w.da  furtwataien., auesies wa (gt) Beta. (ata) tfrat. 131680 WR. + 1.A.c003  TAA Wet AH  aL .at.erast 0.aa  wal at.ea., BAR. (Wee)  UWA. :2009 /0%/ 0088 Taal Tat aow  Tajo, watra 4a, oy rare, WeertTeaHTeR Wall, YI Ro. TH : WRK 080% RR  Reg. No : 06152  Name: Mrs Vidya Patil 42 years / Female  Rx or 1) FOLLIHAIR TAB  1 thet Wer Te Sara Bt a hinoreit bron Sy:  Date : 10-09-2019  30 feaa  ‘  orders wat 1 ft. deat «= 80 fea  3) LIYANA HAIR REJUVINATOR  Uta arafemaredt arte : 12-10-2019  ) Dozit sods 3a | ae ar Sel  30 ftaa  *K 10 Ra SS  5) Morattuseont OUDE Oh Edler) ctieey  ore Aor : Barat was B.cac oferarht araerat aftr eiearst Got ae  Gat : Sua Ua Aaa Ud Hes ANA OMIA "
PRESCRIPTION,"Suet ata St.meardt were aa seat wget aa fer, wate, stewi.sies war.(Gtt) wy at atea.,  i AAA. (Fs ) . (aie Sr caneue wer.T. ; 1A.6008 Wr.F. :2009/02/ 080  ee  ————————— ————————————— e33 oui 0a, Se Rae, WAAICTARE TAT, YL Fo HH : Wve WLR     ATL:  Reg. No : 22416/15 02-04-2015  Name : Mast Neeraj Patil Male 9 years  Rx  1) BANDY PLUSTAB- 1 eae ‘1 tat wat ort we oy . |  2) ZEMPRED 4MG TAB | 10 Raw UT aA AAT 1 THAT ah , : /  3) PRACTIN TAB , ag Rae 1 Wet Wot Va Aaway ay  4) PERMITE CREAM  wet sen moa sinha ae avant ws oy a aT YT. oa Wares aT |  5) FUCIBET CREAM 10 R  fr atic wet eho eat,  “Ot aaaquardt ake s 13-04-2015  The Schaduled Mé zien ere feflareo  RN  Supplied For RONG E TT Li Baaihy  Bore Awe - WTA 29a? Wal.cad ofaardt Brrwrat arnfer zea uf se"
REPORT,"GENERAL DIAGNOSTICS PravantiNe Life Gare (P) Lid Plot 8, Sector-24, Navi Muna     G :  = Ge 1 se GiB Bikénosncs oe! ck ar @ soem     Tol: +91-22-40450000                            ANITA KALSHETH Aeiienter NA Cuaetme a1g-2021 1935:00 eyar eae Bde: Investigation, Obaerved Vater  Complete Haemogram Test  Erythrocytes 1 Toul RBC 492 4nsa Trey. 2 Hemoglobin 4 123-153 ea 3 Hematocrit PCV) 457 By * 4) Mean Corpuscular Vatume (MCV) 928 80-96 ca 5 Mean Corpuscular Hemoglobin (MCH) 292 ASB PS 6 Mean Corpse Hemoglobin Concentration 314 DAMS AL 7 — Red Cell Distribution Width (RDW-CV) 42 1215 * 8 — Red Cell Distribution Width-SD(RDW-SD) 468 32-004 a 9 — Nuclented Red Blood Cella 0.04 0-136 cellspL. 10 Nucleated Red Blood Celli Percentage Os oF *  Platelets LU Platelet Count 274.0 150-430 10° 12 Mean Platelet Volume (MPV) 91 6-12 aL 13 Platelet Distribution Width (PDW) 168 155-183 * 14 Plateleterit (PCT) 0249 012-037 *  ‘Leucocytes: 15 Total Leucocytes Count 80 44-11 10°. 16 — Neutrophils 459 0-77 * 17 Lymphocyte Percentage a3 1644 * 18 Monocytes Percentage a5 20-100 * 19 Eosinophils Percentage 34 or * 20 Batophils Percentage os 0-1 * 21 Neutrophils-Absolute Count 3.67 18-78 10° 22 Lymphocytes-Abrolute Count 30 148 10°. 23 Monocyten-Absolute Count O68 01-10 10°3/pL 24 — Bosinophils-Absolute Count 027 004s 10°3/yL. 25 jophils-Absolute Count 0.07 002 10°  ene No 22295042 we owt  ‘Sample Received Time: 31-49-2021 2000341  Report Relene Dat: 01-04-2021 0:0000 ‘Autorine Sipatory ‘vaborand Signatory  Padent Name: ANKITA KALSHETTI Br Ant Dar De. Maheoh Hamp  Paeay 1D: 2299642 MD (Microbiologia) MD (Biochemistry) Page La     To ew your report, log in www.preverine.capheporta. Feed your Paters AD to eneninad your repost. "
PRESCRIPTION,"Supe ata Stared weer ta Som mgt ta sturft., wr atatve,, oh... ates wer (Ut) waite,     SL she. (aire) | ehstedh. (ag ) | MRA. 39642 A. : LA.coot U.. 22004 /02/owsig 2 owahtra ts, 32 Aare, RATER TaN, TY 30 WA > Ww We RES. No : 2416/15 | 22-07-2017 Name : Mast Neeraj F Patil Male 11 years | —Y) XYZAL10MGTAB CT . 10 Raq 1 est Ot Ue Aaa Ay | 2) EVION CAPS 400 CAPS. - 20 Ray 3) ULACCREAM 20 Rag Pf oes ee se a) FUCIBET CREAM 20 Raw Us Sreaesrat a wt ale wre  . 5 Utd creavaret ass 12-08-2017,"
PRESCRIPTION,"t  Sweet ata S.Aredt wane ta seat ug da  fur. eatdtiva., dtuw.des w.(gt) . (aie  fra nee Wer. + 1AC008  Taal Wat asset  wat stee., Bata. (Fae )  tPF. :2009/02/0088 Taal Wet Asst  g33oueta Us, ao Aare, serrate GM, FI Fo BH : Wve C3     Udi Reg. No: 06152 16-04-2016 Name : Mrs Vidya Patil. Female _ 37 years .-m Rx 1) AZITHRAL 500 mg TABLETS 6 Raz 1 edt dent g Feat Tet 2) XTRAGLO TAB 20 Raw 1 Wat tet wet Aquriac hy 3) BETADINE AD SHAMPOO | 20 Raz ""Seas ws dar (eFaert) siretsteareast 10 at 15 FARE SHU EA Bath, saz yor . | 4) NUFELIX SHAMPOO . 20 Rae NSISaIGA Ua Fay (efeartt) Seo SHA ET Sart, ce Z-) 5) NADOXIN GEL 20 Raz tH tet Yeatat arany  Rei ara aks s 07-05-2016  en  —_—  DOTA AST : NHS 3949 U.EaAc arferardt arereprast amfer eferandt Got wa Gat : PIT wa Aaron ad Sree Naz soda "
PRESCRIPTION,"Ww wh Mansa Clinic...  wut  re Reg No: 2001/03/1356; . Address: Flat No.6, Raviraj Apartment. Opp, MD [Psychological Medicine] Tennis Court, DP Road, Aundh, Pune ~ 07 (Clinic for Psychological and Sexual Health) Contact: 098 81 875915 / 020-41220466  Email :- drivb@yahoo.in  Website :-www.mansaciinic.in  eres ee ee eR ne ete ee a ent nts me mm ar ml A 7 rates ree en er ge Oe en ge ae ee eee     Niraj Patil Kothrud Depot, pune Patient Id: P4740 , By: Dr. Ninad Baste ‘ Prescription(Rx) Date: 6 Mar, 2021 pec . SNM Oe ee Date ser es sce te ae pata teat Lege nt Se oe ae ata sentir ces en a ne a and Tor tems Mere REY vege cy NE * ~ . DrugName ss Strength” | Frequency 5 “Instructions 3 ae ee eA le eee WE eal a cane lat edt Reha co aentitd ai Lev aA it bien Pawel Gan dws netie he PE HSE ce peel ote ceeenrins Means 1 Tablet ARIP MT 10 ha) - 0 - 1 20 day(s} "" 20 tablets . mg After Food Morning Afternoon Night Tablet PEXEP PLUS , oOo - 0 - 1 20 day(s) 2. 50 tablets 12.5 mg . ; After Food Morning Afternoon Night f Tablet P 1(10 . no rovanol ( 1 - 0 - 0 20 day(s) 3. Mg) 10 mg : ; After Food 20 tablets Moming Afternoon Night  WISH YOU A SPEEDY RECOVERY     Dr. Ninad  SU PP LIEV |: Baste  SCHEDULED H prog ale. | Bill No AA}2. Bs? RE a. GEN, STORL-  PRAKASH MED. $. No. 157 Shop  Pune? pA aap -at “weg ees 1% aad ant  cory “PI * seg * OrveNlers ""Wey - al  No. 10 Aundb  \  Generated On: 6 Mar 2021 Page 1 of 1 Powered by Practo "
REPORT,"oF . + . 7 - vy ~ , v : 7 om  a Satya Supt Specialy Hostal a. oo, an o> : nn os  . _Decean Gymkhana. - oe , 7 ae . ne 0 ES 7 | | ,Sahyadti * | DEPARTMENT‘ OF . BEHAVIOURAL SCIENCES AND MENTALATEALITN | ls - SAHYADRI SPECIALTY HOSPITAL — a     ~ PSYCHOLOGICAL EVALUATION REPORT - | "" DEMOGRAPHIC ‘VARIABLES: ~ - ea  Name oe Master Niraj pail a Gender Se ce os Male a ely “pateofBith : 20/03/2006 er eae | Age a ~ - os : F 2B years . “ Education _ / ° : | ae 7 standard | - ~ - Referred by cs / SE Dr. Bhooshan Shukla | ee. # ne og linet:     ~. Referral for ee,  : Psychoeducational Assessment  | Mother 7 eee  rae —_ ron io x aoe wa oo @ Bete a it fee mp peel PLS, mo Boe: aan BE  % boas roe a tf Se T, poe, he . - oa fon a bg ge =  - _, Informant a —  i t 1 ET, fob byt  _ PURPOSE OF TESTING: 7     Testing was conducted i in order to assess his level of intellectual, academic and aaa -  - functioning. =     al at tee SL  ~  He was well groomed and alert when he came in for the assessment. Rapport. was 3 _  be te ap te  9 established properly. He was motivated and co- operative for testing. His attention could be  : aroused and sustained for appreciable period of time. His. receptive ‘and expressive language oo  en mmprece RE AT GINDRE EER UPE, UEP SPE  are if  ‘= =. skills are adequate. He was able to comprehend and follow test instructions. adequately... --- cette  ° TEST ADMINISTERD:  a  - 1. Malin’s Intelligence Scale for Indian Children (MISIC). sees ene  wr et Rr a ene ee aat  2. NIMHANS S.L.D index Specific Learning Disability. (S.L.D)..- » a  3. Thematic Apperception Test (TAT)  zg won. :  ’ :  aan . ae wee - : a  Sahyadri Super Speciality Hospital |... Plot No. 30 C, Erandawane, Karve Road, Pune 411 004 Tel. : + 91 20 6721 3000/2540 3040 | Fax: + 91 20 2540 3270 | www.sahyadrihospital. com -  itals Ltd. (CIN: U85110PN1996PLC099499) Regd. Off. : Survey No, 89 & 90, Plot No. 54, Lokmanya Colony, Kothrud, Pune 411 038  Sahyadri Hosp | Pune - Deccan Gymkhana, Kothrud, Hadapsar, Bibwewadi, Kasba Peth, Nagar Road | Karad | Nashik |    "
PRESCRIPTION,"A yeret ata Saree weptet tat feast wet ta furt, wade, stee.sies wa.(gA) wat ah.ea.,  ABA. (at) BBhael, (58 ) ny “sneue Ur. : LA.C008 aR. :2009 /02/0080 saat Tet avs TTA Wet ASST ga 3ouete 43, 33 Pram, we tT, FF Re TH 1 WY WL nn ads Reg. No: 22416/15 19-09-2015  Name : Mast Neeraj Patil Male 9 years Rx  1) PRACTIN TAB | 20 eae . > 1 Wet Oot Ul Aare BT 2) FLUTIVATE CREAM + ELOVERA CREAM 20 feae  AHA STAAL I TAT ATTA TATATT  Uta argauareat ara s 10-10-2015  gy  ee TL DN ee ee eee Spree Toot : WETS 129 AL. ae eaferad arerorast aftr wars yor we  Gat : Pua wee Fata ad GUT NS ITOMgA "
PRESCRIPTION,"ZLnerwt aaa suatardt= waa stat.eaasit w.da dhe widtate., f-U.UH. aes Ba.(qtt) wat ate,  i . aaa. (Fae ) oer, ey USL. : LA.C008 UWet.af. :2009/02/0080  2330,Uallsla Yo, te fora, URAATCAA eR VEAT, YT 30. HIT : &42I3CO4  Reg. No : 22416/15  | 16-09-2017 Name : Mast Neeraj Patil Male 11 years BZD ®& | , 1) PRACTIN TAB 20 eae 1 AT Oe TAY Sea Ay 5 2) FLUTIVATE CREAM + NIVEA CREAM 20 Raz     Utd aaauareyl artre 2 07-10-2017  ops     DAT SaT : MEHTA 28 URL.c ac eferant areterat afer waart yor aq Gat : Pua Wa tain ud Sig eer soda | "
REPORT,"Reference:Dr.BHOME ARVIND MD,FAARC|SID: 120307012 120307012 Collection Date: 14-01-2021 10:31 AM Registration Date: 14-01-2021 10:31 am Report Date: 14-01-2021 07:42 PM                   NIRAJ A PATIL  REPORT Ta No 919823147602  PID: 11202219             Age:14.80 Years Sex:MALE               Test Description _ Observed Value Biological Reference Interval TEST NAME ; | Glycated Hemoglobin (HbA1C), by HPLC 5.30 . ; 4.01056 %  gene tye oT  ea eng, ARAL TER Ch TER Rg Me  fy  iemcrniieas  interpretation : '  HbA‘1C level reflects the mean glucose concentration over previous 8-12 weeks and provides better indication of long term glycemic control.  For diagnosis of Diabetes Mellitus (>= 18 yrs of age): 5.7 %-6.4 % : Increased risk for developing diabetes.  sf 6.5% : Diabetes  Therapeutic goals for glycemic control :  Adults :< 7% MS Toddlers and Preschoolers : < 8.5% (but > 7.5 %) =. School age (6-12 yrs) : < 8% “s Adolescents and young adults (13 - 19 yrs) : <75 % be. Levels of HbA1C may be low as result of shortened RBC life span in case of hemolytic anemia. ra Increased HbA1C values may be found in patients with polycythemia or post splenectomy patients. aS  Patients with Homozygous forms of rare variant Hb(CC,SS,EE,SC) HbA1c can not be quantitated as there  is no HbA. In such circumstances glycemic control can be monitored using | Plasma glucose levels or serum Fructosamine. oo  . eer: -  The A1c target should be individualized based on numerous factors, such as age, life expectancy, a comorbid conditions, duration of diabetes, risk of hypog lycemia oradverseconsequences from § - ; Pypoaiyeemis, patient motivation and adherence.  Ref : ADA (Standards of Medical Care in Diabetes - 2017)  . ~ _ , poe 2 oo ae rr Ct Tee EEP RR FGI EE ge regen fT EA a ory il a eh     Dr. Venkatesh Keralapurkai  M.B.B.S.,D.C.P., D.N.B.(Patt Page 4 of 12 BSS Reg.No.: 076020 ""Accreditation as per ISO 15819:2012, Cert.No. MC-3143. Refer scope@ www. nabl-india.¢ org"" AG Diagnostics Pvt. Ltd.  { Dr. Awanti Golwilkar |} MO (Pathology) oF  4 Dr. Vinanti Golwilkar § | gmmanpnenrermemmenmcconeenomame!                                     ce carrying forwardly ieee, Dr. Ajit Gols $ "
PRESCRIPTION,"UNMESH ORTHOPAEDIC CLINIC |  Dr. Atul A. Patil  M.S. Orthopaedics Consultant : Trauma Fellow,Katherinen Hospital,Germany, ‘ ¢ Sancheti Hospital,Pune. Pelviacetabular Fellow Parkland Hospital,U.S.A. Ph. : 25533333, 28999108 Hip Arthrosocopy Fellow,Herentals,Belgium. ;  Sanjeevani Hospital, Varvand. Mobile : 9422015760. Ph.:(02119) 283438 Be ' | Date:- / i. : {27.09.2017 Mrs. Patil Vidya Abhay age: 41 Y/F/ Chief Complaints : C/O Rt> Lt knee pain | : ' — neckpain tO LBP : , — heel pain - 9 Bone profile: WNL O/E Knee “y Palpation : . ' Tenderness sit i line a Movements : Painful & restricted terminally Medicines: fo Cap. Altraday ( Sun) 1...x.....x After food * a | pO Tab. Shubheal  x....x.....1 . . / | 2 weeks me — : Voveran TPM Gel ana esos 1 Apply Locally i - ! ert 8 ate ag Aa ASM Sa AIAG Tet aT A. | . ie oT AL - anda wedi Sree ay 7a. AT TS GA HHT HET. Next Followup : 11/10/2017 . 4 | A. Dr. Atul 4-Patil                       » . \  a4 1 is  3 ij Smarak,Pune-411030 ,6.00 p.m. to 9.00 p.m ati Si ad Road,Near Sane Guru Clinic Address- -133 Die, Parvati,Sinhag E- mail : atulapatil@hotmail.com  For Appointment pl call, Saturday, Sunday Closed."
PRESCRIPTION,"Mansa Clinic  Phone: 088 81 675015     Niraj Patil Male, 15 Years Patient ld: P4740 Blood Group A+ 4918830403320 Kothrud Depot, pune  vidyapatilo1o5@qmail.com     By: Dr. Ninad Baste            Prescription(Rx) a Drug Name ‘Tablet PEXEP PLUS ry a o -~ 4 + oo tablets 125mg  Tablet Provanol Sr (40  2, Mp) 40mg to - 8 = 8 20 tablets: Moming Aftemoon Night 1  2 TRACE oe ey Morning = Aftemoon Night  Generated On: 26 Mar 2021 ‘Computer Generated, No Signature RequiredPage 1 ot 1  Date: 25 Mar, 2021  nstructions  20 day{s} ‘After Food  20 day(s) After Food  20 day(s} After Food  Powered by Practo "
REPORT,DCA229E3-F271-4E0A-96DB-C9C9EE08F234 - sakshi patil.jpeg
PRESCRIPTION," at. petal 4.aa etch meat 1.80 ata. uaa Waa  dutta, aewsies wa(ga) wae ey Asa. (sa) ot (  fa -3TEMd Wer... : LA.cook | sPr.af. :2009/02/0088 aera : caa WaT aos  Tat aoe  9330, Baltera Ao, de ferare, BRGATCTA RR TEAM, YI 30. THAT 2 & 4233604  Reg. No: 25255/15 . Date : 19-11-2018 Name: Ms Sakshi Patil 19 years / Female Rx « 1) ZITCARE CAPS | €, . | 1 Nat SUN SaUTAR : 20 fea 2) B GLOW CREAM (RELY ON) GIA SAGA FTA AAT 20 feda many. 3) MOMATE LOTION AHO SaAMae FI Ua AIT . 90 fad way . |  We saravarel aera : 10-12-2018  nm Berea ToT : WHO BIA WRL.LAC orftrarft arrerat anfer wfearkt yof ee Sat : PIN Tea aie ad HUG A HMMA   "
REPORT," Test Description Plasma Glucose:  Observed Value  Biological Reference Interval  Plasma Glucose post glucose, by Hexokinase method 102 < 140 mg/dL : Normal glucose tolerance Zo. 140 - 199 mg/dL : Impaired glucose tolerance / Prediabetes >= 200 mg/dL : Provisional diagnosis of diabetes American Diabetes Assodation Guidelines 2019  . Glucose load given  75 | gms Time post glucose load _ Ars a rd, A  Hormones  Insulin, post glucose, serum byCMIA |... 73.10 . Z _ , Peak upto 150 pU/mL 1. Levels are increased in insulinomas, factitious hypoglycemia, insulin autoimmune syndrome, acromegaly (after ingestion of glucose), Cushings syndrome, corticosteroid administration and levodopa usage. 2. Levels are depressed to absent in diabetes mellitus, pituitary tumors and chronic pancreatic diseases i.e. cystic fibrosis. 3. Insulin/C-peptide ratio is used for differentiating between factitious hypoglycemia and insulinomas where: a ratio < 0 indicates insulinoma; but results may vary in renal failure. 4. Antibodies to insulin form is longstanding  diabetes mellitus treated with insulin hence in these patients monitoring insulin kvels gives better prognosis.  woe 4 1  % a . : et vue a ‘ ee ot ae  ey  @e.. Dr, Venkatesh Keralapurkar   M.B.B.S.,D.C.P., D.N.B.(Path} Page 1 of 2 Reg.No.: 076020     sap MED  af  . pa geet RE eT era a aa) . Benet x  ss Cee ee aa seen RR . a ey hanes. CURR eS : aed < : —_ ERT rr a Pt Soe ae     "
PRESCRIPTION,"newt ata sLatonedt waa states W.aa ftw. wat ate. f.uwr.sizs wT) wr at ahe.,  ara abstr. (Aas ) ohh. (38) Ue. : LA.C008 Uer.F. 12009 /02/0089 afer. jaan TAU Wert Aoet  caqar  Se caiiata Hj Raw waren won, GY 90. A GuRR OH 333 a0 ee, ara ETON eT, GH Ho, IT CREEL  Reg. No : 22416/15 - Date : 07-07-2018 Name : Mast Neeraj Patil 11 years / Male Rx 9 1) ZEMPRED 4mG TAB | 1 Tost aaa VTA at 15 feat 2)XYZALSMGTAB ts” a. PACIRUCUILCIB! rat a 7 Raw  3) DILUCORT OIN TMENT (PRAISE PHARMA h  Seng ine ce ca 15 aa 7 aay . oe  Re eePwanh arte: 21-07-2018 owe  —     DTA Sar : UHrast 11a WL. eae arferardt arreresrat amr zferandt qof aq Gat : PI we Aaron ad were ta SOTA "
REPORT," GENERAL AGNOSTICS.                         a ener cor GED BxEtiosnc a oerasnsur ee SE asters: NA Cent tome NA cocina stant osseo Atta: 01.0827 000000 ere Vis lee 1.020 1,000 - 1.035 60 3-8 Pale Yellow Slightly Hazy ‘Bio-Chemical Examination 3 Leukocytes Negative Negative 6 Niwito ‘Negative Negative 7 Protein Negative ‘Negative 8 Urine Glucose Negative ‘Negative 9 Ketones ‘Negative Negative 10 Urobilinogen ‘Negative ‘Normal 1 Bilirubin ‘Negative Negative 12 Blood ‘Negative Negaine Microscopic Examination 13° Brythrocyten DL <4 ‘Cellynpt 14 Epithelial Cells OL ‘Cellvhpe 1S Conte Absent Absent 16 Crystals Abert Absent 17 Pus Cella OL <3 ‘Cellvbpt 18 Others Absent CRM No 2299042 oa ot Fear ae Roport Release Date: 02-08-2021 00:00:00 ‘Anchortzed Signatory ‘Avaborized Signatory Padent Name: ANKITA KALSHETTI ‘Dr. Dina Abbani (Dr. Mabecs Hampe Puen ID: 2299642 DCP, DNB (Pubology) MD (Blochemlary) = Page Sal 10  ‘To We your report, og in www zveverine.crhaparis Fead your Pasert to ebuminad your report."
PRESCRIPTION,"XYZAL SYRUP RS ae 2 a | eRe | 5 Fh colt she By enue | 2) PROPYNATE NF CREAM HEH » EMODERM, Rea ” CREAM (30GM ( » , a 3) ELOVERA IMF LOTION Se a a as fe a  Ta argavardt arte s - poeint Chee  ""reve tar: WHT 13 ULLAL sia worl dard gi ae : Sa : SUM Wa Aca ud org etaz soa "
PRESCRIPTION,AS4145 Medicines:  1. Capsule Cyra D (20 & 30) 1-0-0X 10 feaa Tea sireat  2. Syrup Gerbisa L 0-0-5ml X 10 feaa Wat AAO  A ER RTS ate Ar. A ele RE IEE NEN NE MEE ane LT  Dr. Ashok Sohoni Book appointments and view your prescription online at docon.co.in 
PRESCRIPTION,EVION CAPS 400 CAPS 1 Wat Ut TY Aaoaz Ae 20 faa 2) MOMATE LOTION aaa sesa a wet stad 20 faq wey . We erakewardt atte : 17-09-2018 | —p 9 ye a i  oy  Drea Sar: Tera! 2h 2 UL.eae erferars arrorat anfer eaart oof aq il GaN : PIA Wa Acton Ud Beg aia saa 
REPORT,"GENERAL CAGNOSTICS: ‘ 7] cecum, @ yg Pot, Secor - 24, Nev Mura) = Si oman                       Gi General” Maarasia, ks. Pi - 400708, i 91>) DIAGNOSTIC Tok 91-22. 40480000 en! QI PME. GLe @& 21 Years) © Monts} ANKITAKALSHETTL dante, ns haere on Na (Cheat Kame NA F Ls Ape Sas. 08 mL 00aRD Iavestigntion Observed Valve Reference Range Peripheral Blood Smear 2% = — RBC Morphol ‘Ne a ven Normochromic 27 WBC Morphology ‘Within Normal Range 78 Platelees ‘Adequate On ‘Smear  CRM No 99942 we oh. Sample Rrseived Time: 31-02-2001 200041 oe . ‘Report Release Date: 01-04-2021 00-00-00 ‘Autborizat Signatory Authorized Sogmatry ‘Puieat Name: ANKITA KALSHETTI Dr Anju Dhar De Mates Hamp Pati 1D: 2269842 MD (Microbiatogia) (MD Gliachemisry) 1» "
PRESCRIPTION," 21. Wee aaa tet ert H20 etait ast wie  aurt.wstaiea., tewsiss va.(Ft) : pa a ea oe Ver... : 14.6008 afar.a. :2009/02/0930 ies CaM Vet AoA  cama 9330, 4alsia 4S, 3 PART, ARCATCTAGR VET, yet 30. HIT: G4IIICO""  Reg. No: 25255/15 Date : 26-09-2018 Name: Ms Sakshi Patil 19 years / Female Rx , 1) Z CAPS CAPSULES “4 Wet Dat TA Sra BT 20 faa 2) NUGLORY PLUS CREAM (NUPER THERAPEUTICS) Galant Bras rat F UAT ALIA 20 feaa may . 3) MOMATE LOTION AHIa SAGA F TAL AAT 20 feaa era} . : 19-10-2018 “ Ue araferoaret are : 19-10-20 ser  ee : Se wae ce arfererrdt areieoraht anther ear yet Fa esraear amr: Wem 114 ALE vere"
PRESCRIPTION,"DR. ASHOK N SOHONI  N.B.B.S., D.C.H. 2 Regd. No. 48430       CLINIC : A1\5, New Friends Soc, Opp ‘Vanaz’, Paud Road, Kothrud, Pune 411 038.  Ph. : 8975345221 *For Emergency only Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to 9:00 p.m. Saturday & Sunday Closed ~ Please apply for number on ""SMINQ"" app. oe Name: Sakshi Patil 3 + “Date: 06-01-2020 09:56 am Age/Sex: 19y / F , Mobile: 9850025111 . Office ID: AS2923 ~. CO aired: 1. Tablet Rynclav 625: 1-1-1X5feaH AAT PRI, GIRT SAAR, Wal SIT it 2. Tablet Mefzest forte: 1-1-1X5ferr | ARaT POUR, Zant Faure, WAT SIVA 3. Tablet Deriphyllin: eee ee ste eee _— . peerage 1-1-1X5 fea md  Feat BRIA, FART AIPA, WAT HAVA 4. Syrup Macbery: . .  5 ml-5ml-5 mi X 5 fade  qed BRIA, GIR HATA, TAY HATA  Dr. Ashok Sohoni WTS AMAAS7 sitar fffeat docon.co.in  meets yar ORE TEE RAE  ATES N IPS ISTY HMMM CSET FIST IU TIT IIE HATED 0S 31509 "
PRESCRIPTION,"DR. ASHOK N SOHONI CLINIC : A1\5, New Friends Soc,  | | Opp ‘Vanaz’, Paud Road, Kothrud, aia M.B.B.S., D.C.H. Bazan Pune 411 038. Regd. No. 48430 Ph. : 8975345221 *For Emergency only  Saturday & Sunday Closed Please apply for number on ""SMINQ"" app.       Time : 9:00 a.m. to 12:30 p.m. & 5:00 p.m. to 9:00 p.m.  Name: Vidya Patil Age/Sex: 51y / F Office ID: AS8923  Date: 07-11-2019 09:11 pm Mobile: 8975345221  site: 1. Drops Toba DM: 2 drops - feaarga ait dar Both eyes 2. Tablet Zyrtec: 0-0-1X 10 feaa Wal Aa ay  Df. Ashok Sohoni Smet aiensd Areuear fear docon.co.in "
REPORT,"GENERAL DIAGNOSTICS PravantiNe Life Gare (P) Lid Plot 8, Sector-24, Navi Muna     G :  = Ge 1 se GiB Bikénosncs oe! ck ar @ soem     Tol: +91-22-40450000                            ANITA KALSHETH Aeiienter NA Cuaetme a1g-2021 1935:00 eyar eae Bde: Investigation, Obaerved Vater  Complete Haemogram Test  Erythrocytes 1 Toul RBC 492 4nsa Trey. 2 Hemoglobin 4 123-153 ea 3 Hematocrit PCV) 457 By * 4) Mean Corpuscular Vatume (MCV) 928 80-96 ca 5 Mean Corpuscular Hemoglobin (MCH) 292 ASB PS 6 Mean Corpse Hemoglobin Concentration 314 DAMS AL 7 — Red Cell Distribution Width (RDW-CV) 42 1215 * 8 — Red Cell Distribution Width-SD(RDW-SD) 468 32-004 a 9 — Nuclented Red Blood Cella 0.04 0-136 cellspL. 10 Nucleated Red Blood Celli Percentage Os oF *  Platelets LU Platelet Count 274.0 150-430 10° 12 Mean Platelet Volume (MPV) 91 6-12 aL 13 Platelet Distribution Width (PDW) 168 155-183 * 14 Plateleterit (PCT) 0249 012-037 *  ‘Leucocytes: 15 Total Leucocytes Count 80 44-11 10°. 16 — Neutrophils 459 0-77 * 17 Lymphocyte Percentage a3 1644 * 18 Monocytes Percentage a5 20-100 * 19 Eosinophils Percentage 34 or * 20 Batophils Percentage os 0-1 * 21 Neutrophils-Absolute Count 3.67 18-78 10° 22 Lymphocytes-Abrolute Count 30 148 10°. 23 Monocyten-Absolute Count O68 01-10 10°3/pL 24 — Bosinophils-Absolute Count 027 004s 10°3/yL. 25 jophils-Absolute Count 0.07 002 10°  ene No 22295042 we owt  ‘Sample Received Time: 31-49-2021 2000341  Report Relene Dat: 01-04-2021 0:0000 ‘Autorine Sipatory ‘vaborand Signatory  Padent Name: ANKITA KALSHETTI Br Ant Dar De. Maheoh Hamp  Paeay 1D: 2299642 MD (Microbiologia) MD (Biochemistry) Page La     To ew your report, log in www.preverine.capheporta. Feed your Paters AD to eneninad your repost. "
PRESCRIPTION,"Suet aaa otmedt weer ta seas wget aa dent, watiaies., atew.sies wa. (gt) wat ate.     rf ata. (Ass ) ofr, ey ULL. : 14.6008 wR. 2009 /02/0088 bie tenth ge 9g zou 4a, Se Rare, waeaiet TEM, Yt Bo HH: A¥w YC ara:  Reg. No : 22416/15  14-04-2015 Name: Mast Neeraj Patil _ Male = 9 years 9 "" Rx 1). ZEMPRED 4MG TAB 15 Rae (2) 1 edt vIscaa Ue Raeene 2) XYZAL SYRUP Pe Raw 5 ot cet sitar ary. 3) FUCIBET CREAM 1S eae aot sitet a ch tg era Oo  Wd aaa aes s 28-04-2015  ? a op  The Scheduled tedicine/s sare Supplied For Mi Day s/c pits  Drea Tar : : weprast vate Ure. cate enforardt arerorest anf erat yet aq | Ga : STM ""aa ten a eG wee TA "
PRESCRIPTION,"SUSI ag SAE nae ta Saas ng aa tert, wade. ewes va. (gt) Waal.     acted. (eg) Wade WSt.F. : LACOOt Ua. :2003/02/o8ss 8 8 gouakia 4a, a Fara, waneaiiee Ta, Gt 30 GH: Wee Wwe} alt:  Name : Mrs Vidya Patil Female 37 years  QO Rx  1) ZEMPRED 4MG TAB 20 Raw 1 et ascarta we Raaane. ~2) PRUGO 10 MG TAB 20 az 1 Wet tet teh Aaortae get 3) RULIDE AZ 500MGM TAB 6 Raz 1 est arrart a TRA wht A) CLINDAC A 1% SOLUTION 20 Raz Were sicker a welt stra rat. C Dee) _5) BETADINE AD SHAMPOO 20 Rag | Ste quarnrdt sisasaga an Far aH, o 5) LOGIFEEL CREAM 20 fear  oer welt agueL as Pie area oer Prorat re wa are. We aaah ake s 14-01-2016 pix  BTCA SOT : Aarost 999 UI.Eac crferardt arereralt aftr waar quot aq GT : STM Wa sate ud weg ster soa  "
PRESCRIPTION,"Ol Uda aun ada sfzlmercdt o.da oa, fer. widtate., stewrstes wa. (gt) WSBT .,  Baa. (Aa ) BAA. (ata) ee, 308 arf. 12009 /02/0089 raw. :21EVC Weta. ALS er asa COUT WT ATH #330, ' ' ta ao,ararfere fo, #3 ferara arecroncersifez TEM, GO 30. WII : VLVEO FOS Reg. No : 06152 Date : 25-02-2019 - Name: Mrs Vidya Patil 42 years / Female > Rx 1) FOLLIHAIR TAB 1 hat Tet tet HINT Bay 20 Raa 2) KETO B LOTION wenrat otras a welt shad 20 Raa Fe _ v7 ayy . rr CJAVT DV 3) MORR 3% LOTION enor wah 1 hat ema a9 Raa TIGA SAKATA aay . ) Ret cratered ate : 18-03-2019 Te     Brea Sor : erat 8943 UT. Ea orferard arreredt anftr earkt got xq aT : Sua we dare ud wag ater soda   "
REPORT,"General roses [Se GP oem, GD Se28bsncs Manan a Pe 40078 7 DIAGNC Tor sor 204400000 oe! TE PME SP @ ANKITA KALSHETHI Amtcenter: BYsw yo Montes Na Cottons NA 13.201 193540 epertReeaine: 0106-271 084000 Investigation ‘Observed Yolne Meferenee Ramee GD Wellness Kidney Profile 1 BUN bod Lee Niger 38 a3. na Sou Note Carson 2 Cowie os vary a Sor Mee Abas pra 1 Ue 20 Germs Meet Craw OLDE 4 Bus Ceninin mo me sos Sr Noset Canoe 5 Ulead Fa 20-63 we or: Mee he, OY 6 Cichm * t3.m3 a ‘rm Mant Oomph coins 7 @GPR erie Cloner Bsa Rae) se yee, ain ren Mee Covuoed eerereanate Sper ecm IS Roy are <5 Interpretation A ena tant     n panel coud be ordered when patient ha ik factors for Kdney dysfunction such a hh blood (hypertension), dlabetes, cardiovascular disease, obetity, elevaied cholesterol, or u family history of kidney disease. A renal function panel may alsa be ordered when someone hax signs and symptoms of kidney dixcase, hough early kidney disease often does nol cause any noticeable symptoms. I enay be initially detecred oultine blood or urine tesing. Renal function panel rele ae not ago but rates iia at chee ray be a problem Wilh te kidneys un hat fre ein sree 1 make a diagaosix and deiermine the cause, Reiuits of the panel are usually considered logeiher, rusher iban separaiely. Individual tant renult can be abnormal due to cuuses other than kidney disease, but taken together with risks and signs und ‘gymptoms they may give an indication of whether kideey disease ia presen.     $M os wont be Ck  came asa ye ot.  Sep eset Tin 35-0120  ‘Report Relewse Date: 02-04-2021 00:00:00 ‘Avthorlzed Signatory Aumboriaed Signatory  Padent Name: ANKITA KALSHETTT Br Anh Dhar De. Mabeds Hampe  ee Ho abi) Moremi) tat     ‘To Wow your repar, login www. praverdine.cepheparta, Fead your Patent iD 10 dowminad your repost."
REPORT,"¢ — ne io (Z) a | @ = Plot, Sector 24, Navi Mumbai ae bo Binenc              = GDB S8oksnc 2. EB PME sie @ 21 Yemfs) 0 Monts) 9 ANKITA RALSHETTI Aaornien RYse NA Cheat tame NA 31-09-2091 195800 RepertRcee Des 01-06-2071 0-00 Investigation ‘Observed Yelne  Ueference Range     ‘Tron Studies {Iron,TIBC, Transferrin saturation} 1 tem  wast 4-1 wa Sera, Mebod: Fee 2 TC ssa 0480 wa Sera, Mead: Fre 1° Transfemin stration ms 20-99 * Serum, Meat: Cae Interpretation 4. Serum iro» measures the level of Iron in the liquid parton of the blood. Low ion levels may seen in anemia euicrocytic and $ypaetcomie) «High levee of verum ison in herediary hemochromatoas, malliple blood tranafuslons, ad « ew other condivans, 2, TIBC (Total iron-binding capacity) measures al the {in blood available to bind with icon, including trntterti. TBC lest isa good indirect measurement of transferrin, The  6y produces wensferrn ie colaionship tothe need fee roa. Whea S08 sores ae low, canaferrin levels increase and Vice vera, Snce ianeforrin isthe primary tton-banding protein, tbe THBC tat fs & ‘Pood Lndinet meavuceenent of traneferrin availablity.     CRM Ne 2299002 yw ot Sunple Rese Trt 31-29-2001 200031  Rapert Relens Dale 01-04-2021 00:00:00 ‘autora Sipnary ‘bored Stgaiony Puent Name: ANKITA KALSHETTI Br Ashu Dae De. Mabeoh Hap Piet 1D: 2299842 MD (Microbiologia) MD Blochemlary Page al 10  ‘To vew your rapar, og in warn prevanine.orghepar, Feed your Patent iD to edna! your repeat, "
REPORT,"SAKSHIAPATIL     RT BHUSAR COLONY 0: trosa82 KOTHRUD Catecion Date: Jovosi2017 02.08 Akt REPORT Sample Date: ovosian17 0208 am PIO No: a04te8 Repot Date ‘oe: 17.07 Yoors SoxFEMALE Jowosia0¥7 03°31 PM Complete Blood Count           (EDTA Whole lod, Automated Cal Counter Result Hemoglobin, EDTA whole blood 14.70 ‘otal Leucocytes (WBC) count 6,500 Platelet count 279,000 Red blood cell count 5.09 POV (Packed Cell Volume) 37.00 MCV (Mean Corpuscular Volume) nm MCH (Mean Corpuscutar Haemoglobin) 23.00 MCHC (Mean Corpuscular Haemoglobin Concentration) 31,60 ROW (Red biood cel distribution width) 16.50 Differential Count Neutrophils 56 ‘Absolute Neutrophils 3.840 Eosinophils 4 ‘Absolute Eosinophis 20 Basophils ° ‘Absolute Basophils ° Lymphocytes 36 Absolute Lymphocytes 2278 Monocytes 5 ‘Absolute Monocytes 325 Page 1 of 2  Biological Reference Interval Male : 14.0 - 17.50 g/dL  Female : 12.3 - 15.3 g/dl  Male & Female : 4,000 - 10,000 Ju  150,000 - 450,000 /uL  Male :4.5 -5.9X 106 /uL. Female :4.1-5.1 x 10""6/uL  Female : 35.90 - 44.60 % 800-9608. 275-332 pgms 334-355 gid 12-14%  40-80 % 2,000 - 7,000 fy.  1-6% 20 - 500 pL.  <1-2% 0-100 fut.  20-40% 41,000 - 3,000 /uL.  2-10% 200 - 1000 Mut     we  ""Reg. Now: 2000/02/1096 "
REPORT,"SAKSHIA PATIL |Roforence:Dr-BOKIL SABRINA, MD  RT BHUSARI COLONY sio:t7oss73%2 KOTHRUD CCotecton Date:  04/08/2017 08:08 AM  REPORT ‘Sample Date: 04/08/2017 09:08 am  PID No: 6204188 Report Date  ‘Age:17.07 Years Sexc FEMALE  iz Bi  R.B.C. Morphology  Mild hypochromia, mild microcytosis, mild anisocytosis.                                                     W.B.C. Aonomaliies : Not detected Platelets Adequate Parasites Not Detected Sane SUGGESTED IRON,TIBC ESTIMATION, IRON SUPPLEMENT FOLLOWED BY Hb ELECTROPHORESIS IF NECESSARY. Please refer to following pediatric reference ranges as applicable ‘Age Group [Child ‘Hb (g/dL) RBC (x 10%6 jul) WBC (ip) ‘MCV (fl) oT da TaieS Fone 135220 —_a50500 Sn0034000 680-720 Ed days Waled Fonae 125710 S608 00 5002700066 0-120 Stays [Ware Fora T0000 SOS STOO ESOT Trike pike [Nate Fora T0140 S05 ST 00O TOTO Srna Zs [Waleg Fora 105-140 5705.00 Sano12000 TOD es Waled Fora Teas A105 F-12000 TAOS eitys tate aot az08.10 306350) TESS ena Teo 410530 HOO 16500 THEO Tian ate TaeTed —a40550 S6003TO) 600 Feral Tae 410820 ron 8000 600920 Rae Some eatophie (UL) Typo THT Bi eno 25000 2700S Tis aa 700-0000 SaR0-TOO0 yas “OSSD SOTO oye 7003800 7500-8560 ays TSH 7008000 7200-5200              End of Report  04/08/2017 03:31 PM "
REPORT,"REPORT _ TeiNo: 918830403320  PID: 11202220  ‘Age:43.80 Years Sex FEMALE        Collection Date: 13-02-2021 09:46 AM Registration Date: 13-02-2021 09:46 am Report Date: [13-02-2021 05:07 PM     Complete Blood Count (EDTA Whole Blood) Hemoglobin (Hb), EDTA whole blood Method: Photometry Total Leucocytes (WBC) count Method : Coulter Principle / Microscopy Platelet count Method : Coulter Principle / Microscopy Red blood cell (RBC) count Method: Coulter Principle PCV (Packed Cell Volume) Method: Calculated MCV (Mean Corpuscular Volume) Method: Derived from RBC histogram MCH (Mean Corpuscular Hb) Method: Calculated MCHC (Mean Corpuscular Hb Conc.) Method: Calculated RDW (RBC distribution width) Method: Derived from RBC Histogram WBC Differential Count Method: VCSn / Microscopy / Calculated Neutrophils Absolute Neutrophils  Eosinophils Absolute Eosinophils  Basophils Absolute Basophils  Lymphocytes Absolute Lymphocytes  Monocytes Absolute Monocytes  78.60  es is  Is iS  Fa 8  eo  a 2,106  Biological Reference Interval  12.3- 15.3 gdb 4000-10000/jiL 150000 - 450000 /uL 4.10 - 5.10 x 1076 /uL 35.9 - 44.6 % 80.0 - 96.0 fL  27.5 - 33.2 pgms 33.4 - 35.5 g/dL.  11.6 - 14.6 %  40-80% 2000 - 7000 /uL.  1-6% 20-500 /uL  0-2% 0-100 /pL  20-40% 1000 - 3000 /uL.  2-10% 200 - 1000 ML. "
REPORT,"   VIDYA A PATIL, sip: 120307432  Collection Date:  13-02-2021 09:46 AM  PORT _ TeiNo: 918830403320 Registration Date: PID: 1 1202220 13-02-2021 09:46 am  Report Date:  ‘Age-43.80 Years Sex FEMALE [13-02-2021 05:07 PM     Complete Blood Count Findings  RBC Normocytic, Normochromic W.BC. No abnormality detected Platelets Adequate  Remark: ON FOLLOWUP.  ? ON HEMATINIC SUPPLEMENTS. SUGGESTED CLINICAL CORRELATION, TO CONTINUE HEMATINIG SUPPLEMENTS & FOLLOW UP."
REPORT,"VIDYA A PATIL,  REPORT _ TetNo: 918830403320 PID: 11202220  ‘Age:43.80 Years Sex FEMALE  Reference:Dr.-- sip: 120307432  Collection Date: 13-02-2021 09:46 AM Registration Date: 13-02-2021 09:46 am Report Date: [13-02-2021 05:07 PM     Test Description pid Profile Mi     Cholesterol (Total), serum by Enzymatic method  Triglycerides, serum by Enzymatic method  HDL Cholesterol, serum by Enzymatic method  VLDL Cholestrol, serum by calculation  LDL Cholesterol, serum by calculation  Cholesterol(TotalyHDL Cholesterol Ratio  LDL Cholesterol/HDL Cholesterol Ratio  Observed Value Biological Reference Interval  178  81  16 116  3.87  2.52  Desirable : < 200 mg/dL Borderline high : 200 - 239 mg/dL High : >/= 240 mg/dL.  Normal : < 150 mg/dL. Borderline high : 150-199 mg/dL. High : 200-499 mg/dL  Very high : >/= 500 mg/dL  Men : > 40 mg/dL Women : > 50 mg/dL  <30 mg/dL.  Optimal : <100 mg/dL. Near optimaVabove optimal : 100-129 mg/dL. Borderline high : 130-159 mg/dL  High : 160-189 mg/dL  Very high : >/= 190 mg/d.  Males : Acceptable ratio </= 5.00 Females : Acceptable ratio </= 4.50  Males : Acceptable ratio </= 3.60 Females : Acceptable ratio </= 3.20  Reference : ATP Ill, NCEP Guidelines and National Lipid Association (NLA) 2014 Recommendations,  ‘As per most international and national guidelines including Lipid Association of india 2016  1. Lipoprotein and lipid levels should be considered in conjunction with other atherosclerotic cardiovascular disease (ASCVD) riak determinants to assess treatment goals and strategies.  2. Non-fasting lipid levels can be used in screening and in general risk estimation."
REPORT,"IDYA A PATIL,  REPORT _ TeiNo: 918830403320  PID: 11202220  ‘Age:43.80 Years Sex FEMALE  IReference:Dr.—  sip: 120307432  Collection Date: 13-02-2021 09:46 AM Registration Date: 13-02-2021 09:46 am Report Date: [13-02-2021 05:07 PM     Test Description Plasma Glucose : Plasma gucose fasting, by Hexokinase method  Plasma guucose post prandial, by Hexokinase method  Clinical Chemistry  Creatinine, serum by Jaffe w/o deproteinization Urea, serum by GLDH-urease  Observed Value  96  99  0.70 21 End of Report  Biological Reference Interval  <.100 mg/d 100 to 125 mg/dL : Impaired fasting ghicose tolerance / Prediabetes  >/= 126 mg/dL : Suggestive of diabetes melitus  (On more than one occasion) ‘American Diabetes Association Guidelines 2020  < 140 mg/dL 140 to 199 mg/dL : Impaired Glucose tolerance / Prediabetes >/= 200 mg/dL : Suggestive of diabetes mellitus  (On more than one occasion) American Diabetes Association Guidelines 2020  0.6 to 1.2 mg/dL 17 to 49 mg/dL "
REPORT,"www.dhandepathlab.com : = www.dhandelab.com Dedicated to Excellence dhandepathlab@gmail.com       A i) 04\s5 DIAGNOSTICS PVT. LTD.     LABORATORY: Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashish N. Dhande     REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020 M.D. (Path) 1.0. (Path) ‘94030 85417, 96379 24415, 90492 34055 a eg te manera ADDRESS Timing 8.00 am.to 8.30 pm. Sunday : 8.00 am. to 12.30 p.m. Rg N08 sath No. seaonT a fii oT Patient's Name: MRS NEMADE KUSUM LAXMAN Patient ID No. +: 2201769 Age/Sex 68 Yrs / Female Reg DvTm + 08-04-2021 04:37pm Reff. By Dr. Nene Suhas;MBBS,DCH Sample Coll.DvTm ——; 08-04-2021 04:37pm Sample Collected _: _AtDhande Pathlab Diagnostics Pvt. Ltd Report DT 08-04-2021 10:07pm           CRP (C REACTIVE PROTEIN),SERUM        ization Result Units Reference Range C-Reactive Protein, Serum rH 9,90 mg/L. 0-5     (Serum, Immuno-turbidimetric method)  COMMENTS: 1. C Reactive Protein (CRP) is the most sensitive acute phase reactant for inflammation.  2. The levels increase dramatically after severe trauma, bacterial infection, surgery & neoplastic proliferation.  3. Itis most useful as an indicator of activity in Rheumatoid arthritis, Rheumatic fever, tissue injury or necrosis.  4. Itis used in inflammatory disorders for monitoring course and effect of therapy. It assesses response to antibiotic treatment and differentiates between active and inactive disease forms with concurrent infection.  5. As compared to ESR, CRP shows an earlier rise in inflammatory disorders which begins in 4-6 hrs, the intensity of the rise being higher than ESR and the recovery being earlier than ESR. Unlike ESR, CRP levels are not influenced by hematologic conditions like Anemia, Polycythemia ete.  (R= Rechecked, H = High,     Low)     =End OF Repos"
REPORT," Dedicated to Excellence dhandepathlab@gmail.com i 7 > aA ) j U4‘ \5 DIAGNOSTICS PVT. LTD. LABORATORY : Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashish N. Dhande & REGISTERED Paud Road, Puno - 38. Phone : 2543 2950, 2545 9494, 2545 2020 M.0. (Path) M.D. (Path) 94030 85417, 96379 24415, 90492 34055 ""i og Ne 2140752 ADDRESS Timing :8.00 am. to 8.30 pm. Sunday : 8.00 am to 12.30 p.m. ed Rag No.8 ato No. 52017 — oe ri “ Patient's Name: MRS NEMADE KUSUM LAXMAN Patient ID No. +: 2201769 Age/Sex 68 Yrs / Female Reg DvTm + 08-04-2021 04:37pm Reff. By Dr. Nene Suhas;MBBS,DCH Sample Coll. DuTm 18-04-2021 04:37pm     Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd, Report DuTm  08-04-2021 10:07pm        ERYTHROCYTE SEDIMENTATION RATE (ESR)           Result     Reference Range ESR :Ho74 mmatlhour — 0-20  (EDTA, Automated ESR by Modified Westergren method ‘with temperature correction)     COMMENTS: 1. ESR is an acute phase reactant which indicates presence and intensity of an inflammatory process. 2. Itis not diagnostic of a specific disease but has got a prognostic value to monitor the course or response to treatment of certain diseases. 3. Extremely high levels (>100mm/hr) indicate severe systemic disease such as in cases of malignancy, hematologic diseases, paraproteinemias, collagen disorders, renal diseases and severe infections like bacterial endocarditis, tuberculosis 4. Causes of increased ESR are Infections (Acute rheumatic fever, osteomyelitis, bacterial endocarditis, TB, PID, pyogenic arthritis), Inflammatory diseases (Rhematoid arthritis, SLE, Temporal arteritis, Polymyalgia theumatica), Acute Myocardial Infarction, Anaemia, administration of dextran or OC pills, ete. 5. Reasons for falsely decreased ESR are Abnormally shaped RBCs (sickle cells, spherocytes, acanthocytes), Microcytosis, HbC disease, Hypofibrinogenemia, Extreme leukocytosis, Drugs (quinine, salicylates, high steroid levels).  (R= Recheck, H= High, L= Low.)  End Of Report: "
REPORT,"Dedicated to Excellence dheadepethish@jgurall-oces  PH TEW YTV GbidGnosrics pvr. rr.  LABORATORY: Chinar Apartments, Sheelavinar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashi        ‘ish N. Dhande  REGISTERED Paud Road, Pune - 38. Phono : 2543 2950, 2545 9494, 2545 2020 M.D. (Path) M.D. (Path) 94030 85447, 96379 24415, 90492 34055 a fag te manera ADDRESS Timing 8.00 am.to 8.30 pm. Sunday : 8.00 am. to 12.30 p.m. a Rg No.8 sag Ne CTT ‘cow an fit on = Patient's Name: MRSNEMADE KUSUM LAXMAN Patient ID No. + 2201769 Age/Sex 68 Yrs / Female Reg Dum + 08-04-2021 04:37pm Reff. By Dr. Nene Suhas:MBBS,DCH Sample Coll.DvTm ———; 08404-2021 04:37pm Sample Collected _: At Dhande Pathlab Diagnostics Pvt. Ltd Report DT 08-04-2021 10:07pm        BLOOD EXAMINATION REPORT              Result Units Reference Range Ferritin : 32.90 ng/mL. 11-306 (Serum, CLIA)     Note: Increase in serum ferritin due to inflammatory conditions (Acute phase response) can mask a diagnostically low result.  Comments:  ‘Serum ferritin appears to be in equilibrium with tissue ferritin and is a good indicator of storage iron in normal subjects and in most disorders. In patients with some hepatocellular diseases, malignancies and inflammatory diseases, serum ferritin is a disproportionately high estimate of storage iron because serum ferritin is an acute phase reactant. In such disorders iron deficiency anemia may exist with a normal serum ferritin concentration. In the presence of inflammation, persons with low serum ferritin are likely to respond to iron therapy.  Increased Levels: Iron overload — Iron supplementation, Hemochromatosis, Thalassemia & Sideroblastic anemia. Malignant conditions - Acute myeloblastic & Lymphoblastic leukemia, Hodgkin's disease & Breast carcinoma Inflammatory diseases - Pulmonary infections, Osteomyelitis, Chronic UTI, Rheumatoid arthritis, SLE, burns, ete. Acute & Chronic hepatocellular disease.  Decreased Levels: Iron deficiency anemia  (R= Rechecked, H = High       "
REPORT," LABORATORY :Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashish N. Dhande                                  & REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020 . (Path) .D. Path.) 94030 85417, 96379 24415, 90492 34055 ag No S201 og. no. z0an4r7s2 a Timing :8.00 a.m. to 8.30pm. Sunday : 8.00 a.m. to 12.30 p.m. Lastest 88 eg Ne 380017 a ee Pc cr “6 Patient's Name: MRS NEMADE KUSUM LAXMAN Patient ID No. +: 2201769 Age/Sex 68 Yrs / Female Reg DvTm + 08-04-2021 04:37pm Reff. By Dr. Nene Suhas;MBBS,DCH Sample Coll. DvTm + 08-04-2021 Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd Report DuTm + 08-04-2021 10:07pm D DIMER Result Reference Range D-Dimer 758.00 ng/mL Less than 500 (Citrate plasma, ELE) Remark D-Dimer is high. Please correlate clinically and with treatment history. Interpretation  1. D-dimer is a fibrin degradation product, a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. The product increases in conditions inducing inappropriate fibrinolysis.  2. D-dimer is a marker of thrombotic disorders, hence it can be used in diagnosis of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE),ete.  3. The test results should be correlated with Imaging studies (e.g. Colour Doppler),  4. The negative predictive value (NPV) with a cut off of 500 ng/mL. is 95 to 100% for DVT & PE.  5, Elevated D-dimer is seen in hypercoagulability, DVT (Deep Vein Thrombosis, DIC (Disseminated Intravascular Coagulation), recent surgery, trauma or infection.  Limitations:  1. False Negative: Anticoagulant therapy.  2. False Positive: Elderly, Liver disease, Pregnancy, Eclampsia, Heart disease, Rheumatoid arthritis, some cancers, High triglycerides, Hemolysis, Lipemia, Hyperbilirubinemia,  (R= Rechecked, H = High, L= Low.)    "
REPORT,"    www.dhandepathlab.com  +S) www.dhandelab.com CA Dedicated t0 Excellence dhandepathlab@gmail.com            Pathiad  FEW) TV Eiidenosrics pvr. rv.  LABORATORY : Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr, Ashish N. Dhande                                 REGISTERED  Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020. 4.0. Path) M.D. Path)  RODRESS 94030 85017, 96379 24415, 90492 34055, fm te ro mw  ‘Timing : 8.00 a.m. to 8.30 pm. Sunday : 8.00 a.m. to 12.30 p.m. ‘sR Ne ns hg. 3480007 — a or — Patient's Name =: MRS NEMADE KUSUM LAXMAN Patient ID No. + 2201769 AgelSex 68 Yrs / Female Reg Duin 08.04.2021 04:37pm Reff By Dr Nene Suhas:MBBS,DCH Sample ColLDUTm ——: 08-04-2021 04:37pm Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd. Report DvTm +: 08-04-2021 10:07pm Haemogram (CBC)  Anvestigation ‘Result Units ‘Reference Range  Haemoglobin 2h 10.60 gmsidl 120-150  RBC Count 410 millcumm 38-58  Haematocrit (PCV) 33.40 % 36-47  MCV (Mean Corpuscular Volume) 46 a 83-101  MCH (Mean Corpuscular Hb) 85 pe 27-32  MCHC (Mean Corpuscular Hb Cone.) 31.74 emidl 32-36  RDW (Red cell Distribution Width) ae % 116-140  RBC Morphology Predominantly Normocytic Normochromic.  ‘Total WBC (Leucocyte) Count 7230 feamm 4000 11,000  Neutrophils : 74 % 40-75  Lymphocytes 18 % 20-40  Eosinophils ou % 1-6  Monocytes : oO % 1-10  Basophils % % 0-2  Absolute Neutrophil Count 5350 feamm 2000-7000  Absolute Lymphocyte Count : B01 feamm 1000-3000  Absolute Eosinophil Count nD fcumm 20-500  Absolute Monocyte Count 506 feamm 200-1000  Absolute Basophil Count 0 feamm 0-100  Platelet Count 190000 Jeamm — 1,30,000-450,000  MPV (Mean Platelet Volume) 83 i 18-120  Platelet Remarks Adequate     PBS For Parasites + Malarial Parasites Not Seen EDTA Whole Blood - [Tests done on ful automate fve part Haematcogy analyzer, XNLSSO, (Sysmex) BC-6800 Pus (Mindray). WC, RBC. Patelet count by Impedance method, WAC Diflerental by Foorescent Flowcytomety& other parameters are calculated] Different WC count, Pitelet Count ae correlated rcroscopicaly. Al abnormel Haemograms are reviewed and confimed micoscopcally.  (G-Rechecked = gh, L= Law) End Of Report."
REPORT,Patient: Ms. Patil Sakshi Sampling Dt: 05-Jan-2021 11:40 am Sex/Age : Female 21 Yrs 0 Month 0 Days Reporting Dt: 05-Jan-2021 2:09 pm Ref By = Spine Health Clinic Ref Dr : Patient ID: 012101143 .P.D. e VALU UULEAM HAEMATOLOGY Test Name Result Unit Biological Reference Interval HAEMOGRAM ON CELL COUNTER Haemoglobin(Hb) 13.10 gm/di 12-16 R.B.C. Count 5.02 Mil/Cmm 45-65 Pcv 41.30 % 36-52 Mcv 82.30 fl 80.0-96.0 MCH 26.10 pg 27.5-33.2 MCHC 31.72 Pg 31.5-34.5 ROW 15.80 1-16 WBC Count Total WBC Count 9000 Jomm 4000-10000 Differential Count Neutrophils 54 % 40-70 Lymphocytes 36 % 20-45 Eosinophils 05 % 00-06 Monocytes 05 % 00-08 Basophils 00 % 0-1 Platelet Count 245000 Jomm 150000-450000  Peripheral Smear Examination RBC Morphology  WBC Morphology Platelets  Normocytic Normochromic within normal limits Adequate on smear  cee END OF REPORT a 
REPORT,Patient: Ms. Patil Sakshi Sampling Dt: 05-Jan-2021 11:40 am Sex/Age : Female 21 Yrs 0 Month 0 Days Reporting Dt: 05-Jan-2021 2:36 pm RefBy _: Spine Health Clinic Ref Dr : Patient ID: 012101143 |.P.D. WANN           BIOCHEMISTRY Test Name. Result Unit Biological Reference Interval Blood Sugar Random Blood Sugar Random 102 mg/dl upto 150 Instrument Used : Merilyzer Auto Quant 200i-(Fully Automated Biochemistry Analyzer)        END OF REPORT     De.V.D.Kulkarni Checked By (4.D. Path) 
REPORT,Patient: Ms. Patil Sakshi Sampling Dt: 0S-Jan-2021 11:40 am     Sex/Age : Female 21 Yrs 0 Month 0 Days Reporting Dt: 05-Jan-2021 1:33 pm  Ref By — : Spine Health Clinic Ref Dr ir  Patient iD: 012101143 LPO a TINUE ENDOCRINOLOGY  Test Name Result Unit Biological Reference Interval     VITAMIN D( 25 Hydroxy cholecalciferol OR 25-OH Vitamin D )  VITAMIN D( 25 Hydroxy 488 ng/ml Deficiency (Seriously Deficient):<12 cholecalciferol OR 25-OH Vitamin Insufficiency ( Deficient):12-30  D) sufficiency ( Adequate ):30-60 Instrument Used Beckman Coulter Access-II -Fully Automated Chemiluminescence System Vitamin B 12  VITAMIN B12 199.70 pg/ml 174-878  METHOD CLA  INSTRUMENT USED Roche Cobas e 411 - Fully Automated Chemiluminescence System     END OF REPORT     De.V.D.Kulkarni Checked By (4D. Path) _x000c_
REPORT,Patient: Ms. Patil Sakshi Sampling Dt: 05Jan-2021 11:40. am Sex/Age : Female 21 Yrs 0 Month 0 Days Reporting Dt: 05-Jan-2021 1:50 pm Ref By: Spine Health Clinic Ref Dr :  Patient ID: 012101143 LP.D. WOU              BIOCHEMISTRY Test Name. Result Unit Biological Reference Interval ‘Serum Uric Acid ‘Serum Uric Acid 5.27 mg/dl Male : 3.5 to 7.2 mg/dL. Female : 2.7 to 6.0 mg/dL Instrument Used : Merilyzer Auto Quant 200i-(Fully Automated Biochemistry Analyzer) END OF REPORT     Dr.V.D.Kulkarni Checked By _x000c_
REPORT,"Dedicated to Excellence  LABORATORY : Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station,  www.dhandepathlab.com www.dhandelab.com dhandepathlab@gmail.com  DIAGNOSTICS PVT. LTD.  Dr. Nitin L. Dhande  Dr. Ashish N. Dhande                                REGISTERED Pauld Road, Pune = 38. Phone : 2543 2950, 2545 9494, 2545 2020, 90492 34055, M.D. (Path) M.D. (Path) ADDRESS Timing: 8.30 a.m. to 8.30 pm. Sunday :'8.30 a.m. to 12.30 p.m. de dn amu Reg at oval (AAAI = _mm Patient's Name MR. NEMADE LAXMAN VISHWANATH Patient ID No. 401303 Age/Sex 74 Yrs / Male Reg DvTm 01-2021 10:50am Reff. By Dr. Bhome Arvind, MD(Chest) Sample Coll. D/Tm 01-2021 00:00 Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd Report DuTm 01-2021 06:22pm BIOCHEMICAL TEST Investigation Result Units Reference Range Glucose Fasting, Plasma : 86 mg/dL Normal : 70 - 100 (Hexokinase method) Impaired Fasting Glucose (IFG) 100 - 125 Diabetes Mellitus : >=126 (On more than one occasion) (American Diabetes Association guidelines 2018) Glucose Post Prandial, Plasma pH 444 mg/dL Normal : 70 - 140  (Hexokinase method)  Remark  (R= Rechecked,     Impaired Tolerance : 140 - 19 Diabetes Mellitus : >=200  (On more than one occasion)  (American Diabetes Association guidelines 2018)  Fasting BSL is normal, PP BSL is high. Please confirm wheather today's dose of antidiabetic medicine was  missed/mistimed.  End Of Repos"
REPORT,"www.dhandepathlab.com www.dhandelab.com dhandepathlab@gmail.com  | 4S) DIAGNOSTICS PVT. LTD.  LABORATORY :Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashish N. Dhande  Dedicated to Excellence                             & REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020, 90492 34055 M.D. (Path) M.D. (Path) ADDRESS Timing :8.30 a.m. 108.30 p.m. Sunday : 8.30 a.m. to 12.30 p.m. nade adeateuaiez Reg at oval UAHA = _ mine Patient's Name: MR. NEMADE LAXMAN VISHWANATH Patient ID No. +: 1401303 Age/Sex 74 Yrs / Male Reg DvTm 9-01-2021 10:50am Reff. By Dr. Bhome Arvind MD(Chest) Sample Coll. D/Tm 01-2021 00:00 Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd. Report DuTm -01-2021 06:22pm CORTISOL AM Investigation Result Units Reference Range SERUM CORTISOL A.M. : 120 meg/dL. At8.00am.  :6.2-19.4 meg/dL. (Serum, ECLIA) At400 p.m. :23-11.9 megidl.  Post Dexamethasone:0 - 5.0 meg/dL. PostACTH — : 28.0- 60.0 meg/dL.  Note:  Cortisol is best measured in the morning when evaluating for possible Adrenal Insufficiency & best measured in the aftemoon or evening to differentiate normal and Cushing Syndrome subjects  Diurnal rhythmicity of cortisol is increased by systemic disease and stress.  Clinical Use: Direct assessment of Adrenal function.  Increased Levels in - Cushing's Syndrome, Ectopic ACTH syndrome, Ectopic CRH syndrome, Adrenal adenoma / carcinoma, Adrenal micronodular dysplasia, Adrenal macronodular hyperplasia, Stress.  Decreased Levels in :- Addi     ns disease, Pituitary dysfunction.  (R= Rechecked, H!= High, L= Low.)      End Of Report. "
REPORT,"Dedicated to Excellence     LABORATORY     Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station,  www.dhandepathlab.com  www.dhandelab.com  dhandepathlab@gmail.com  r. Nitin L. Dhande  DIAGNOSTICS PVT. LTD.  Dr. Ashish N. Dhande                 & REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020, 90492 34055 M.D. (Path) M.D. (Path) ADDRESS Timing: 8.30 a.m. to 8.30 p.m. Sunday : 8.30 a.m. to 12.30 p.m. Meee dateyiacea  Reg a ova COMA = ae  Patient's Name: MR. NEMADE LAXMAN VISHWANATH Patient ID No. +: 1401303  Age/Sex 74 Yrs / Male Reg DvTm + 22-01-2021 10:50am  Reff. By Dr. Bhome Arvind, MD(Chest) Sample Coll D/Tm 22-01-2021 00:00  Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd. Report DuTm 22-01-2021 06:22pm  CORTISOL PM  Investigation Result Reference Range  SERUM CORTISOL P.M. (Serum, ECLIA)     Note:  489     At8.00am. :6.2-19.4 megidL. At4.00pm, :23- 11.9 meg/dL.  Post Dexamethasone:0 - 5.0 meg/dL. Post ACTH: 28.0 - 60.0 meg/dl.  Cortisol is best measured in the morning when evaluating for possible Adrenal Insufficiency & best measured in the afternoon or evening to differentiate normal and Cushing Syndrome subjects  Diurnal rhythmicity of cortisol is increased by s  Clinical Use: Direct assessment of Adrenal function.     ‘stemic disease and stress.  Increased Levels in :- Cushing's Syndrome, Ectopic ACTH syndrome, Ectopic CRH syndrome, Adrenal adenoma / carcinoma, Adrenal micronodular dysplasia, Adrenal macronodular hyperplasia, Stress.  Decreased Levels :- Addisons disease, Pituitary dysfunction,  (R= Rechecked, H = High, L= Low.) "
REPORT,"SAKSHIA PATIL eT tenes a eenene T 421443971 Collection Date: 20-04-2021 01:36 PM Tol No: 919850025222 ‘Sample Date: Pap: 11202218, 20-04-2021 01:36 pm Report Date: FO ~~ age:21.80 Years Soxc FEMALE 20.04.2021 07:53 PM Complete Blood Count Result Biological Reference Interval (EDTA Whole Blood) Hemoglobin (Hb), EDTA whole blood 13.70 12.3- 18.3 gldL Method: Photomety Total Leucocytes (WBC) count 8,400 4000-10000/pL ‘Method : Coulter Principle / Microscopy Platelet count 279,000 180000 - 450000 /L. “Method : Coulter Principle / Microscopy Red blood cell (RBC) count 5.24 4.10-5.10 x 10°6 JL. Method: Coulter Principe PCV (Packed Cell Volume) 42.70 35.9 - 44.6 % Method: Calculated MCV (Mean Corpuscular Volume) 82.00 80.0 - 96.0 1L Method: Deelved from RBC histogram MCH (Mean Corpuscular Hb) 26.40 27.8 - 33.2 pgms Method: Calculated MCHC (Mean Corpuscular Hb Conc.) 32.20 33.4 - 35.5 gidL. Method: Calculated RDW (REC distribution width) 14.20 11.6 - 14.6% Method: Detived from RBC Histogram WBC Differential Count ‘Method: VCSn/ Microscopy / Calculated Neutrophils 65 40 - 80 % Absolute Neutrophils 5,460 2000-7000 JL. Eosinophils 3 1-6% Absolute Eosinophils 282 20 - 500 /pL Basophils 0 0-2% Absolute Basophils 0 0-100 /uL Lymphocytes 28 20-40% Absolute Lymphocytes 2,352 1000 - 3000 /uL Monocytes: 4 2-10% Absolute Monocytes 336 200 - 1000 iL. : e     Dr. Venkatesh Keralapurkar M.B.B.S.,D.C.P., D.N.B.(Path)    "
REPORT,"SAKSHIA PATIL  Tel Ne: 919850025222 Pao: 11202218,     ‘Ago:21.50 Years Sec FEMALE  Rotorence:Dr SUPEKAR RAJESHWAR P., MISID: 121443371 s214aaa71  Collection Date:  20-04-2021 01:36 PM  ‘Sample Date:  20-04-2021 01:36 pm  Report Date:  20-04-2021 07:53 PM     Fini RBC Normoeytie, Normochromic wc. No abnormality detected Platelets ‘Adequate  Remark =: = "
REPORT,"SAKSHIA PATIL Reference:Dr.SUPEKAR RAJESHWAR P., M|SID: 121443374     s214asa7t Collection Date: 20-04-2021 01:36 PM Tol No: 919850025222 ‘Sample Date: Pao: 11202218, 20-04-2021 01:36 pm = Report Date: ‘Ago:21.50 Years Sox FEMALE 20.04.2021 07:53 PM Test Description ‘Observed Value Biological Reference Interval Ferritin, serum by CMIA 9.46 Female : 4.63- 204 ng/mL  Ferritin is the majpr Iron storage proteln for the body. Ferritin Is found chiefly In the cytoplasm of cells of the reticuloendothelial system and is a constituent of normal human serum. Generally the concentration of ferrtin is directly proportional to the total iron stores in the body. There Is a significant posttive correlation between age and serum ferritin concentrations in females, but not in males. Patients with iron deficiency ‘anemia have serum ferritin concentration approximately one-tenth of normal while patients with Iron ‘overload (hemochromatosis, hemosiderosis) have serum ferritin concentrations much higher than normal. Ferritin isa positive acute phase reactant in both adults and children, whereby chronic inflammation  results in a disproportionate Increase In ferrtin in relation to ron reserves. Elevated ferrin Is also observed In acute and chronic liver disease, chronic renal fallure, and in some types of neoplastic disease. _x000c_"
REPORT,"20-04-2021 01:36 PM        Tol No: 919850025222 ‘Sample Date:  Pap: 11202218, 20-04-2021 01:36 pm _ Report Date:  ‘Age:21.50 Years Sox FEMALE: 20.04.2021 07:53 PM  Test Description Observed Value Biological Reference Interval  TEST NAME  Giycated Hemoglobin (HDAC), by HPLC 5.30 4.0105.6.%  Interpretation :  HDAIC level reflects the mean glucose concentration over previous 8-12 weeks and provides better Indication of long term glycemic control.  For diagnosis of Diabetes Mollitus (>/= 18 yrs of ago) : 5.7 %-6.4% : Increased risk for developing diabetes. >1= 6.5% : Diabetes  ‘Therapeutic goals for glycemic control = Adults :< 7%  ‘Toddlers and Preschoolers : < 8.5% (but > 7.5 %) School age (6-12 yrs) :< 8%  Adolescents and young adults (13 - 19 yrs): <7.5%  Levels of HbA1C may be low as result of shortened RBC Ife span in case of hemolytic anemia. Increased HbA‘C values may be found in patients with polycythemia or post splenectomy patients. Patients with Homozygous forms of rare variant Hb(CC,SS,EE,SC) HbAtc can not be quantitated as there Is no HBA. In such circumstances glycemic control can be monitored using plasma glucose levels or ‘serum Fructosamine.  ‘The Ac target should be individualized based on numerous factors, such as age, Ife expectancy, ‘comorbid conditions, duration of diabetes, risk of hypoglycemia or adverse consequences from hypoglycemia, patient motivation and adherence.  Ref : ADA (Standards of Medical Care in Diabetes - 2017)  Dr. Venkatesh Keralapurkar M.B.B.S.,D.C.P., D.N.B.(Path  Reg.No.: 076020        "
REPORT,"SAKSHIA PATIL Roference:Dr SUPEKAR RAJESHWAR P., MISID: 121443371     421443371 Collection Date: 20-04-2021 01:36 PM Tol No: 919850025222 ‘Sample Date: Pap: 11202218, 20-04-2021 01:36 pm Report Date: ‘Age:21.50 Years Sex FEMALE 20.04.2021 07:53 PM Test Description Observed Valua Biological Reference Interval Haematology. Erythrocyte Sedimentation Rate, EDTA Whole Blood 18 Female under 50 Yrs : Upto 20mm/hr.  Female 50 - 85 Yrs : Upto 30mm/tr. Female > 85 yrs : Upto 42mm/hr. Results corrected to 18 deg. celsius  Technique : Automated Westergren Method 1. ESR & markedly elevated n manodionel gammopathy such as mutipke myeloma, in severe polycbonal hypergbobulinemis due {0 inflammatory disease, and in hyperfbrnogenemb. 2. Moderate elevations are common in active inflammatory  disease such as rheumsteid arthrits, chronic infections, colagen disease and neoplastic disease  3. ESR has litle dagrostic value i these disorders but can be useful in montoring disease activky.  4. Usefulin the disgnass and in manitaring palymyaloia rheumatica and temporal arteritis.  5. Moderate increase is seen in pregnancy (beghnnhg at the 10th to 12th week) and returns to normal about 1 manth  postpartun ed cls uth an soronmal or reg stop, sich as ste col or spheecytes, der oe formation and    "
REPORT,"SAKSHI A PATIL  Tel No: 919850025222 PID: 11202218  ‘Age:21.50 Years Sex: FEMALE     Reference:Dr.SUPEKAR RAJESHWAR P., M|SID: 121443371 121443371 Collection Date: 20-04-2021 01:36 PM Sample Date: 20-04-2021 01:36 pm Report Date: 20-04-2021 07:53 PM              Test Description CRP(hs) - C- Reactive Protein high sensitivity  Clinical Information :  Observed Value Biological Reference Interval  3.01 See clinical information below ‘ Method : Nephelometry / Immunoturbidimetry     1. C-reactive protein (CRP) is a biomarker of inflammation. Plasma CRP concentrations increase rapidly and dramatically (100-fold or more) in response to tissue injury or inflammation.     2. High-sen  ity CRP (hs-CRP) is more precise than standard CRP when measuring baseline (.e.  normal) concentrations and enables a measure of chronic inflammation. It is recommended for cardiovascular risk assessment. Atherosclerosis is an inflammatory disease and hs-CRP has been endorsed by multiple guidelines as a biomarker of atherosclerotic cardiovascular disease risk.  Low cardiovascular risk : < 2.0 mg/L High cardiovascular risk : >/= 2.0 mgf. Acute inflammation: > 10.0 mg/L  3. A single test for high-sensitivity CRP (hs-CRP) may not reflect an individual patient's basal hs-CRP level. Repeat measurement may be required to firmly establish an individuaf's basal hs-CRP concentration. The lowest of the measurements should be used as the predictive value.  Reference : Mayo Medical Laboratories "
REPORT,"SAKSHIA PATIL JRoference:Dr. SUPEKAR RAJESHWAR P., M[SID: 121443371 121443371  Collection Date:  20-04-2021 01:36 PM        Tel No: 919850025222 ‘Sample Date Pip: 11202218 20-04-2021 01:36 pm ees Report Date ‘Age:21.50 Years Sex FEMALE 20-04-2021 07:53 PM Test Description Observed Value Biological Reference Interval Coagulation D-Dimer, Citrate plasma 165.37 0 to 500 ng/ml (FEU)  Upto four fold higher results may be observed in normal pregnancy. Method : ELFA/ CLIA  Note D-Dimer assay results may be affected by sample integrity, drug history and assay platform used.  Kindly interpret the result in view of above factors and clinical details. In case of any discrepancy, repeat the estimation on fresh sample for confirmation.  D-Dimer is a fibrin degradation product. D-Dimer is increased in : 1) DIC ( Disseminated Intavascular Coagulation ).  2) DVT ( Deep Vein Thrombosis ).  3) Hypercoagulable states.  4) Recent surgery, trauma, infection. Increased levels may also be seen in the following conditions : Liver disease, cardiac disease, rheumatoid arthritis, eclampsia, malignancy, hemolysis, lipemia & hyperbitrubinemia.  Please interpret with caution if patient is on anticoagulant therapy.  End of Report "
REPORT,"F  VIDYA A PATIL  ‘Tet No: 918890403320 Pio: 11202220     ‘Age:44.00 Years Sox FEMALE  Roteronce:Dr SUPEKAR RAJESHWAR P., M|SID: 121443372 sa1aaaa72  Calection Date:  20.04.2021 01:38 PM  ‘Sample Date:  20.04.2021 01:38 pm  Report Date:  20.04.2021 04:45 PM     Test Description CRP(hs) - C- Reactive Protein high sensitivity  Clinical Information  ‘Observed Value Biological Reference Interval 475 See clinical information below Method : Nephelometry / immunoturbidimetry  1. Creactive protein (CRP) is a biomarker of inflammation. Plasma CRP concentrations increase rapidly and dramatically (100-fold or more) in response to tissue injury or inflammation.  2. High-sensitvity CRP (ha-CRP) is more precise than standard CRP when measuring baseline (Le. Rormal) concentrations and enables a measure of chronic inflammation. It is recommended for cardiovascular risk assessment. Atherosclerosis is an inflammatory disease and hs-CRP has been endorsed by mulfiple guidelines as a biomarker of atherosclerotic cardiovascular disease risk.  Low cardiovascular tisk: < 20 mg/l High cardiovascular risk : >/= 2.0 mgf ‘Acute inflammation: > 10.0 mg/l  3. A single test for high-sensitivity CRP (hs-CRP) may not reflect an individual patient's basal hs-CRP level. Repeat measurement may be required to firmly establish an individuat's basal hs-CRP concentration, The lowest of the measurements should be used as the predictive value.  Reference : Mayo Medical Laboratories  Veta  Dr. Venkatesh Keralapurkar ,, D.N.B.(Path)  M.B.B.S.,D.C.P. Reg.No.: 076020     Page 1 of 2 _x000c_"
REPORT,"Roteronce:Dr SUPEKAR RAJESHWAR P., M|SID: 121443572  VIDYA A PATIL, siaeaa72  Collection Dat:  20.04.2021 01:38 PM  “Tot No: 918830405320 ‘Sample Date: Pio: 11202220 20.04.2021 01:38 pm Report Date:  ~~~ Age:44.00 Years Sex FEMALE 20.04.2021 04:45 PM ‘Observed Value Biological Reference Interval  Negative (0.03) Negatlve :< 1.4 Index (SIC) Positive : >/= 1.4 Index (SIC)  Test Description SARS-CoV-2 IgG Antibodies, Serum by CMIA          Remarks : * SARS-CoV-2 IgG antibodies usually appear after 2 weeks (14 days) of infection. Presence of IgG antbodies  ‘may / may not indicate immunity. * Detection of SARS-CoV.2 IgG antibodies may be useful for a. Understanding whether an individual is exposed to infection with SARS-CoV.2 including asymptomatic Individuals. 'b. Understanding the seroprevalence in cormunities and especially high isk or vulnerable populations.  * This test may not detect post vaccine immune response to all vaccine types. Anti SARS-CoV-2 spike protein (S1/S2) IgG is recommended in such cases.  ** SARS-CoV.2 IgG test is not useful for diagnosis of acute infection.  Reference: IOMR Advisory dated 23/06/2020  End of Report "
REPORT,"SAKSHIA PATIL RT BHUSARI COLONY KOTHRUD  REPORT  PID No: 6204188 ‘Age:17.08 Years Sex FEMALE  |Reterence:Or.BOKIL. SABRINA, MD  ‘ip: 470538106 Cotection Date: l28-06-2017 09:54 AM ‘Sample Date: 28-06-2017 09:54 am Report Date: 18-06-2017 01:13 PM     ‘Test Description Hormones :  E2- Estradiol level, serum by CMIA  ‘TSH(Ultrasensitive), serum by CMIA  FSH - Follde Stimulating Hormone, Serum by CMIA  L¥-Leutinising Hormone Specific, serum by CMIA  (Observed Valuo  38.00  1.83  434  10.60  Biological Reference Interval  ~:Menstruating Female:  Follicular phase : 21 - 254 pa/mL.  Midoycle : 38 - 649 pg/mL  Luteal phase : 21 312 pa/mL Postmenopausal Female:~  fot on HRT : upto 28 pay.        0.40 - 4.00 plUfmt Ref: NACB guideline 2002  In first trimester of pregnancy suggested antithyroid ab testing if TSH is between 25 to 5.0 ulU/mL  Ref: Clinical Thyroidology July 2010 Vol 22  Females : 14-16 yrs : 0.9 - 12.4 mIU/mL Follicular phase : 3.03 -8.08 mIU/mL. Mid-cycle : 2.55 - 16.69 mIU/mL Luteal phase : 1.38 - 5.47 mIU/mL Menopausal : 26.72 - 133.41 mIU/mL        Female 15 yrs : 0.5 - 20.7 mIU/mL 16 yrs : 0.4 - 29.4 mIU/mL ‘Adult :  Follicular phase : 1.80 - 11.78 mIU/mL Mid-cycle peak : 7.59 - 89.08 mily/mL Luteal phase :0.56 - 14.00 mIU/mL Post-menopausal:(Without HRT) 5.16- 61.99 mIU/mL  Veit  Dr. Venkatesh Keralapurkar M.B.I P., D.N.B.(Path)"
REPORT,"SAKSHI A PATIL Reference:Dr.BOKIL SABRINA ,MD     RT BHUSARI COLONY ‘SID: 170538106 KOTHRUD Collection Date: [28-06-2017 09:54 AM REPORT Sample Date: [28-06-2017 09:54 am PID NO: 6304188 Report Date: Age:17.08 Years Sex: FEMALE 8-06-2017 01:13 PM Test Description Observed Value Biological Reference Interval Hormones: Testosterone (Total),serum by CMIA 68.53 Females  12 to 16 yrs: <7 - 75 ng/dL 17 to 18 yrs : 20 - 75 ng/dL >/ = 19 yrs :8 - 60 ng/dL Tanner stages  I (prepubertal) : <7 - 20 :<7-47  Ill: 17-75  IV: 20-75  V (young adult) : 12 - 60  Testosterone is a major androgenic hormone. Decreased levels-Males:Partial or complete hypogonadism due  to primary/seoondary or tertiary testicular failure. Females :Primary or secondary ovarian failure, post- og9phorectomy. Increased levels- Pre-pubertal boys/girls: Precocious puberty Males :Testiaular/adrenal tumors, androgen abuse. Females:Polycystic ovarian syndrome, congenital adrenal hyperplasia and ovarian/adrenal tumors.  Note: Early-morning testosterone levels in young males are around 50% higher than p.m. levels. Testosterone levels can fluctuate substantially between different days, hence andragen status assessment should be based on more than a single measurement. "
REPORT,"Test Description Observed Value Biological Reference Interval Prolactin (HPRL) Total , serum byCMIA 7.11 Female : 5.18 - 26.53 ng/mL  Interpretation  MALE:  Hyperprotactinaemia in males may be associated with decreased libido, impotence, infertility, gynaecomastia. FEMALE :  Prolactin secretion from pituitary shows significant diumal, episodic and cyclical variations.  Following is a suggested approach to hyperprolactinaemia in females -     [Serum Prolactin levels Interpretation Remark 5.18 to 26.53 ngimi Normal Biological reference Interval 26.53 to 50 ng/ml Mild prolactin excess Often seen with physiological  conditions like physical/emotional stress, exercise, pregnancy, lactation, etc. This may not be associated with clinical hyperprolactinaemia & needs review after a month  51 to 75ngiml Moderate prolactin excess | Often associated with clinical hyperprolactinaemia (short luteal phase.oligomennorthea), hypothyroidism (often subclinical), macroprolactinemia  [Above 100 ngmi Marked prolactin excess | Often associated with clinical hyperprolactinaemia- hypogonadism, amenorrhea, galactorthea, hypothyroidism (often subclinical), macroprolactinaemia.  [Above 200 ng/ml Marked prolactin excess. | Often associated with pituitary adenoma requiring further workup. High levels may be repeated with tripooled sample                 References : 1. Diagnosis & Treatment of hyperprolactinaemia. The endocrine society clinical practice guideline, 2011 2. Diagnosis & Management of hyperprolactinaemia. Canadian Medical Association CMAJ .Sept.16, 2003; 169(6) "
REPORT,"Dedicated to Excellence        www.dhandepathlab.com www.dhandelab.com dhandepathlab@gmail.com  DIAGNOSTICS PVT. LTD. Dr. Nitin L. Dhande     Dr. Ashish N. Dhande                 LABORATORY. :Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, REGISTERED Pauid Road, Pune = 38. Phone : 2543 2950, 2545 9494, 2545 2020, 90492 34055, M.D. (Path,) M.D. (Path) ADDRESS Timing:8.30am.to8.30 pm. Sunday ""8.30 am. to 12.30 p.m. aN gt urn  Reg ate novam UT ee : mm  Patient's Name MR. NEMADE LAXMAN VISHWANATH Patient ID No. + 1401303  Age/Sex 74 Yrs / Male Reg DvTm 2 22-01-2021 10:50am  Reff. By Dr. Bhome Arvind MD(Chest) Sample Coll. D/Tm +: 22-01-2021 00:00  Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd Report DuTm +: 22-01-2021 06:22pm  BIOCHEMICAL TEST Investigation Result Units Reference Range ‘lucose Fasting, Plasma : 86 mg/dL Normal : 70 - 100 (exokinase method) Impaired Fasting Glucose (IFG) 100 - 125 Diabetes Mellitus : >=126 (On more than one occasion) (American Diabetes Association guidelines 2018) ucose Post Prandial, Plasma pH 444 mg/dL Normal : 70 - 140     (Hexokinase method)  Remark  (R= Rechecked,        Impaired Tolerance Diabetes Mellitus : >=200 (On more than one occasion)  140 - 199  (American Diabetes Association guidelines  2018)  Fasting BSL is normal, PP BSL is high. Please confirm ‘wheather today's dose of antidiabetic medicine was  missed/mistimed.  End Of Report-       "
REPORT,"  & REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020, 90492 34055 M.D. (Path) M.D. (Path) ADDRESS Timing : 8.30 a.m, to 8.30 p.m. Sunday : 8.30 a.m. to 12.30 p.m. nade dete, puourse Reg Dat oval UATE naw Patient's Name: MR. NEMADE LAXMAN VISHWANATH Patient ID No. +: 1401303 Age/Sex 74 Yrs / Male Reg DvTm 22-01-2021 10:50am Reff. By Dr. Bhome Arvind MD(Chest) Sample Coll D/Tm 01-2021 00:00 Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd. Report DuTm 2-01-2021 06:22pm CORTISOL AM Investigation Result Un Reference Range SERUM CORTISOL A.M. : 120 megidL. At8.00am, :6.2- 19.4 megidl. (Serum, ECLIA) At4.00pm,:23- 11.9 megidL.  Note:  Post Dexamethasone:0 - 5.0 meg/dL.  Post ACTH  28.0 - 60.0 meg/dL.  Cortisol is best measured in the morning when evaluating for possible Adrenal Insufficiency & best measured in the afternoon or evening to differentiate normal and Cushing Syndrome subjects  Diurnal rhythmicity of cortisol  Clinical Use:     Direct assessment of Adrenal function.  increased by systemic disease and stress,  Increased Levels in :- Cushing's Syndrome, Ectopic ACTH syndrome, Ectopic CRH syndrome, Adrenal adenoma / carcinoma, Adrenal micronodular dysplasia, Adrenal macronodular hyperplasia, Stress.  Decreased Levels in :- Addisons disease, Pituitary dysfunction.  (R= Rechesked,     High,     <Low)  End Of Repos"
REPORT,"LABORATORY  Dedicated to Excellence  Chinar Apartmer     Sheelavihar Colony,  www.dhandepathlab.com www.dhandelab.com dhandepathlab@gmail.com  DIAGNOSTICS PVT. LTD.     )pp. Paud Phata Police Station,  Dr. Nitin L. Dhande            Dr. Ashish N. Dhande                       & REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020, 90492 34055 M.D. (Path) M.D. (Path) ADDRESS Timing : 8.30 a.m, to 8.30 p.m. Sunday : 8.30 a.m. to 12.30 p.m. nade dete, puourse Reg Dat oval UATE naw Patient's Name: MR. NEMADE LAXMAN VISHWANATH Patient ID No. +: 1401303 Age/Sex 74 Yrs / Male Reg DvTm 22-01-2021 10:50am Reff. By Dr. Bhome Arvind MD(Chest) Sample Coll D/Tm 01-2021 00:00 Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd. Report DuTm 2-01-2021 06:22pm CORTISOL AM Investigation Result Un Reference Range SERUM CORTISOL A.M. : 120 megidL. At8.00am, :6.2- 19.4 megidl. (Serum, ECLIA) At4.00pm,:23- 11.9 megidL.  Note:  Post Dexamethasone:0 - 5.0 meg/dL.  Post ACTH  28.0 - 60.0 meg/dL.  Cortisol is best measured in the morning when evaluating for possible Adrenal Insufficiency & best measured in the afternoon or evening to differentiate normal and Cushing Syndrome subjects  Diurnal rhythmicity of cortisol  Clinical Use:     Direct assessment of Adrenal function.  increased by systemic disease and stress,  Increased Levels in :- Cushing's Syndrome, Ectopic ACTH syndrome, Ectopic CRH syndrome, Adrenal adenoma / carcinoma, Adrenal micronodular dysplasia, Adrenal macronodular hyperplasia, Stress.  Decreased Levels in :- Addisons disease, Pituitary dysfunction.  (R= Rechesked,     High,     <Low)  End Of Repos    "
REPORT,Patient = Ms. Patil Sakshi Sampling Dt: 05-Jan-2021 11:40 am        SexiAge : Female 21 Yrs 0 Month 0 Days Reporting Dt : 05-Jan-2021 2:09 pm  Ref By _ = Spine Health Clinic Ref Dr :  Patient ID: 012101143 |.P.D. e WANT UU HAEMATOLOGY  Test Name Result Unit Biological Reference Interval  HAEMOGRAM ON CELL COUNTER  Haemoglobin(Hb) 13.10 gmidi 12-16  R.B.C. Count 5.02 MilvCmm 45-65  Pov 41.30 % 36-52  Mev 82.30 f 80.0-96.0  MCH 26.10 Pg 27.5-33.2  MCHC 31.72 Pg 31.5-34.5  RDW 15.80 11-16  WBC Count  Total WBC Count 9000 fomm 4000-10000  Differential Count  Neutrophils 54 % 40-70  Lymphocytes 36 % 20-45  Eosinophils 05 % 00-06  Monocytes 05 % 00-08  Basophils 00 % on  Platelet Count 245000 Jemm 15000-45000  Peripheral Smear Examination  RBC Morphology Normocytic Normochromic  WBC Morphology within normal limits  Platelets Adequate on smear  END OF REPORT —————  hoe  De.V.D. Kulkarni Checked By oll tn aaa 
REPORT,Patient = Ms. Patil Sakshi Sampling Dt: 05-Jan-2021 11:40 am        Sex/Age : Female 21 Yrs 0 Month 0 Days Reporting Dt: 05-Jan-2021 2:36 pm Ref By : Spine Health Clinic Ref Dr : Patient ID: 012101143 I.P.D. ° WOMAN BIOCHEMISTRY  Test Name Result Unit Biological Reference Interval Blood Sugar Random Blood Sugar Random 102 mg/dl upto 150 Instrument Used : Merilyzer Auto Quant 200i-(Fully Automated Biochemistry Analyzer)  ————— END OF REPORT —————     De.V.D. Kulkarni Checked By (M.D. Path) 
REPORT,Patient: Ms. Patil Sakshi Sampling Dt: 05-Jan-2021 11:40 am     SexiAge : Female 21 Yrs 0 Month 0 Days Reporting Dt: 05-Jan-2021 1:33 pm  Ref By _: Spine Health Clinic Ref Dr :  Patient ID: 012101143 |.P.D. e WALL UU ENDOCRINOLOGY  Test Name Result Unit Biological Reference Interval  VITAMIN D(25 Hydroxy cholecalciferol OR 25-OH Vitamin D     VITAMIN D( 25 Hydroxy 4.88 ng/ml Deficiency (Seriously Deficient):<12 cholecalciferol OR 25-OH Vitamin Insufficiency ( Deficient):12-30 D)  sufficiency ( Adequate ):30-60  Instrument Used Beckman Coulter Access-II -Fully Automated Chemiluminescence System  Vitamin B 12  VITAMIN B12 199.70 pg/ml 174-878 METHOD CLIA  INSTRUMENT USED  Roche Cobas e 411 - Fully Automated Chemiluminescence System  END OF REPORT —————     Checked By 
REPORT,"Patient = Ms. Patil Sakshi Sampling Dt: 05-Jan-2021 11:40 ar        SewAge : Female 21 Yrs 0 Month 0 Days Reporting Dt : 05-Jan-2021 1:50 pn Ref By _ = Spine Health Clinic Ref Dr , Patient ID: 012101143 .P.D. e WAN UULY UU BIOCHEMISTRY Test Name Result Unit Biological Reference Interval Serum Uric Acid Serum Uric Acid 5.27 mg/dl Male : 3.5 to 7.2 mg/dL. Female : 2.7 to 6.0 mg/dL Instrument Used : Merilyzer Auto Quant 200i-(Fully Automated Biochemistry Analyzer) ———— No oF nePoR ————     Dr.V.D. Kulkarni Checked By ietsn (tei "
REPORT,"www.dhandepathlab.com www.dhandelab.com  Dedicated to Excellence      IAGNOSTICS PVT. LTD.     dhandepathlab@gmail.com  LABORATORY : Chinar Apartments, Sheelavinar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashish N. Dhande  REGISTERED Paud Road, Pune - 38. Phono : 2543 2950, 2545 9494, 2545 2020 M.D. (Path) M.D. (Path) 94030 85447, 96379 24415, 90492 34055 a fag te manera ADDRESS Timing 8.00 am.to 8.30 pm. Sunday : 8.00 am. to 12.30 pm. a Rg N68 ato. No. seeconT ‘coon fit = Patient's Name: MRSNEMADE KUSUM LAXMAN Patient ID No. + 2201769 Age/Sex 68 Yrs / Female Reg Dum + 08-04-2021 04:37pm Reff. By Dr. Nene Suhas:MBBS,DCH Sample Coll.DvTm ———; 08404-2021 04:37pm Sample Collected _: At Dhande Pathlab Diagnostics Pvt. Ltd Report DT 08-04-2021 10:07pm        CRP (C REACTIVE PROTEIN),SERUM           Investigation Result Reference Range  C-Reactive Protein, Serum 2H 9,90 mg/L 0-5  (Serum, Immuno-turbidimetric method)     COMMENTS:  1. C Reactive Protein (CRP) is the most sensitive acute phase reactant for inflammation.  2. The levels increase dramatically after severe trauma, bacterial infection, surgery & neoplastic proliferation.  3. Itis most useful as an indicator of activity in Rheumatoid arthritis, Rheumatic fever, tissue injury or necrosis.  4. Its used in inflammatory disorders for monitoring course and effect of therapy. It assesses response to antibiotic treatment and differentiates between active and inactive disease forms with concurrent infection.  5. As compared to ESR, CRP shows an earlier rise in inflammatory disorders which begins in 4-6 brs, the intensity of the rise being higher than ESR and the recovery being earlier than ESR. Unlike ESR, CRP levels are not influenced by hematologic conditions like Anemia, Polycythemia ete.     (R= Rechecked, H = High,     Low)     ind Of Report. "
REPORT,"WWW nano peniso Conk  Dedicated to Excellence  SSS EN TV Sitenostics pvr. ur.     www.dhandelab.com dhandepathlab@gmail.com  LABORATORY : Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashish N. Dhan        & REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020 M.D. (ath) M.D. (Pat (94030 85417, 96379 24415, 90492 24055 ng No S201 og ne 140 ADRS Timing :8.00 am. to 8.30pm. Sunday : 8.00 a.m. to 12.30 p.m. ao a Fag Wo. 908 = iva rc ae Patient's Name: MRS NEMADE KUSUM LAXMAN Patient ID No. +: 201769 Age/Sex 68 Yrs / Female Reg DuTm +: 08-04-2021 04:37pm Reff. By Dr. Nene Suhas;MBBS,DCH Sample Coll DyTm +: 08-04-2021 04:37pm Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd Report DuTm + 08-04-2021 10:07pm        ERYTHROCYTE SEDIMENTATION RATE (ESR)           Investigat Result Reference Range  ESR :Ho74 mmat I hour 0-20  (EDTA, Automated ESR by Modified Westergren method ‘with temperature correction)  COMMENTS:  1. ESR is an acute phase reactant which indicates presence and intensity of an inflammatory process.  2. Itis not diagnostic of a specific disease but has got a prognostic value to monitor the course or response to treatment of certain diseases.  3. Extremely high levels (>100mm/hr) indicate severe systemic disease such as in cases of malignancy, hematologic diseases, paraproteinemias, collagen disorders, renal diseases and severe infections like bacterial endocarditis, tuberculosis  4. Causes of increased ESR are Infections (Acute rheumatic fever, osteomyelitis, bacterial endocarditis, TB, PID, pyogenic arthritis), Inflammatory diseases (Rhematoid arthritis, SLE, Temporal arteritis, Polymyalgia rheumatica), Acute Myocardial Infarction, Anaemia, administration of dextran or OC pills, ete.  5. Reasons for falsely decreased ESR are Abnormally shaped RBCs (sickle cells, spherocytes, acanthocytes), Microcytosis, HbC disease, Hypofibrinogenemia, Extreme leukocytosis, Drugs (quinine, salicylates, high steroid levels).  (R= Rechecked,     igh, L= Low)    "
REPORT,"www.dhandepathlab.com  www.dh:  andelab.com  Dedicated to Excellence dhandepathlab@gmail.com  DHAND ‘VETTE biaenostics pvr. rp.  LABORATORY : Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashi            ‘ish N. Dhand  REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020 M.D. (Path) ™.0. (Path ‘94030 85417, 96379 24415, 90492 34055 _ fag to 40 ADDRESS Timing: 8.00 am.to 8.30 pm. Sunday : 8.00 am. to 12.30 p.m. Rg Ne 68 nag Ne es ri aon Patient's Name: MRSNEMADE KUSUM LAXMAN Patient ID No. + 2201769 Age/Sex 68 Yrs / Female Reg DvTm + 08-04-2021 04:37pm Reff By Dr. Nene Suhas:MBBS,DCH Sample Coll.DvTm ——; 08-04-2021 04:37pm Sample Collected _: At Dhande Pathlab Diagnostics Pvt, Ltd Report Di Tin 08-04-2021 10:07pm        BLOOD EXAMINATION REPORT              Investigation Result Reference Range Ferritin : 32.90 ng/mL, 11 - 306     (Serum, CLIA)  Note: Increase in serum ferritin due to inflammatory conditions (Acute phase response) can mask a diagnostically low result.  Comments Serum ferritin appears to be in equilibrium with tissue ferritin and is a good indicator of storage iron in normal subjects and in most disorders. In patients with some hepatocellular diseases, malignancies and inflammatory diseases, serum ferritin is a disproportionately high estimate of storage iron because serum ferritin is an acute phase reactant. In such disorders iron deficiency anemia may exist with a normal serum ferritin concentration. In the presence of inflammation, persons with low serum ferritin are likely to respond to iron therapy.  Increased Levels: Iron overload — Iron supplementation, Hemochromatosis, Thalassemia & Sideroblastic anemi Malignant conditions - Acute myeloblastic & Lymphoblastic leukemia, Hodgkin’s disease & Breast carcinoma Inflammatory diseases - Pulmonary infections, Osteomyelitis, Chronic UTI, Rheumatoid arthritis, SLE, burns, ete. Acute & Chronic hepatocellular disease.             Decreased Levels: Iron deficiency anemia  (R= Rechecked, H = High, L= Low.)  End Of Report:"
REPORT,"Www .ciandcepetin      ———— www.dhandelab.com Dedicated to Excellence dhandepathlab@gmail.com  HAND SVPTTI:V bisenostics pvr. vr.     LABORATORY  : Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Ur. Nitin L. Dhande | Dr. Ashish N. Dhande                                         REGISTERED Paud Road, Pune -38, Phone : 2543 2950, 2545 9494, 2545 2020 M.D. Path) M.D. (Path) ‘94030 85417, 96379 24415, 90492 34055 ng No.1 vg ha 0140052  ADDRESS Timing :8.00 am. to830 pm. Sunday : 8.00 am. to 12.30 p.m. a Rg No.8 at fog No. seeaatT Ree Date osiou2021 oo 311 Patient's Name: MRS NFMADF.KUSUM LAXMAN Patient ID No. 2201769 Age/Sex 68 Yrs / Female Reg DvTm 8-04-2021 04:37pm Reff Ry Dr Nene Suhas;MRRS,DCH Sample Coll. Dv js-04-2021 04:57pm Sample Collected _: _AtDhande Pathlab Diagnostics Pvt, Ltd Report Di‘Tin 08-04-2021 10:07pm  D DIMER estization Result Reference Range  D-Dimer MH 758.00 ng/ml. Less than 500  (Crate plasma, ELEY  Remnark + D-Dimer is high. Please correlate clinically and with treatment  history. Interpretation  1. D-dimer is a fibrin degradation product, a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. The product increases in conditions inducing inappropriate fibrinolysis,  2. D-dimer is a marker of thrombotic disorders, hence it can be used in diagnosis of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE),ete.  3. The test results should be correlated with Imaging studies (e.g. Colour Doppler)  4. The negative predictive value (NPV) with a cut off of 500 ng/mL. is 95 to 100% for DVT & PE.  5, Elevated D-dimer is seen in hypercoagulability, DVT (Deep Vein Thrombosis, DIC (Disseminated Intravascular Coagulation), recent surgery, trauma or infection.     Limitations:  1. False Negative: Anticoagulant therapy.  2. False Positive: Elderly, Liver disease, Pregnancy, Eclampsia, Heart disease, Rheumatoid arthritis, some cancers, High triglycerides, Hemolysis, Lipemia, Hyperbilirubinemia.     (R= Rechecked, I= High, L= Low.)     End Of Report. "
REPORT,"LABORATORY. : Chinar Apartments, Sheelavihar Colony, Opp. Paud Phata Police Station, Dr. Nitin L. Dhande | Dr. Ashish N. Dhande     & REGISTERED Paud Road, Pune - 38. Phone : 2543 2950, 2545 9494, 2545 2020 M.D. (Path,) M.D. (Path) ADDRESS 94030 85417, 96379 24415, 90492 34055 Fog No 5201 og No 201NUTTS2 Timing : 8.00 a.m. to 8.30 p.m. Sunday : 8.00 a.m. to 12.30 p.m. 68 Rag Ne 58 at Fag No 80017     CANTATA 2a                             Reg Date 08/04/2021 Patient's Name MRS NEMADE KUSUM LAXMAN Patient ID No. 2201769 Age/Sex 68 Yrs / Female Reg DvTm + 08-04-2021 04:37pm Reff. By Dr. Nene Suhas;MBBS,DCH Sample Coll D/Tm 18-04-2021 04:37pm Sample Collected At Dhande Pathlab Diagnostics Pvt. Ltd Report DuTm +£ 08-04-2021 10:07pm Haemogram (CBC)  Investigation| Result i Reference Range  Haemoglobin 10.60 gms/dL 12.0- 15.0  RBC Count : 410 millcumm 38-58  Haematocrit (PCV) rh 33.40 % 36-47  MCV (Mean Corpuscular Volume) rh 8146 fL 83-101  MCH (Mean Corpuscular Hb) rh 25.85 ps 27-32  MCHC (Mean Corpuscular Hb Conc.) sh 34.74 gm/dL 32-36  RDW (Red cell Distribution Width) 2H 159 % 116-140  RBC Morphology : Predominantly Normocytic Normochromic.  Total WBC (Leucocyte) Count : 7230 Jeu mm 4,000 - 11,000  Neutrophils 74 % 40-75  Lymphocytes rh o18 % 20-40  Eosinophils : Ol % 1-6  Monocytes : 07 % 1-10  Basophils : 00 % 0-2  Absolute Neutrophil Count 2 5350 ‘umm 2000 - 7000  Absolute Lymphocyte Count : 1301 Jeu mm 1000 - 3000  Absolute Eosinophil Count » R ‘umm 20 - 500  Absolute Monocyte Count 2 506 ‘umm 200 - 1000  Absolute Basophil Count ome fu mm 0-100  Platelet Count : 190000 feu mm 1,50,000 - 4,50,000  MPV (Mean Platelet Volume) 2 83 1 78-120  Platelet Remarks : Adequate  PBS For Parasit     Malarial Parasites Not Seen  EDTA Whole Blood - [Tests done on fully automated five part Haematology analyzer , XNLSEO, (Sysmex) BC-6800 Plus (Mindray). WBC, RBC, Platelet count by Impedance method, WBC Differential by Fluorescent Flowcytomety & other parameters are calculated | Differential WBC count Platelet Count are corelated ‘microscopically. All abnormal Haemograms are reviewed and confirmed microscopically  (R= Rechecked,     igh, L= Low)  End Of Report-"
PRESCRIPTION,"  Dr. Hemant Manjrekar  M.D. (Medicine), D.C.H.  Consulting Physician (Regi. No. 51039)  Consulting Room :  7, Siddharth Complex,  Aaykar Colony,  Paud Road,  Pune - 411 038,  Tel. - Clinic 8805553407 8805005550  Email - hmanjrekar@yahoo.com                                Date + 12-03-2021 02:05 Ph Mobile No. + 9765058282 Sex :M 118/58mmofHg, Fasting- 108, PP- 210 Lunch Dinner | Days ma 1 10 AWA aes 12U 90 A ey (eae ie (Ps 90 _ 90 a B a 1 0 Fact s 2 [eso |tsF 9 ena) eC 10 ont                             nt)  Vy "
REPORT,"GENERAL DIAGNOSTICS Prevent Life Care (P) Lid  Plot 6, Sector- 24, Navi Mumbai Maharashiva, India. Pn - 400705     General G DIAGNOSTIC                Tet: +91-22-40450000 ee! : 21 Year(s) 0 Months(s)0 ANKITA KALSHETTI AgeiGender: pi Yew Referred By NA (eat Name: NA Catlecion Date 31-03-2021 19:55:00 Report cease Date: 01-04-2021 0:00:00, Lipid Profile Total Cholesterol m2 Desirable: <200 mpd  Borderline high = 200-2: High: > 240  Triglycerides 750 Desirable: <150 mill Borderline High: 150 - 199 High: > 200-499  3 HDL-Cholesterol 326 30-0 mei.        4 LDL Cholesterol 103.60 Opeimat:<100; mitt ‘Near Optimal: 100-129;  Serum, Method: Phototry Neat Opa: 100125        High: 160-18 Very high: >190 5 Cholesterol HDL ratio. Optimal: 3.5 Serum, Meth: Calculated Near Optimal: 3.5 - 5.0 High 250 6 VLDL Cholesterol 15.00 6-40 mei. 7 Now HDL Cholesterol 118.60 Desirable: <130 mill  Borderline high: 130-159 High 160-189 Very High 190  8 LDL MDL ratio 197 Optimal: 2.5 Near Optimal: 25-35 High 25  Interpretation        cs are very hig an 1000 mg/l its i children ‘dramatically in response to meals, increasing as much as $ to 10 gher than fasting levels just a few hours after eating. Even fasting levels vary considerably day to day. Therefore, modest changes in fasting twiglycerides measured on different days are not considered to be abnormal              2. HDL-Cholesterol: HDL- C is considered to be beneficial, the so-called ""good"" cholesterol, because it removes excess cholesterol from tissues and carries itt the liver for disposal. If HDL-C is less than 40 mg/dL. for men and less than 50 mg/dl for women, there is an increased risk of heart disease that is independent of other risk factors, including the LDL-C level. The NCEP guidlines suggest that an HDL cholesterol value greater than 60 mgs protective and shouldbe treated sa negative risk factor.           3. LDL-Cholesterol: Desired goals for LDL-C levels change based on individual risk factors. For young adults, less than 120 ‘mg/dl. is acceptable. Values between 120-159 mg/dL. are considered Borderline high. Values greater than 160 mg/dL. are considered high, Low levels of LDL cholesterol may be seen in people with an inherited lipoprotein deficiency and in people with hyperthyroidism, infection, inflammation, or cirrhosis,             CRM No :2299042 uP . Sample Received Time: 31-03-2021 20:00:41     Iepert Relea Date: 01-04-2021 00:00:00 Authorized Signatory Authorized Signatory Patio Name: ANKITA KALSHETTI a Dr. Mahesh Hampe ean Des DCP, DNB (Pathology) MD (Biochemistry) Page $ of 10     iacleissplecs cnet Acs tarasiiaaniiamtesiiainiails iaetiesintiaiash en tata iennigas "
REPORT," GENERAL DIAGNOSTICS ms G Preven Lier Lt ja) mo © General Pus Secors 2a NevMnbs! | = & Gb bikénosnc Navara, Pa“ #00708 a ce for sot 224045000 z PME. )  Name: ANKITA KALSHETTI Aas/Gender: Fh eee a = NA Cnt Nae NA  Liver Function Test  1 iti eu ost on12 mw Auevaed Siaery Autor Sigmon  Report Release Date: 01-04-2021 00:00:00, Patiat Name: ANKITA KALSHETTI Patient ID: 2299942  Dr. Dina Abbani DCP, DNB (Pathology)  To view your report,  Dr. Mahesh Hampe  MD (Biochemistry) Page 4 of 10  log in ww preventine orgieports. Feed your Patient ID to download your report. "
REPORT,"REPORT ABHAY A PATIL ADITI, BHUSARI COLONY KOTHRUD  Tel No: 9823147602,  PID NO: 68144 Age:41.09 Years Sex: MALE  Complete Blood Count (EDTA Whole Blood, Automated Cell Counter)  Result  Hemoglobin, EDTA whole blood 13.10 Total Leucocytes (WBC) count 9,900 Platelet count 307,000 Red blood cell count 4.90 PCV (Packed Cell Volume) 39.90 MCV (Mean Corpuscular Volume) 81.50 MCH (Mean Corpuscular Haemoglobin) 26.80  MCHC (Mean Corpuscular Haemoglobin Concentration) 32.90  Differential Count  Neutrophils 59 Absolute Neutrophils 5,841 Eosinophils 5 Absolute Eosinophils 495 Basophils ] Absolute Basophils ti] Lymphocytes 32 Absolute Lymphocytes 3,168 Monocytes 4 Absolute Monocytes 396 - kK REE Page 1 of 7                      METROPOLIS  EXCELLENCE IN DIAGNOSTICS Isr your heslth, nothing [ess willl da  Reference:Dr.PHADNIS MADAN, MD     SID: 130003608 130003608 Collection Date: 07/04/2013 09:57 AM Sample Date: 07/04/2013 09:57 am Report Date: 07/04/2013 01:44 pm  Biological Reference Interval Male : 14.0 - 17.50 gm/dl  Female : 12.3 - 15.3 gm/dl  Male & Female : 4,000 - 10,000 /uL 150,000 - 450,000 /uL  Male : 4.5 - 5.9 X 10°6 / pl Female : 4.1 - 5.1 x 10°6 / ul  Male : 41.50 - 50.40 % 80.0 - 96.0 fL 27.5 - 33.2 pgms  33.4 - 35.5 gm/dL  % 2,000 - 7,000 /uL  % 0 - 500 /uL  % 0 - 100 /uL  % 1,000 - 3,000 /uL  % 0 - 1000 /uL  Dr. Ajit S Golwilkar, MD, DCP Regn.No.: 32660       Tel.: 020-4100 8200 } 2566 6612 Email: drgl@metropolisindia.com      _x000c_"
REPORT,"REPORT ABHAY APATIL Reference:Dr.PHADNIS MADAN, MD SID: 130003608  ADITI, BHUSARI COLONY 130003608 KOTHRUD Collection Date:  07/04/2013 09:57 AM Tel No: 9823147602, Sample Date:  07/04/2013 09:57 am PID NO: 68144 Report Date: Age:41.09 Years Sex: MALE 07/04/2013 01:44 pm     Peripheral Blood Smear Examination  R.B.C. Morphology : Normocytic, Normochromic W.B.C. Abnormalities : Not detected Platelets : Adequate Parasites : Not detected Comment :o=- Dr. Ajit S Golwilkar, MD, DCP Regn.No.: 32660 Page 2 of 7                     METROPOLIS  EXCELLENCE IN DIAGNOSTICS ier your heslth, nothing [ems willl de       'Tel.: 020-4100 8200 / 2566 6612 Email; drgl@metropolisindia.com        _x000c_"
REPORT,"REPORT ABHAY APATIL Reference:Dr.PHADNIS MADAN, MD SID: 130003608  ADITI, BHUSARI COLONY 130003608 KOTHRUD Collection Date:  07/04/2013 09:57 AM Tel No: 9823147602, Sample Date:  07/04/2013 09:57 am PID NO: 68144 Report Date: Age:41.09 Years Sex: MALE 07/04/2013 01:44 pm     Test Description Observed Value Biological Reference Interval Lipid Profile Mini:  Cholesterol (Total), serum by Enzymatic method 177 a NCEP Guidelines  Triglycerides, serum by Enzymatic method 108 NCEP Guidelines  HDL Cholesterol, serum by Enzymatic method 44 wa NCEP Guidelines  VLDL Cholestrol, serum by calculation 22 5 to 51 mg/dL LDL Cholesterol, serum 111 NCEP Guidelines Cholesterol(Total)/HDL Cholesterol Ratio 4,02 Males : Acceptable ratio </= 5.00  Females : Acceptable ratio </= 4.50  LDL Cholesterol/HDL Cholesterol Ratio 2.53 Males : Acceptable ratio </= 3.60 Females : Acceptable ratio </= 3.20  NCEP Guidelines  Desirable Borderline Undesirable Totai Cholesterol (mg/dl) Below 200 200-240 Above 240 HDL Cholesterol! (mg/dl) Above 60 40-59 Below 40 Triglycerides (mg/dl) Below 150 150-499 Above 500 LDL Cholesterol (mg/dl) Below 130 130-160 Above 160 - Dr. Ajit S Golwilkar, MD, DCP Regn.No.: 32660 Page 3 of 7              METROPOLIS  EXCELLENCE IN DIAGNOSTICS Isr your heslth, nothing [ess willl da                 Tel: 020-4100 8200 / 2566 6612 Email: drgl@metropolisindia.com    _x000c_"
REPORT,"REPORT ABHAY APATIL Reference:Dr.PHADNIS MADAN, MD SID: 130003608     ADITI, BHUSARI COLONY 130003608 KOTHRUD Collection Date:  07/04/2013 09:57 AM Tel No: 9823147602, Sample Date:  07/04/2013 09:57 am PID NO: 68144 Report Date: Age:41.09 Years Sex: MALE 07/04/2013 01:44 pm  Test Description Observed Biological Reference Interval  Liver Function Test :  Bilirubin-Total, serum by Diazo method 0.46 0.10 - 1.20 mg/dL Neonates : Upto 15.0 mg/dL  Bilirubin-Conjugated, serum by Diazo method 0.08 Upto 0.3 mg/dL Bilirubin-Unconjugated, serum by calculation 0.38 0.1 to 1.0 mg/dL SGOT (AST), serum by Enzymatic method 32 Upto 35 IU/Lt SGPT (ALT), serum by Enzymatic Method 45 30 - 65 U/Lt Alkaline Phosphatase,serum by pNPP-kinetic 78 Adult Male : 20 - 130 IU/Lt Protein (total), serum by Biuret method 7.86 6.4 to 8.2 gm/dL Albumin, serum by Bromocresol purple method 4.08 3.2 to 4.5 gm/dL Globulin, serum by calculation 3.78 2.3 - 3.5 gnvdL —XX--  Dr. Ajit S Golwilkar, MD, DCP Regn.No.: 32660  Page 4 of 7              METROPOLIS  EXCELLENCE IN DIAGNOSTICS Isr your heslth, nothing [eae willl da            Tel: 020-4100 8200 } 2566 6612 Email: drgl@metropolisindia.com        _x000c_"
REPORT,"REPORT ABHAY APATIL Reference:Dr.PHADNIS MADAN, MD SID: 130003608     ADITI, BHUSARI COLONY 130003608 KOTHRUD Collection Date: 07/04/2013 09:57 AM Tel No: 9823147602, Sample Date: 07/04/2013 09:57 am PID NO: 68144 Report Date: Age:41.09 Years Sex: MALE 07/04/2013 01:44 pm Test Description Observed Value Biological Reference Interval TEST NAME Glycated Hemoglobin (HbA1C), by HPLC 6.40 %  Interpretation :  For diagnosis of Diabetes Mellitus </=5.4% :Normal 5.5 % - 6.4% : High risk / prediabetes; requires screening by plasma glucose criteria. >/=6.5% : Diabetes; confirmed by repeating test on different day.  For monitoring of Diabetes Mellitus, HbA1C target goal : ADA (2009) < 7% AACE (2011) </= 6.5%  Dr. Ajit S Golwilkar, MD, DCP Regn.No.: 32660  Page 5 of 7              METROPOLIS  EXCELLENCE IN DIAGNOSTICS Isr your heslth, nothing [ess willl da          'Tel.: 020-4100 8200 / 2566 6612 Email: drgl@metropolisindia.com         _x000c_"
REPORT,"ABHAY ASHOK PATIL Reference:Dr.PHADNIS MADAN, MD ADITI, BHUSARI COLONY SID: 160614473 KOTHRUD Collection Date: 01/02/2017 08:43 AM REPORT Sample Date: 01/02/2017 08:43 am PID NO: 68144 Report Date: Age:45.07 Years Sex: MALE 01/02/2017 06:47 PM Test Description Observed Value Biological Reference Interval TEST NAME Glycated Hemoglobin (HbA1C), by HPLC 6.90 %  Interpretation :  For diagnosis of Diabetes Mellitus </=5.7% :Normal 5.7 %- 6.4% : High risk / prediabetes; requires screening by plasma glucose criteria. >/=6.5% : Diabetes; confirmed by repeating test on different day.  Ref : ADA (Standards of Medical Care in Diabetes - 2017)  For monitoring of Diabetes Mellitus, HbA1C target goal :  ADA (2017) < 7%  The A1C target should be individualized based on numerous factors, such as age, life expectancy, comorbid conditions, duration of diabetes, risk of hypoglycemia or adverse consequences from hypoglycemia, patient motivation, and adherence.  Page 5 of 9 prt, DPB Reg.Now 6o209  GOLWILKAR  METROP@LIS }  Pathology Sp                             _x000c_"
REPORT,"ABHAY ASHOK PATIL Reference:Dr.PHADNIS MADAN, MD  ADITI, BHUSARI COLONY SID: 160614473  KOTHRUD Collection Date:  01/02/2017 08:43 AM  REPORT Sample Date: 01/02/2017 08:43 am  PID NO: 68144 Report Date:  Age:45.07 Years Sex: MALE 01/02/2017 06:47 PM     Test Description Observed Value Biological Reference Interval Haematology : Erythrocyte Sedimentation Rate, EDTA Whole Blood 16 Male under 50 Yrs : Upto 15mm/hr  Mak 50 - 85 Yrs : Upto 20mm/hr. Results corrected to 18 deg. celsius  Technique : Automated Westergren Method.  Clinical Chemistry  Creatinine, serum by Jaffe w/o deproteinization 0.79 0.6 to 1.2 mg/dL Urea, serum by GLDH-urease 17 17 to 49 mg/dL Uric Acid, serum by Uricase method 5.30 Male : 3.50 to 7.20 mg/dL  The major causes of hyperuricemia are increased purine synthesis, inherited metabolic disorder, excess dietary Purine intake, increased nucleic acid turnover, malignancy, cytotoxic drugs and decreased excretion due  to chronic renal failure or increased renal reabsorption .  Hypouricemia is much less common than hyperuricemia. It may be secondary to severe hepatocelfular disease with redticed purine synthesis, defective renal tubular reabsorption, overtreatment of hyperuricemia with allopurinol, as well as some cancer therapies (eg, 6-mercaptopurine).  wf ! a { . ’ . ” - 4 in s, i a 4) isha S. Pa dh Page 6 of 9 Prt, DPB Reg.Now 68229       Maen ast  e. Pathology Sp:                      _x000c_"
REPORT,"Reference:Dr.PHADNIS MADAN, MD  ABHAY ASHOK PATIL ADITI, BHUSARI COLONY SID: 160614473 KOTHRUD Collection Date: 01/02/2017 08:43 AM REPORT Sample Date: 01/02/2017 08:43 am PID NO: 68144 Report Date: 01/02/2017 06:47 PM     Age:45.07 Years Sex: MALE  Observed Value Biological Reference Interval  Test Description Clinical Chemistry :  Hormones 0.40 - 4.00 pIU/mL  TSH(Ultrasensitive), serum by CMIA 2.35 Ref: NACB guideline 2002 s 7 - Ls i i M 4 ve fe . \w é a r é ” — ws <0 if wae 4, \ . \- ~ ’ - 4 s, h alee Page 7 of 9  GOLWILKAR  METROP@LIS }  Pathology Sp "
REPORT,"ABHAY ASHOK PATIL Reference:Dr.PHADNIS MADAN, MD ADITI, BHUSARI COLONY SID: 160614473 KOTHRUD Collection Date: 01/02/2017 08:43 AM REPORT Sample Date: 01/02/2017 08:43 am PID NO: 68144 Report Date: Age:45.07 Years Sex: MALE 01/02/2017 06:47 PM Test Description Observed Value Biological Reference Interval TEST NAME Microalbumin in Urine, by Immunoturbidimetery 1.60 Upto 30 mg/Lt Interpretation :  1, Microalbuminuria refers to albumin excretion that is above normal range but below the level of detection of of routine tests for protein in urine.  2. Microalbuminuria (defined as excretion of > 30 mg / Litre of albumin per day or an albumin creatinine ratio of 30 - 299 pg/mg in a random urine specimen) is an early indicator of chronic kidney disease due to diabetes, hypertension & glomerular disease.  3. it is also an important risk factor for cardiovascular disease.  4. Confirmation of microalbuminuria should be based on repeat testing over a 2 to 3 months period.  a 5 isha S. Pa dh: Page 8 of 9 Pri, DPB Reg.Now 6209  GOLWILKAR  METROP@LIS }  Pathology Sp"
REPORT,"ABHAY ASHOK PATIL Reference:Dr.PHADNIS MADAN, MD ADITI, BHUSARI COLONY SID: 160614473 KOTHRUD Collection Date: 01/02/2017 08:43 AM REPORT Sample Date: 01/02/2017 08:43 am PID NO: 68144 Report Date: Age:45.07 Years Sex: MALE 01/02/2017 06:47 PM        Urine Routine Examination  (Sample : Urine) Result Biological Reference Interval Physical  Quantity Examined 5.0 ml  Appearance Clear -  Colour Pale yellow -  Chemical (Dipstick)  pH 5.5 4.6 - 8.0 Protein Absent Absent Glucose Absent Absent Acetone Absent Absent Bile Pigments Absent Absent Urobilinogen Not significant Not Significant Microscopy _ R.B.Cs Absent 0 - 2 per hpf . sy Pus cells 1-2 0 - 5 per hpf ; ah ve Epithelial cells Occasional 0 - 5 per hpf ¢ or Casts Not Detected - Crystals Not Detected . - ‘ - - <> _- “% 7 > ad “, . . r i. Wo : End of Report on \ ~  ” : - 4 s, h Dr.(Mrs.) Manisha S. Patwardh Page 9 of 9 ie MD, DPB Reg.No.: cone              GOLWILKAR  METROP@LIS }  Pathology Sp                 _x000c_"
REPORT,"VIDYA ABHAY PATIL Reference:Dr.PATWARDHAN AVANTI., MBE SID: 170538471 Collection Date: 27-07-2017 11:12 AM  REPORT Sample Date: 27-07-2017 11:12 am  PID NO: 88523 Report Date:  Age:40.02 Years Sex: FEMALE 8-07-2017 06:06 PM     Test Description Observed Value Biological Reference Interval Clinical Chemistry : Uric Acid, serum by Uricase method 5.40 Female : 2.60 to 6.00 mg/dL  The major causes of hyperuricemia are increased purine synthesis, inherited metabolic disorder, excess dietary purine intake, increased nucleic acid turnover, malignancy, cytotaxic drugs and decreased excretion due  to chronic renal failure or increased renal reabsorption .  Hypouricemia is much less common than hyperuricemia. It may be secondary to severe hepatocellular disease with redticed purine synthesis, defective renal tubular reabsorption, overtreatment of hyperuricemia with allopurinol, as well as some cancer therapies (eg, 6-mercaptopurine).  4 re       Or. Sneha Dhawale, D.C.P., D.N.B.(Path) Reg.No.: 2006/03/1650 Page 1 of 2              Maen ase  Pathology Sp             _x000c_"
REPORT,"VIDYA ABHAY PATIL  REPORT  PID NO: 88523 Age:40.02 Years Sex: FEMALE  Reference:Dr.P ATWARDHAN AVANTI., MBE  SID: 170538471 Collection Date: 27-07-2017 11:12 AM Sample Date: 27-07-2017 11:12 am Report Date: 8-07-2017 06:06 PM     Test Description Observed Value Hormones: FSH - Follide Stimulating Hormone, Serum by CMIA( 5.58 4 Days Of Cyde ) LH-Leutinising Hormone Specific, serum by CMIA 4.48 DOCc:4 Out-Sourced Testing* Free Testosterone, Serum by CLIA 0.50  Sample is processed at Metropolis Healthcare Ltd., Mumbai 4  “w  End of Report  Page 2 of 2  GOLWILKAR  METRO     Biological Reference Interval  Females :  14- 16 yrs : 0.9 - 12.4 mIU/mL Follicular phase : 3.03 -8.08 mIU/mL Mid-cycle : 2.55 - 16.69 mIU/mL Luteal phase : 1.38 - 5.47 mIU/mL Menopausal : 26.72 - 133.41 mIU/mL  Female :  15 yrs : 0.5 - 20.7 mIU/mL  16 yrs : 0.4 - 29.4 mIU/mL  Adult :  Follicular phase : 1.80 - 11.78 mIU/mL Mid-cycle peak : 7.59 - 89.08 mIU/mL Luteal phase :0.56 - 14.00 mIU/mL Post-menopausal :(Without HRT) 5.16- 61.99 mIU/mL  Method ; CLIA  9 yrs day - 17 yrs: 1.0 - 5.2 pg/ml  Adult : 0.2 - 4.1 pg/ml  Follicular phase : 0.45 - 3.17 pg/ml  Luteal phase : 0.46 - 2.48 pg/ml  Oral contraceptives :0.55-2.01 pg/ml + Post Menopausal ; 0.29 - 1.73 pg/ml  % a os             Or. Sneha Dhawale, D.C.P., D.N.B.(Path) Reg.No.: 2006/03/1650      _x000c_"
REPORT,"ABHAY ASHOK PATIL ADITI, BHUSARI COLONY KOTHRUD  REPORT  PID NO: 68144 Age:46.04 Years Sex: MALE  Complete Blood Count                                 (EDTA Whole Blood, Automated Cell Counter) Result Hemoglobin, EDTA whole blood 11.70 Total Leucocytes (WBC) count 9,700 Platelet count 326,000 Red blocd cell count 4.94 PCV (Packed Cell Volume) 36.50 MCV (Mean Corpuscular Volume) 73.90 MCH (Mean Corpuscular Haemoglobin) 23.70 MCHC (Mean Corpuscular Haemoglobin Concentration) 32.10 RDW (Red blood cell distribution width) 14.80 Differential Count Neutrophils 51 Absolute Neutrophils 4,947 Eosinophils 10 Absolute Eosinophils 970 5 Basophils 0 A Absolute Basophils 0 Lymphocytes 32 Absolute Lymphocytes 3,104 wn, Monocytes 7 . Absolute Monocytes 679 - th. y Page 1 of 9  GOLWILKAR  Reference:Dr.--  SID: 170540232 Collection Date: 08-11-2017 09:46 AM Sample Date: 08-11-2017 09:46 am Report Date:  08-1 1-2017 05:03 PM  Biological Reference Interval 14.0 - 17.50 g/dL  4000-10000/pL 150000 - 450000 /uL 4.50 - 5.90 x 10°6 /uL 41.5 - 50.4 %  80.0 - 96.0 fL  27.5 - 33.2 pgms 33.4 - 35.5 g/dL 11.6- 14.0%  40 - 80%  2000 - 7000 /uL  s . — 1-6% * a 20 - 500 /uL  0-2% a 0-100 /uL ° ~e  20-40 % 1000 - 3000 /uL  a «4 2-10% Be :  * 200 - 1000 JUL vos  aL Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864      _x000c_"
REPORT,"ABHAY ASHOK PATIL Reference:Dr.-- SID: 170540232  ADITI, BHUSARI COLONY Collection Date:  KOTHRUD 08-11-2017 09:46 AM REPORT Sample Date: 08-11-2017 09:46 am PID NO: 68144 Report Date:  08-11-2017 05:03 PM  Age:46.04 Years Sex: MALE     Complete Blood Count  R.B.C. Morphology : Mild hypochromia, mild microcytesis. W.B.C. Morphology : Mild eosinophilia Platelets : Adequate  Comment : Spoor SreD IRON,TIBC ESTIMATION, IRON SUPPLEMENT & FOLLOW  s - Le a) t x é . ‘\ é - , ra ot ! AS « if ae Ho 4 1 . ’ _ 4 , ‘, 5 Gee - Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864 Page 2 of 9  GOLWILKAR  METROP@LIS }  Pathology Sp                         _x000c_"
REPORT,"ABHAY ASHOK PATIL ADITI, BHUSARI COLONY KOTHRUD  REPORT  PID NO: 68144 Age:46.04 Years Sex: MALE  Reference:Dr.-- SID: 170540232 Collection Date: 08-11-2017 09:46 AM Sample Date: 08-11-2017 09:46 am Report Date: 08-11-2017 05:03 PM     Test Description Lipid Profile Mini:  Cholesterol (Total), serum by Enzymatic method  Triglycerides, serum by Enzymatic method  HDL Cholesterol, serum by Enzymatic method  VLDL Cholestro!, serum by calculation  LDL Cholesterol, serum by calculation  Cholesterol(Total)/HDL Cholesterol Ratio  LDL Cholesterol/HDL Cholesterol Ratio  NCEP Guidelines  Desirable Total Cholesterol (mg/dl) Below 200 HDL Cholesterol (mg/dl) Above 60 Triglycerides (mg/dl) Below 150 LDL Cholesterol (mg/dl) Below 130  GOLWILKAR     Observed Value Biological Reference Interval  245 ar — NCEP Guidelines 133 NCEP Guidelines 51 a ~ NCEP Guidelines 27 5 to 51 mg/dL 167 NCEP Guidelines 4.80 Males : Acceptable ratio </= 5.00 Females : Acceptable ratio </= 4.50 3.28 Males : Acceptable ratio </= 3.60 Females : Acceptable ratio </= 3.20 Borderline Undesirable _ 200-240 Above 240 % "". 40-59 Below 40 . 150-499 Above 500 130-160 4 Above 160 ve rf’ f. . “Ww ra - Fa ra wt ! ‘4 «° if os MoT i) 4 ~ ” ¥ : al 4 1 s, i ; Gee aL Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864 Page 3 of 9      _x000c_"
REPORT,"ABHAY ASHOK PATIL ADITI, BHUSARI COLONY KOTHRUD  REPORT  PID NO: 68144 Age:46.04 Years Sex: MALE  Test Description Liver Function Test :  Bilirubin-Total, serum by Diazo method  Bilirubin-Conjugated, serum by Diazo method Bilirubin-Unconjugated, serum by calculation SGOT (AST), serum by Enzymatic method SGPT (ALT), serum by Enzymatic Method Alkaline Phosphatase,serum by pNPP-kinetic Protein (total), serum by Biuret method Albumin, serum by Bromocresol purple method  Globulin, serum by calculation  GOLWILKAR          Page 4 of 9  Reference:Dr.--     Observed  0.31  25  33  73  7.82  4.08                       SID: 170540232 Collection Date: 08-11-2017 09:46 AM Sample Date: 08-11-2017 09:46 am Report Date: 08-11-2017 05:03 PM  Biological Reference Interval       0.10 - 1.20 mg/dL Neonates : Upto 15.0 mg/dL  Upto 0.3 mg/dL  0.1 to 1.0 mg/dL  15 - 37 U/Lt  Upto 65 U/Lt  Adult Male : 46 - 116 U/Lt 6.4 to 8.2 g/dL  3.4 to 5.0 g/dL  2.3 - 3.5 g/dL  aL Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864      "
REPORT," ABHAY ASHOK PATIL Reference:Dr.-- ADITI, BHUSARI COLONY SID: 170540232 KOTHRUD Collection Date: 08-11-2017 09:46 AM REPORT Sample Date: 08-11-2017 09:46 am PID NO: 68144 Report Date:        Age:46.04 Years Sex: MALE 08-11-2017 05:03 PM Test Description Observed Value Biological Reference Interval TEST NAME Glycated Hemoglobin (HbA1C), by HPLC 7.10 %  Interpretation :  For diagnosis of Diabetes Mellitus <5.7% :Normal 5.7%-6.4% : High risk / prediabetes; requires screening by plasma glucose criteria. >/=6.5% : Diabetes; confirmed by repeating test on different day.  Ref : ADA (Standards of Medical Care in Diabetes - 2017)  For monitoring of Diabetes Mellitus, HbA1C target goal :  ADA (2017) < 7%  The A1C target should be individualized based on numerous factors, such as age, life expectancy, comorbid conditions, duration of diabetes, risk of hypoglycemia or adverse consequences from hypoglycemia, patient motivation, and adherence.  *% a oe I x 4 * ra é. . \w é a r a a as « if wane no \ \ ~ a] ¥ - 4 sy *  aL Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864  Page 5 of 9              GOLWILKAR  METROP@LIS }  Pathology Sp                 _x000c_"
REPORT,"ABHAY ASHOK PATIL Reference:Dr.--  ADITI, BHUSARI COLONY SID: 170540232  KOTHRUD Collection Date:  08-11-2017 09:46 AM  REPORT Sample Date: 08-11-2017 09:46 am  PID NO: 68144 Report Date:  Age:46.04 Years Sex: MALE 08-1 41-2017 05:03 PM     Test Description Observed Value Biological Reference Interval Haematology : Erythrocyte Sedimentation Rate, EDTA Whole Blood 16 Male under 50 Yrs : Upto 15mm/hr  Mak 50 - 85 Yrs : Upto 20mm/hr. Results corrected to 18 deg. celsius  Technique : Automated Westergren Method.  Clinical Chemistry  Creatinine, serum by Jaffe w/o deproteinization 0.83 0.6 to 1.2 mg/dL Urea, serum by GLDH-urease 18 17 to 49 mg/dL Uric Acid, serum by Uricase method 4.90 Male : 3.50 to 7.20 mg/dL  The major causes of hyperuricemia are increased purine synthesis, inherited metabolic disorder, excess dietary Purine intake, increased nucleic acid turnover, malignancy, cytotoxic drugs and decreased excretion due  to chronic renal failure or increased renal reabsorption .  Hypouricemia is much less common than hyperuricemia. It may be secondary to severe hepatocelfular disease with redticed purine synthesis, defective renal tubular reabsorption, overtreatment of hyperuricemia with allopurinol, as well as some cancer therapies (eg, 6-mercaptopurine).  aL Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864  Page 6 of 9       Maen ast  e. Pathology Sp:                      _x000c_"
REPORT,"Reference:Dr.-- SID: 170540232  ABHAY ASHOK PATIL ADITI, BHUSARI COLONY KOTHRUD Collection Date: 08-11-2017 09:46 AM REPORT Sample Date: 08-11-2017 09:46 am Report Date:  PID NO: 68144 08-11-2017 05:03 PM     Age:46.04 Years Sex: MALE  Observed Value Biological Reference Interval  Test Description  Clinical Chemistry :  Hormones TSH(Ultrasensitive), serum by CMIA 3.08 0.40 - 4.00 IU/mL Ref: NACB guideline 2002 s 7 - Ls i i M é * \ é a te é ” ee “ a * * ‘ if woe nT \ ~ ” ’ - 4 ‘, h te “ Page 7ot9 Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864        GOLWILKAR  METROP@LIS }  Pathology Sp               _x000c_"
REPORT,"                       ABHAY ASHOK PATIL Reference:Dr.-- ADITI, BHUSARI COLONY SID: 170540232 KOTHRUD Collection Date: 08-11-2017 09:46 AM REPORT Sample Date: 08-11-2017 09:46 am PID NO: 68144 Report Date:        Age:46.04 Years Sex: MALE 08-11-2017 05:03 PM Test Description Observed Value Biological Reference Interval TEST NAME Microalbumin in Urine, by Immunoturbidimetery 6.40 Upto 30 mg/Lt Interpretation :  1, Microalbuminuria refers to albumin excretion that is above normal range but below the level of detection of of routine tests for protein in urine.  2. Microalbuminuria (defined as excretion of > 30 mg / Litre of albumin per day or an albumin creatinine ratio of 30 - 299 pg/mg in a random urine specimen) is an early indicator of chronic kidney disease due to diabetes, hypertension & glomerular disease.  3. it is also an important risk factor for cardiovascular disease.  4. Confirmation of microalbuminuria should be based on repeat testing over a 2 to 3 months period.  aL Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864  Page 8 of 9              GOLWILKAR  METROP@LIS }  Pathology Sp                 _x000c_"
REPORT,"                       ABHAY ASHOK PATIL Reference:Dr.--  ADITI, BHUSARI COLONY SID: 170540232  KOTHRUD Collection Date:  08-11-2017 09:46 AM  REPORT Sample Date: 08-11-2017 09:46 am  PID NO: 68144 Report Date:  Age:46.04 Years Sex: MALE Urine Routine Examination  08-11-2017 05:03 PM        (Sample : Urine) Result Biological Reference Interval Physical  Quantity Examined 5.0 ml  Appearance Clear -  Colour Pale yellow -  Chemical (Dipstick)  pH 6.0 4.6 - 8.0 Protein Absent Absent Glucose Absent Absent Acetone Absent Absent Bile Pigments Absent Absent Urobilinogen Not significant Not Significant Microscopy _ R.B.Cs Absent 0 - 2 per hpf . “y Pus cells 1-2 0 - 5 per hpf ; 4 ""* aad a . Epithelial cells Occasional 0 - 5 per hpf ¢ ¢ r Casts Not Detected - Crystals Not Detected . - ‘ - - <> a a “0 F veer Wo End of Report \ ~ ad : - 4 ‘, h . Gee aL Dr. Shubhangi Sasturkar, MBBS DCP Regn. No. 082864 Page 9 of 9              GOLWILKAR  METROP@LIS }  Pathology Sp"
